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CHAPTERl 
Introduction 
Chapter I 
Coronary heart disease (CHD) is an increasing global problem carrying heavy social 
and economic costs. Coronary heart disease is responsible for about 50% of 
cardiovascular mortality, which itselfs accounts for 30-50% of all deaths in developed 
nations t. It is the major cause of premature death, in women as in men - women 
lagging behind men by some ten years in this age-related disease. Knowledge on risk 
factors for CHD has accumulated in recent years. Research evidence now lends strong 
support to the view that CHD is in part preventable by reduction of modifiable risk 
factors. The greater the number of risk factors known to be causally related to the 
disease, the greater the power to reduce the disease burden in the community by 
reducing the levels of such pathogenic risk factors, though depending on the 
modifiability of the risk factors and their strength related to disease. Diet is among the 
modifiable risk factors and provides a simple and non-pharmacologic method for 
prevention of atherosclerosis and coronary heart disease. 
Steinberg and co-workeri hypothesized that low density lipoprotein (LDL) that has 
undergone oxidative damage is considerably more atherogenic than native LDL. 
Evidence that LDL oxidation occurs in vivo and contributes to the clinical 
manifestations of atherosclerosis supports the oxidative modification hypothesis. The 
link between oxidation of LDL and atherogenesis is hypothesized to be the basis for a 
beneficial effect of antioxidants on the incidence of subclinical and clinical coronary 
artery disease3• Observational studies have indicated that dietary antioxidants may 
exert a protective effect on incidence and mortality of coronary heart disease, though 
the evidence is not conclusive 4.'. Free iron has been implicated in lipid peroxidation 
and ischaemic myocardial damage, and it has been suggested that iron is an 
independent risk factor for myocardial infarction". Serum copper and ceruloplasmin as 
another complex of prooxidants operating through oxidative modification of LDL have 
been suggested to be independent risk factors for coronary heart disease7• 
The scope of this thesis is to describe and validate a new method of dietary assessment 
applied in the elderly population of the Rotterdam Study and subsequently focus on 
nutritional factors that may inhibit or promote the progression of atherosclerosis and 
coronary heart disease. 
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Dietary assessment in the elderly: validation of a semiquantitative 
food frequency questionnaire 
ABSTRACT 
Objective: The study was conducted to assess the relative validity of a l70-item 
semiquantitative food frequency questionnaire (SFFQ) adapted for use in the elderly. 
Desigll & sl/bjects: The study was carried out in a sample of 80 men and women aged 55 to 
75 years participating in a community based prospective cohort study in Rotterdam, The 
Netherlands. The two-step dietary assessment comprised a simple self-administered 
questionnaire (20 min.) followed by a structured interview with trained dietitians (20 min.) 
based on the completed questionnaire. Multiple food records (FR) collected over a one year 
period served as reference method. 24-h urine urea was used as indirect marker for protein 
intake. 
Resl/lts: Compared with FR, the SFFQ generally overestimated nutrient intake as reflected by 
difference in means and the ratio of SFFQ to FR. Energy adjustment reduced the observed 
overestimation. Pearson's corre1ation coefficients varied from close to 0.5 to about 0.9 for 
crude data, and after adjustment for age, sex, total energy intake, and for within-person 
variability in daily intake from 0.4 to 0.8. Cross-classification into quintiles resulted in correct 
classification into the same or adjacent quintile of 75.8% for crude and 76.8% for energy-
adjusted data. Validation of protein intake estimated by SFFQ with protein excretion from 
24-h urine urea indicated overestimation of protein intake by SFFQ. Spearman correlation 
coefficient between protein intake estimated from urea excretion and SFFQ was 0.67. 
COIlc/l/sioIlS: Adaptation of a SFFQ for use in the elderly resulted in a valid and time-
efficient dietary assessment instrument. Its ability to adequately rank study subjects according 
to their dietary intake supports its application in epidemiological studies in the elderly. 
7 
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INTRODUCTION 
Dietary assessment has been difficult in epidemiological studies in elderly populations. 
Limited recall due to fading memory or disabilities in sight or attention may require a 
more complicated approach and may result in a higher respondent burden I.' and low 
participation rate. To simplify dietaJY assessment we adapted a previously validated 
semiquantitative food frequency questionnaire3 •• for use in an elderly population. This 
paper describes the relative validity of the modified semiquantitative food frequency 
questionnaire (SFFQ) as compared to 15-d food records (FR) over a one year period in 
a sample of 80 men and women aged 55 to 75 years. As external marker for protein 
intake mean 24-h urine urea excretion of four non-consecutive days was used. The 
validity of the questionnaire is primarily defined as its ability to rank study subjects 
according to nutrient intake. Since the performance of any questionnaire also depends 
on the actual study population the present validation study was conducted within the 
population-based cohort of the Rotterdam Study. 
METHODS 
Subjects 
Subjects recl1lited for the validation study comprised a sub-sample of the population-
based Rotterdam Stud/ participating in a randomized double blind trial examining the 
effect of a reduced sodium and increased potassium and magnesium dietary intake au 
mild hypertension. Exclusion criteria were history of myocardial infarction, angina 
pectoris, diabetes mellitus, impaired renal function, a salt restricted diet on medical 
advice or antihypertensive treatment as previously described". Of the 100 subjects (51 
men, 49 women) enrolled in the study, complete follow-up was achieved in 97 persons. 
Two persons withdrew because of admission to hospital and one person because of 
other reasons. Dietary assessment by FR and SFFQ during the course of the validation 
study was successfully completed by 80 subjects (39 men, 41 women; pat1icipation 
rate 82.5%). Reasons for drop out during the one year period of dietary assessment 
were attributable to refusal and to unavailability or inability to manage keeping a food 
record diary. 
Study design 
Dietary assessment in the current validation study was undertaken as outlined in 
8 
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figure 1. Multiple food records collected over a year to cover all seasons with respect 
to different food consumption patterns served as reference method. In total, fifteen 
days of food records distributed over six collection periods were obtained. Collection 
period one, five, and six consisted of each three consecutive days of dietary 
assessment. Collection period two, three, and four consisted of each two consecutive 
days of dietary assessment and fell in the intervention period of the trial6• The fifteen 
recording days were balanced across the days of the week. The modified semi-
quantitative food frequency questionnaire (SFFQ) applied covered the habitual food 
intake during the preceeding year. It was administered during baseline recruitment of 
the Rotterdam Study and approximately two months after completion of the last three-
day period of dietary assessment. Data for both SFFQs were obtained in 71 subjects 
and were used to estimate reproducibility of the SFFQ. The second SFFQ was used for 
assessment of relative validity of the SFFQ compared to FR. 
Measurements 
Semiquantitative food frequency questionnaire (SFFQ) 
The SFFQ aims to assess habitual food intake during the past year. It contains 170 food 
items in 13 food groups and questions about dietary habits, supplementation, and 
prescribed diets. It is a version of a previously validated SFFQ3.4 adapted for use in the 
elderly. The two-step dietary assessment comprised a simple self-administered 
questionnaire (20 minutes) followed by a structured interview with a dietitian (20 
minutes allocated) based on the completed questionnaire. This method increases time 
efficiency and facilitates measuring diet in elderly subjects. The self-administered 
questionnaire consisted mainly of a meal-based checklist of foods which was filled in at 
home. Participants had to mark the foods they had consumed at least twice a month in 
the preceding year. The dietary interview was conducted at the study center by dietitians. 
The dietitians aimed at obtaining accurate information on amount and consumption 
frequency of food items noted by participants as consumed frequently in the 
questionnaire. For each item the frequency was recorded in times per day, week, or 
month. The number of servings per frequency was expressed in natural units (e.g. slice of 
bread, apple), household measures (e.g. cup, spoon) or grams (cooked vegetables, mixed 
dishes). Additional information about dietary habits, supplement use, (e.g. type, amount, 
frequency), and prescribed diets during the past year was also obtained. 
9 
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Figure 1: Study design valid.tion study 
Time frame 1990- SeptJOct Dec/Jan FeblMar Apr/May JunlJul Jul/Aug SeptJOct 
1992 1992 1992/3 1993 1993 1993 1993 1993 
Stalus Baseline Baseline End of 
Rotterdam Validation Validation 
Study Study Study 
Measurements SFFQ SFFQ 
3·dFR 2-d FR 2-dFR 2-d FR 3·dFR 3-d FR 
24-h urine 24-h 24-h 24-h 
urine urine urine 
SFFQ semiquantitative food frequency record 
FR food record 
Food records (FR) 
The food record method was introduced and explained prior to the first recording 
period during a home visit by a dietitian. A food record diaty including written 
instructions and examples was handed out. During the home visit the dietitian asked 
the participant to fill commonly used tableware and cutlery (glasses, spoons etc.) with 
water and recorded the obtained volume. Furthermore, the amount of butter, 
margarine, jam, spreads, cheese, and meat products used on bread were weighed and 
recorded, as was the amount of milk and sugar used in tea and coffee. Completed food 
record diaries were collected at the next visit to the study center. A dietitian checked 
for completeness of the food records while participants were present to answer any 
arising questions. Food records obtained during the dietary assessment collection 
period two to four fell into the intervention period of the trial (figure 1). Subjects 
assigned to the intervention group received a mineral salt for use in cooking and at the 
table (sodium:potassium:magnesium 8:6:1 mmol; SagaSaU© [Akzo Nobel, 
Netherlands) and certain foods prepared with mineral salt. Controls received common 
salt and foods. Study foods included bread, cheese, meat products, and canned and 
instant soups. Salt and foods for both groups looked identical and were provided free-
of-charge by means of a double blind coding system based on the randomization 
10 
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numbers. Participants were asked to avoid changes in dietary habits and lifestyles 
during the intervention period. Whether they adhered to the protocol was checked by 
direct questioning. Provision of free-of-charge foods was monitored. To check if 
provision of free-of-charge foods influenced food and nutrient intake during this 
period, food group and estimated nutrient intakes were calculated separately for 
intervention (6 days ofFR) and non-intervention period (9 days ofFR). Differences in 
mean food intake due to intervention were evaluated by analysis of variance. Food 
intake during the intervention period was significantly higher for bread (146 vs. 139 
gld; P = 0.047), cheese (59 vs. 48 gld; p < 0.001), and soups (300 vs. 269 gld; 
P = 0.045) and significantly lower for vegetables (188 vs. 207 gld; p = 0.018). 
Increased consumption of bread, cheese, and soups points towards elevated use of 
foods provided free-of-charge during the intervention period. However, decreased 
consumption of vegetables and increased consumption of soups may rather be 
attributable to seasonal influence, since the intervention period took place from 
December to May (figure I). Food consumption during the intervention period 
translated into a statistically significant increased intake for energy, total protein, 
vegetable protein, total fat, monounsaturated fat, saturated fat, pyridoxine, niacin, 
sodium, calcium, and zinc. Adjustment for energy removed these effects for all 
nutrients except for iron, calcium, and sodium. To evaluate whether the intervention 
period affected the questionnaires ability to adequately rank study subjects according 
to their intake we compared Pearson's correlation coefficients between SFFQ and FR 
with (15-d FR) and without (9-d FR) the intervention period. Differences observed 
were in general minor. Deviations larger than 0.05 between the correlation coefficients 
of9-d and 15-d of food records were only observed for saturated fat (0.50 versus 0.58), 
cholesterol (0.46 versus 0.53), mono/disaccharides (0.63 versus 0.70), and thiamine 
(0.50 versus 0.60) Given that an effect due to intervention was not Clearly 
distinguishable from seasonal influence and because all seasons were to be balanced, 
we decided to consider IS days of food recording for the present analysis. 
Calculation of intake of nutrients and food groups 
Mean individual nutrient intake per day was calculated from the FR as the average of 
the fifteen recording days. SFFQ data were converted to mean daily intake by 
multiplying consumption frequency, number of serving units and weight of unit (either 
standard or individual). The weight of a standard was derived from common Dutch 
II 
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household measures. If the number of servings was omitted, the median number among 
all other questionnaires was taken instead. FR and SFFQ data were both converted to 
nutrient intake using the computerized Dutch Food Composition Table'. Nutrient intake 
through nutritional supplements was not considered since brand labels were not recorded 
with sufficient accuracy. For calculation of sodium intake only the sodium content of 
foods was considered. 
Urine collections 
Seventy-six participants completed the collection of four non-consecutive 24-h urine's 
as outlined in figure l. They were instructed both in writing and orally about the 
method of urine collection and the necessity to obtain a complete 24-h urine collection. 
Completeness of the 24-h urines was checked by direct questioning when the urines 
were handed in. Data on the urine container were verified and, if necessary, missing 
information was obtained from participants. Urine samples were stored at _20°C before 
analysis. The urea concentration (mmolll) was determined by spectrophotometry and 
multiplied by urine weight to obtain total urea (gld). Assuming that urea N is a 
constant proportion (85%) of urinary nitrogen (Un)', protein intake from 24-h urine 
collections was estimated as 6.25 x (Un + 2) according to Isaksson9• A mean value of 
the four separate days was used to compare the estimated protein intake from urine 
excretion with the reported intake by FR and SFFQ. 
Assessment of underreporting on group level 
For evaluation of plausibility of dietary intake data, the ratio of energy intake (EI) to 
basal metabolic rate (BMR) was calculated. A cut-off depending on sample size and 
duration of dietary assessment identifYing minimum plausible levels of energy 
expenditure expressed as a multiple of basal metabolic rate (BMR) for groups was 
defined according to Goldberg et al.lO. Applying this cut-off enables detection of the 
extent of gross underreporting. In the current validation study BMR was predicted 
from standard equations based on the age-specific fonnulae published by Schofield et 
al. I '. Subsequently, the ratio of EI to BMR for both SFFQ and FR was calculated and 
used for evaluation of underreporting that may have occurred and as a measure of 
external validation for intake of energy on group level. The cut-off for EIIBMR was 
predicted with 95% confidence interval to be 1,48 for both men and women on group 
level for FR and SFFQ. 
12 
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Data analysis 
Means and standard deviations for energy, nutrients, and energy-adjusted nutrients 
estimated by SFFQ and FR were calculated. Energy-adjusted nutrient intakes Were 
derived by adding the median nutrient intake to the residuals from regression analysis of 
nutrient on energy intake 12. In addition, the ratio of nutrient intake assessed by SFFQ to 
that assessed by FR and the difference between methods were calculated to enable a 
more detailed evaluation of agreement between methods. Mean differences in crude and 
energy-adjusted nutrient intake due to age and gender, period of dietary assessment, and 
day ofthe week were evaluated by analysis of variance. 
Relative validity of the SFFQ compared to the food record method was assessed by 
calculating Pearson's correlation coefficients (unadjusted and adjusted for age, sex, and 
energy) between nutrient estimates ofFR and SFFQ. To correct for variability in the day-
to-day variation of food record measurements, correlation coefficients were deattenuated 
using the variance ratio (within-person variance divided by between-person variance) 
calculated from the repeated FR13. 
To evaluate the ability of both methods to classifY individuals similarly in categories of 
nutrient intake, cross-classification of nutrient scores into quintile categories was carried 
out. Quintile categories were assigned for both assessment methods separately. The 
overall percentage of individuals classified into the same, the adjacent, or the extreme 
quintile category was determined. Furthennore, the study population was divided into 
quintile categories according to nutrient intake assessed by SFFQ. For each quintile 
category the corresponding mean nutrient intake as assessed from FR and SFFQ was 
calculated. 
Skewed nutrient distributions were log-transformed (protein, total fat, saturated fat, 
monounsaturated fat, polyunsaturated fat, cholesterol, linolenic acid, 
mono/disaccharides, niacin, sodium, phosphorus, and magnesium) to reduce skewness 
and approximate normality. All statistical tests were performed on the transformed data. 
Analysis was performed by use of SAS® (Release 6.10; SAS Institute, Cary, NC, USA). 
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RESULTS 
Table I shows selected characteristics for participants of the validation study and 
participants of the Rotterdam Study for whom dietary data were obtained during 
baseline recruitment. In general, there were no marked differences between both 
groups. Participants ofthe validation study were slightly younger (66.7 vs. 67.7 years) 
and heavier (75.9 vs. 73.6 kg). They were less often current cigarette smokers (I8.8 vs. 
23.3%), less often on a prescribed diet (7.0 vs. 13.4%) and used more often 
supplements (42.9 vs. 35.4%). The proportion of those living in a single household was 
considerably lower (17.7 vs. 26.2). During the one year period of dietary assessment in 
the validation study 7.5% of the subjects gained more than 3 kg of body weight and 
18.8% lost more than 3 kg. A prescribed diet was followed by three women. None of 
them lost or gained more than 3 kg of body weight during the dietary assessment 
period. 
For women, the mean ratio of energy intake to basal metabolic rate (EIIBMR) was 
below the cut-off (1.48) for both methods of dietary assessment (SFFQ: 1.46; FR: 
1.41), whereas for men a value below the cut-off (1.48) was observed for FR (1.46) 
and above the cut-off for SFFQ (1.52). Comparison of EIIBMR for men and women 
combined with the predetermined cut-off indicates presence of underreporting of 
energy for FR (SFFQ: 1.49; FR: 1.44). Body mass index (BMI) was identified to be a 
determinant for underreporting of energy intake by SFFQ and FR. A significant 
inverse association (adjusted for age and sex) between BMI and EIIBMR (SFFQ: 
r = -0.29; P = 0.010; FR: r = -0.36; p = om I) was present. Other possible determinants 
in the OCCurrence of underreporting of energy such as weight change during the study 
or cognitive function showed no association with EIIBMR. 
Crude and energy-adjusted nutrient intakes were significantly different for men and 
women and were age-dependent. Analysis of variance revealed that energy and 
nutrient intake for the collection period of FR were significantly different between the 
collection periods for most macro nutrients (energy, total protein, vegetable protein, 
total fat, saturated fat, monounsaturated fat, polynnsaturated fat, total carbohydrates, 
mono/disaccharides, polysaccharides, water), and vitamin C. Adjustment for energy 
removed most of the difference between the collection periods; significant differences 
were only seen for total protein, water, magnesium, iron, sodium, potassium, and 
14 
Validation of a semiquantitative food frequency questionnaire 
Table 1: Comparison of baseline characteristics for participants of dietary assessment in 
the Rotterdam Study and participants of the curreut validation study (means [SD] if not 
othenvis. stated) 
Study sample 
Variables 
Women (%) 
Age (years) 
Body weight (kg) 
Body mass index (kg/m') 
Systolic blood pressure (mm Hg) 
Diastolic blood pressure (mm Hg) 
Energy (kJ)! 
Protein (% ofenergy)1 
Fat (% of energy)! 
Carbohydrates (% of energy)! 
Obesity (%)' 
Current cigarette smoking (%) 
Consumption of alcohol (%) 
Prescribed diet (%) 
Use ofsupptements (%) 
Single household (%) 
Equivalent household income (%) 
< 1500 Hfl 
> 3000 Hfl 
College/university education (%) 
Validation Study 
(n ~ 80) 
51.3 
66.7(4.6) 
75.9 (10.1) 
27.0 (3.1) 
158 (14) 
90 (9) 
8.89 (1.94) 
18.6 (3.0) 
42.3 (7.3) 
35.5 (6.9) 
16.3 
18.8 
85.9 
7.0 
42.9 
17.7 
18.8 
5.0 
3.8 
I nUlrient intake estimated from semiquantiative food frequency questionnaire 
2 defined as body mass index (BM!) ;::: 30 
15 
Rotterdam Study 
(n ~ 5434) 
59.1 
67.7 (7.8) 
73.6 (11.6) 
26.3 (3.6) 
139(22) 
74(11) 
8.26 (2.10) 
16.8(3.1) 
43.2 (6.9) 
36.4 (6.2) 
14.3 
23.3 
79.2 
13.4 
35.4 
26.2 
20.8 
10.0 
8.5 
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riboflavin. Linear trend analysis showed a decrease in nutrient intake with duration of 
dietary assessment. 
In table 2 mean (SO) energy and nutrient intakes for SFFQ and FR are presented. For 
most macronutrients, minerals, and vitamins, mean intake as estimated by SFFQ was 
higher compared to intake estimated from (FR). Overestimation of SFFQ as compared 
to FR was also reflected by the mean difference of the nutrient estimates of both 
methods. The mean difference in energy intake ofSFFQ to FR was 351 (SO 1472) kJ/d. 
The difference in vegetable protein intake of 12.5 gld (SO 8.3) and of 
mono/disaccharides of 8.2 gld (SO 29.1) contributed most to the observed difference in 
energy intake. For fhrther evaluation of agreement between methods, the ratio of 
nutrient intake assessed by SFFQ to that assessed by FR was calculated. For energy 
and all nutrients except for polyunsaturated fat, and sodium, values greater than 100% 
were obtained. Estimates of macro nutrient intake by SFFQ were in general within 10% 
of the mean FR values. For most micronutrients the deviations from the FR results 
were higher than for the macronutrients. 
Table 2 presents variance ratios used for deattenuation of the correlation coefficients. 
Also, correlation coefficients between SFFQ and FR obtained for crude data, data 
adjusted for age, sex, and energy, and data corrected for day-to-day variability of FR 
measurements are shown. Relative validity of SFFQ to FR as assessed by Pearson's 
correlation coefficients resulted in values for crude data ranging from 0.47 for water 
intake to 0.89 for alcohol intake (mean 0.65). Adjustment for age, sex, and energy 
resulted in slightly lower correlation coefficients for most nutrients (mean 0.57; range 
0.39 (saturated fat) to 0.82 (alcohol). Correction of variability due to day-to-day 
variation of food record measurements yielded deattenuated and adjusted correlation 
coefficients in the range of 0.44 for iron to 0.85 for alcohol intake (mean 0.61). Oue to 
their relatively large day-to-day variation, the effects of deattenuation were most 
pronounced for cholesterol, and vitamin C. In addition, crude data (intraclass 
correlation coefficient) on the reproducibility of the two SFFQ's administered on 
average two years apart are given in table 2. Intraclass correlation coefficients were 
between 0.49 for riboflavin and 0.88 for alcohol with a mean value of 0.70. 
Cross-classification of nutrient scores into quintile categories was undertaken to evaluate 
the ability of both methods to classifY individuals similarly in categories of nutrient 
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Table 2: Mean (SD) nnment intake, SFFQIFR ratio, mean diflfer."ce (SD), and Pearson's correlation coefficient between SFFQ and FR 
Energy (kJ) 
Total protein (g) 
Vegetable protein (g) 
Total fat (g) 
Monounsaturated fat (g) 
Polyunsaturated fat (g) 
Saturated fat (g) 
Linolenic acid (mg) 
Cholesterol (mg) 
Total carbohydrate (g) 
Mono/disaccbarides (g) 
Polysaccharides (g) 
Dietary fiber (g) 
Alcohol' (g) 
Water (ml) 
Thiamine (mg) 
Riboflavin (mg) 
Pyrodixine (mg) 
Vitamin C (mg) 
SFFQ FR 15 days 
Variance ratio 
FR 
witbinlbetween 
Difference 
SFFQ- FR 
Ratio 
mean SD mean SD subject variance mean SD p I mean 
8899 1937 8552 
97.8 22.6 86.5 
42.7 10.4 30.2 
84.6 25.7 83.3 
29.5 9.8 30.0 
16.2 8.0 14.6 
32.6 9.9 32.2 
13.4 7.5 10.5 
238 73 227 
224.1 
106.9 
116.7 
23.2 
11.2 
2634 
1.33 
2.36 
1.82 
105.2 
59.1 217.6 
40.7 98.7 
27.1 116.4 
6.0 16.4 
16.2 II.l 
605 2171 
0.34 1.06 
0.59 1.47 
0.43 1.55 
45.8 91.5 
1828 
20.3 
7.7 
24.0 
9.0 
6.0 
9.5 
5.5 
55 
50.5 
30.2 
27.7 
4.1 
13.6 
412 
024 
0.38 
0.33 
39.6 
1.09 
1.32 
\.\0 
1.55 
1.74 
2.02 
1.34 
1.01 
4.38 
0.81 
1.01 
0.93 
1.34 
1.01 
0.78 
2.26 
L13 
2.27 
2.70 
351 1472 • 
11.3 16.2 n", 
12.5 8.3 **'" 
1.2 21.6 n.s. 
0.3 8.8 D.S. 
-D,S 8.6 n.s. 
1.6 6.4 D.S. 
2.9 6.2 n 
11.6 64.2 n.s. 
6.5 41.6 n.s. 
8.2 29.1 • 
02 20.0 D.S. 
6.7 4.6 .... 
0.1 7.3 n.s. 
463 550 D.S. 
0.27 0.27 **'" 
0.88 0.48 .n 
0.26 0.35 .n 
13.5 38.4 ** 
105 
114 
145 
105 
104 
102 
116 
140 
107 
104 
110 
101 
144 
109 
123 
128 
165 
118 
121 
Intraclass 
crude 
0.71 
0.78 
0.56 
0.65 
0.58 
0.67 
0.64 
0.56 
0.77 
0.74 
0.68 
0.63 
0.67 
0.81 
0.88 
0.72 
0.49 
0.79 
0.75 
Pearson's 
correlation coefficient§ 
0.69 
0.73 
0.62 
0.57 
0.56 
0.57 
0.49 
0.54 
0.53 
0.72 
0.70 
0.73 
0.64 
0.89 
0.47 
0.60 
0.59 
0.62 
0.68 
n.a. 
0.63 
0.57 
0.48 
0.49 
0.52 
0.39 
0.52 
0.48 
0.77 
0.74 
0.64 
0.59 
0.82 
0.52 
0.42 
0.54 
0.46 
0.64 
n.a. 
0.66 
0.59 
0.50 
0.52 
0.62 
0.52 
0.54 
0.59 
0.79 
0.76 
0.66 
0.62 
0.85 
0.53 
0.45 
0.56 
0.49 
0.70 
table 2 continued 
Variance ratio Difference Ratio Intraclass Pearson's 
SFFQ FRI5 days FR SFFQ-FR SFFQIFR carr. coerr.§ correlation coefficient§ 
withinlbetween (%) SFFQO/SFFQ' 
mea. SD mea. SD subject variance mea. SD p' mea. crude crude adj.' adj.,deatt.J• 
Sodium '(mg) 2360 756 2522 739 1.78 -161 577 • 95 0.71 0.73 0.55 0.58 
Potassium (mg) 4725 1010 3550 701 1.42 1175 784 ... 134 0.71 0.63 0.50 0.52 
Iron (mg) 15.1 3.4 12.0 2.8 1.14 3.1 2.6 ... 128 0.65 0.67 0.42 0.44 
Calcium (mg) 1174 398 \022 364 0.96 152 305 ... 119 0.79 0.73 0.70 0.72 
Phosphorus (mg) 2108 810 1677 560 0.83 430 540 ... 104 0.77 0.76 0.72 0.74 
Magnesium (mg) 318.9 77.8 308.1 65.4 1.02 10.8 52.0 n.s . 114 0.80 0.75 0.69 0.71 
Zinc (mg) 11.8 3.0 10.5 2.9 1.82 1.24 2.31 ... 128 0.77 0.70 0.51 0.54 
§ based on log~transformed values (protein, fat, saturated fat, monounsaw.rated fat, polyunsaturated fat, linolenic acid, cholesterol, monoldisaccharides, sodium, 
phosphorus, magnesiUm, niacin) 
n.a. not applicable; D.S. Dot signifcant;· p < 0.05; ** p<O.OOl; .""" p<O.OOOI 
paired t-test (for polyunsaturated fat, linoleic acid, dietary fiber, alcohol, and pyridoxine Wilcoxon sign rank: test) 
2 intraclass correlation coefficient SFFQO/SFFQ (SFFQ applied during baseline recruittnent of the Rotterdam Study/SFFQ applied in the validation study); n "" 71 
3 correlation coefficient adjusted for age,sex, and energy 
4 correlation coefficient deattenuated (corrected for within-person variation in food records) 
5 alcohol intake for subjects consuming alcohol (FR: 84%; SFFQ: 88010); Spearman correlation coefficient 
6 sodium content of foods only 
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Table 3: Comparison of SFFQ scores with mean daily nutrient intakes derived from FR, 
based on cross classification 
Overall proportion (%) of subjects classified into 
same adjacent extreme same adjacent extreme 
quintile quintile quintHe quintile quintile quintile 
category category category category category category 
for energy ~ adjusted nutrients 
Energy 43.8 38.8 1.3 !l.a. n.a. n.a. 
Total protein 42.5 41.3 0.0 43.8 38.8 0.0 
Vegetable protein 43.8 31.1 1.3 41.3 31.3 1.3 
Total fat 36.3 36.3 0.0 32.5 36.3 0.0 
Saturated fat 33.0 36.3 0.0 42.5 35.0 1.3 
Monounsaturated fat 37.5 41.3 1.3 32.5 48.8 1.3 
Polyunsaturated fat 27.5 53.8 1.3 35.0 43.8 1.3 
Linolenic acid 31.3 43.8 1.3 30.0 42.3 1.3 
Cholesterol 32.5 41.3 3.8 31.3 43.8 3.8 
Total carbohydrates 43.8 37.5 0.0 48.8 40.0 0.0 
Mono/disaccharides 50.0 36.3 0.0 51.3 30.0 0.0 
Polysaccharides 50.0 36.3 0.0 36.3 50.0 1.3 
Dietary fiber 42.5 37.5 0.0 35.0 42.5 2.5 
Alcohol 70.0 22.5 0.0 75.0 26.3 1.3 
Water 22.5 50.0 0.0 26.3 45.0 1.3 
Thiamine 38.8 30.0 1.3 37.5 41.3 1.3 
Riboflavin 37.5 33.8 0.0 33.8 35.0 1.3 
Pyrodixine 37.5 40.0 0.0 38.8 40.0 1.3 
Vitamin C 46.3 30.0 0.0 47.5 32.5 0.0 
Sodium 48.8 35.0 1.3 47.5 37.5 0.0 
Potassium 41.3 36.3 1.3 40.0 41.3 1.3 
Iron 42.5 42.5 0.0 40.0 35.0 0.0 
Calcium 36.3 42.5 0.0 42.5 33.8 0.0 
Phosphorus 55.0 36.3 0.0 48.8 33.8 1.3 
Magnesium 46.3 32.0 0.0 43.8 42.5 0.0 
Zinc 34.0 46.3 0.0 33.8 46.3 0.0 
n.a. Ilot applicable 
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Table 4: Mean nutrient intake assessed by Cood records according to quintile categories 
oC nutrient intake assessed by FR and SFFQ, respectively 
Energy (kJ) 
Percent energy from 
Protein 
Fat 
Carbohydrates 
Total protein (g) 
Vegetable protein (g) 
Total rat (g) 
Saturated rat (g) 
Monounsaturated Cat (g) 
Polyunsaturated rat (g) 
Linolenic acid (mg) 
Cholesterol (mg) 
Total carbohydrate (g) 
Mono/disaccharides (g) 
Polysaccharides (g) 
Dietary fiber (g) 
Alcohol (g) 
Water (ml) 
Thiamine (mg) 
Riboflavin (mg) 
Pyridoxine (mg) 
Vitamin C (mg) 
Sodium from food (mg) 
Potassium (mg) 
Iron (mg) 
Calcium (mg) 
Pitospitorus (mg) 
Magnesium (mg) 
Zinc (mg) 
Quintile categories based on FR 
QI Q2 Q3 Q4 Q5 
6393 7489 8251 9280 11339 
14.3 15.8 16.6 17.8 20.7 
29.7 33.8 36.3 39.3 42.8 
33.1 39.6 43.3 47.0 51.2 
63.4 75.7 83.8 93.5 116.1 
20.6 25.7 30.1 32.9 41.7 
55.9 68.1 79.9 93.0 119.8 
21.3 27.4 30.7 36.1 45.7 
19.1 24.3 28.6 34.4 43.7 
7.6 11.1 13.4 16.2 24.5 
4.7 7.2 9.2 11.9 19.7 
157.0 193.8 219.2 258.1 306.1 
151.2 190.0 216.2 238.1 292.1 
60.1 80.3 93.6 115.9 143.9 
81.1 99.5 116.1 127.4 157.8 
10.9 14.0 16.3 18.3 22.6 
0.6 3.1 8.8 16.9 35.4 
1620 1949 2171 2371 2744 
0.75 0.92 1.02 1.17 1.41 
0.98 1.27 1.44 1.66 2.02 
1.11 1.37 1.56 1.73 2.01 
44.7 68.6 86.7 108.0 149.4 
1663 2097 2452 2744 
2608 3160 3532 3924 
8.4 10.6 11.8 12.9 
3652 
4529 
16.1 
575 833 1003 1175 1522 
1062 1337 1577 1870 2541 
223.8 272.8 301.0 333.8 409.3 
7.3 9.0 10.2 11.3 14.8 
20 
Quintile categories based on 
SFFQ 
QI Q2 Q3 Q4 Q5 
6774 8050 8318 9063 10506 
14.9 16.3 16.9 18.1 18.9 
34.2 34.9 36.7 36.6 39.5 
35.6 40.0 44.2 44.2 50.3 
70.9 74.4 86.3 93.6 107.4 
23.1 26.8 32.5 32.8 35.8 
65.6 76.4 78.5 87.2 109.0 
25.5 30.6 31.1 32.8 41.2 
23.7 26.0 30.7 31.8 37.9 
9.7 12.2 14.3 17.4 19.2 
6.6 8.7 10.0 11.5 15.9 
209.2 190.4 220.3 242.7 271.8 
166.1 200.9 214.0 236.5 270.3 
67.5 87.5 99.5 115.5 123.7 
87.7 103.6 113.9 135.3 141.4 
13.1 14.8 16.0 17.7 20.4 
1.9 4.2 8.6 15.6 33.9 
1890 1977 2220 2252 2516 
0.88 0.99 0.97 1.17 1.28 
1.17 1.30 1.53 1.60 1.77 
1.22 1.43 1.57 1.73 1.82 
58.3 74.0 94.9 103.0 127.4 
1846 2291 2483 2620 3368 
2853 3371 3589 3853 4086 
9.2 10.8 11.7 14.0 14.2 
645 1014 976 1095 1379 
1182 1352 1616 1917 2320 
236.7 287.7 292.5 351.6 372.2 
8.3 9.3 10.4 11.4 13.3 
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intake. Table 3 presents the proportion of subjects classified into the same, the adjacent, 
and the extreme quintile category for crude and energy-adjusted nutrients. On average 
39.0 % ( crude) and 38.9 % (energy-adjusted) of the subjects were correctly classified 
into the same quintile category by both methods of dietary assessment. Severe 
misclassification i.e. classification of subjects into the extreme quintile category occurred 
only for 0.5 % (crude data) respectively 1.0 % (energy-adjusted data) subjects. Overall, 
classification into the same or adjacent quintile category was 75.8 %, respectively 76.8 % 
(energy-adjusted data). The SFFQ's ability to separate nutrient intake as estimated by 
FR by quintile derived from the SFFQ is demonstrated in table 4, where nutrient intakes 
of FR according to quintile categories of nutrient intake determined by both SFFQ and 
FR are presented. Mean nutrient intakes as determined by FR reflected the greater 
variance in estimates of nutrient intakes compared to SFFQ. 
Protein intake as calculated from the mean urea excretion from four 24-h urine 
collections was 81.2 gld (SO 16.0) and was on average 6.2 gld (SO 14.1) lower than 
protein intake from FR (87.4 gld (SO 19.9», and 17.8 gld (SO 15.4) from SFFQ (99.0 
gld (SO 21.8». The mean difference in protein intake was somewhat higher in men than 
in women. Spearman correlation coefficients between protein intake estimated from urea 
excretion and FR and SFFQ were 0.69 (p = 0.001) and 0.67 (p < 0.001) respectively. The 
proportion of subjects classified into the same, adjacent, and extreme quintile category 
by protein intake estimated from urea excretion and methods of dietary assessment was 
42.1%, 38.2% and 0% for SFFQ and 43.4%, 38.2% and 1.3% for FR, respectively. 
~iscrepancy in protein intake by FR and SFFQ to protein intake calculated from urea 
excretion was not associated with age, BMl, body weight, or weight change during the 
stndy. 
DISCUSSION 
We evaluated the relative validity of nutrient intake estimated by a SFFQ adapted for 
dietary assessment in the elderly as compared to 15-day estimated food records. 
Measures of concordance used in the present validation stndy encompassed the 
correlation coefficient, cross-classification by quintile categories, the difference 
between means, and the ratio of SFFQ to FR. Correlation coefficient and cross-
classification are usually considered as an index of accuracy by which the 
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questionnaire assessment can rank individuals by dietary intake level, while the 
difference between means and the ratio between the two methods of dietary assessment 
express the average tendency of individuals to over- or underestimate their dietary 
intake. Compared to FR, the SFFQ generally overestimated nutrient intake as reflected 
by difference in means and the ratio of SFFQ to FR greater than 100% for all nutrients 
except sodium. Overestimation of protein intake estimated from SFFQ was 
furthermore indicated by independent validation of protein intake with protein 
excretion calculated from 24-h urine urea. The ability of the SFFQ to rank subjects 
adequately according to their dietary intake was reflected by Pearson's correlation 
coefficients varying from close to 0.5 to about 0.9 for crude, and 0.4 to 0.8 for data 
adjusted for age, sex, total energy intake and within-person variability in daily intake, 
respectively, and a degree of correct classification into the same or adjacent quintile of 
75.8% for crude and 76.8% for energy-adjusted data, respectively. 
Given that neither method of dietary assessment is perfect, it is crucial that the errors 
of both methods be as independent as possible to avoid spuriously high estimates of 
validity. Among the available and feasible comparison methods for validating a 
(S)FFQ, diet records are likely to have the least correlated errors l4• Probably the main 
source of error in the reference method is the possibility of a change in diet due to the 
measurement process itself, while the main sources of error in the questionnaire are the 
ability of the subject to describe the usual frequency of intake, restrictions imposed on 
a fixed list of foods, memory, interpretation of questions, and the assumption of 
average serving sizes for most foods. Diet records are open-ended and do not depend 
on memory. They allow a more direct assessment of portion sizes, and errors in 
interpretation relate to the dietitian coding the records rather than to the subjects". The 
choice of recording pattern for estimated food records was based on the consideration 
that it is likely that several short recording periods are less demanding for the elderly 
participants than one long period. Thereby, we expected to reduce the chances of 
having changes and simplifications of the diet during the recording days. 
Ideally, the subjects in a validation study should be a random sample of the study 
population in which the questionnaire is being used. In the present study, validation 
was carried out in a subsample of the population-based cohort of the Rotterdam Study, 
recruited for a study on blood pressure6• Since the main focus of the study was on 
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blood pressure reduction subjects may have been less focused on their diet than 
participants recruited specifically for a validation study. With respect to the cohort of 
the Rotterdam Study this may have resulted in a less selected and more representative 
study sample, a view that is supported by comparison of participants by selected 
baseline characteristics (table 1) with participants of the Rotterdam Study that 
underwent dietary assessment. However, embedding the validation study in a 
hypertension trial may have had a direct effect on dietary intake given that certain 
foods were provided free-of-charge during the intervention period. To check whether 
inclusion of these records affected the results of the current validation study we 
compared mean dietary energy-adjusted intake on group level for the intervention 
period with the non-intervention period and found only minor significant differences in 
energy-adjusted nutrient intake. These differences could possibly be explained by 
seasonal effects since the intervention period took place during the winter time. We 
also investigated whether exclusion of the six recording days that fell into the 
intervention period had an effect on Pearson correlation coefficients, e.g. on the 
questionnaire's ability to adequately rank study subjects. Again, differences observed 
were minor and not of the magnitude to suspect serious bias. Based on these results we 
decided to include the dietary records collected during the intervention period to have 
all seasons balanced and to obtain more stable estimates. 
Conscious or unconscious underreporting of foods can have a profound effect on the 
quality of the reference data and thus on the apparent validity of the method to be 
evaluated. Presence of underreporting is now generally considered for all dietary 
assessment methods'6• For evaluation of possible underreporting that may have 
occurred in estimates of nutrient intake and as a measure of indirect validation for 
energy intake on group level in the current study, the ratio of energy intake to basal 
metabolic rate was used (EIIBMR). EIIBMR is regarded to be a satisfactory 
independent validator of energy intake17·'9• Comparing mean EIIBMR for FR and 
SFFQ with a pre-determined cut-off indicated the presence ofunderreporting of energy 
on groUp level for FR. Declining motivation of participants to record their food intake 
with duration of dietary assessment or possibly use of the recording period as an 
opportunity for weight loss by some participants may be likely explanations. The 
observed significantly inverse relation between BMI and energy intake observed in the 
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current study and several other studies2o.2l points towards marked underreporting by 
obese subjects. 
Besides the use of EIIBMR for evaluation of possible underreporting, we used 24-h 
urine urea excretion caIlected over four non-consecutive days as an independent measure 
of validity of dietary protein intake. The reported protein intake tended to be higher than 
the protein output as calculated from urea excretion. This was more pronounced for 
SFFQ than FR. OveraIl, mean urea excretion per day in the current study corresponded 
weIl with reference values for analytes of24-h urine collections known to be complete'. 
The Spearman correlation coefficient obtained was of similar magnitude than in other 
studies26•27 indicating the questionnaire's ability to adequately rank subjects acccording 
to their protein intake. 
The SFFQ validated in the present study is an adapted version for use in the elderly of 
a previously validated SFFQ compared to three 3-day FR conducted 4-5 months apart. 
On average, the original questionnaire covered 85% on food level and 91 % on nutrient 
level of the food record intake. Food intake of the original SFFQ was lower for most 
food groups except for vegetables, citrus fruit, bread, and added fats compared to three 
3-day FR. On nutrient level, intake estimated by the questionnaire resulted in a lower 
intake for most nutrients except for vegetable protein, polyunsaturated fat, dietary 
fiber, and vitamin C. Correlation coefficients between the original version of the SFFQ 
and 9-d FR ranged from 0.40 - 0.83 for crude and 0.33 - 0.79 adjusted for age and sex, 
respectivel/. Questionnaire modification was mainly determined by use of a two-step 
dietary assessment approach and more detailed information on vegetable, fruit, and 
meat consumption, and inclusion of some additional items. In combination with the 
different way of administration - partly self-administered (a questionnaire mainly 
consisting of a meal-based checklist of foods to fill in at home) and partly by a dietary 
interview conducted by trained dietitians - these modifications may have contributed to 
the differences in the results of both methods. 
In epidemiological studies nutrient intakes are usuaIly classified in quintiles, quartiles 
or tertiles for calculation of measures of disease association. Thus information of the 
ability of the applied questionnaire to correctly assign subjects according to their 
dietary intake is impoliant to obtain correct associations and risk estimates. The SFFQ 
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validated in the current study showed a relatively high degree of correct classification 
within one quintile category of dietary intake (75.8 % for crude, respectively 76.8 % 
for energy-adjusted data) and a low level of severe misclassification (0.5 % for crude, 
respectively 1.0 % for energy-adjusted data). In comparison to other studies conducted 
in the e1derlyl5·19.29.3o the questionnaire demonstrated similar ability to correctly assign 
individuals according to their dietary intake. 
Published correlation coefficients between nutrient intakes recorded by a (S)FFQ and 
by a reference method have varied considerably depending e.g. on the reference 
method applied and the number of days recorded. The correlation coefficients observed 
in the current study ranged from close to 0.5 to about 0.9 for crude and from 0.4 to 0.8 
for adjusted data indicated relatively good validity and were similar to results of 
studies where either a (S)FFQ or dietary history were validated in the 
elderly I5.18.19.28.30.34. In comparison with results obtained in validation studies 
conducted in middle-aged popUlations, results obtained in the elderly were by no 
means less reliable and valid3,4,29,35.41. This supports the idea that age has little adverse 
effects on the validity of questionnaires if administered appropriate, e.g. by interview 
as pointed out by Block & Hartman" by use of memory strategies, prior notification of 
a dietary interview4l, or by combination of methods2, and adaptation of existing dietary 
assessment methods as advocated in the present study. Our adapted SFFQ based on a 
two-step dietary assessment may be used with confidence in dietary assesstrient of 
older subjects in epidemiologic studies. 
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Dietary assessment in the elderly: application of a two-step 
semiquantitative food frequency questionnaire for epidemiologic 
studies 
ABSTRACT 
Objective: Description and application of an adapted semiquantitative food frequency 
questiOlmaire (SFFQ) for dietary assessment in the elderly population of the Rotterdam Study 
Desigll: Dietary assessment consisting of a two-step approach was performed in 5434 
participants (2225 men, 3029 women) ofthe Rotterdam Study from 1990 to 1993, a population-
based prospective cohort of7983 subjects aged 55 to 95 years (participation rate 78%). 
Statistical allalysls: Nutrient intake was calculated for men and women in four age groups (55-
64 years, 65-74 years, 75-84 years, 85-95 years) and linear trend analysis for differences in mean 
nutrient intake across age groups (55-64 years, 65-74 years, and 75-95 years) by regression 
analysis was conducted. Influence of baseline characteristics on energy and nutrient intakes 
adjusted by age and sex was investigated by one-way-analysis of variance. 
ReslIlts: The adapted SFFQ made it possible to measure nutrient intake in the elderly within a 
limited time frame (2 x 20 min) across a wide age range (55 to 95 years). For nutrient intake we 
observed a general decline in mean intake of energy and most nutrients with age in men. In 
women the relation with age was not consistent: for most nutrients mean intake showed a 
decrease by age ( e.g. water, magnesium, potassium), for some an increase (e.g. total fat, 
saturated fat, mono/di-saccharides), and some nutrients showed no substantial change (e.g. 
calcium, retinol). Reported nutrient intake was influenced by body mass index, smoking status, 
socioeconomic status, and activites of daily living. A prescribed diet was reported by 12.9% of 
participants and 34.6% used supplements on a regular basis. 
29 
COlic/liS/OilS: The described two-step approach for dietary assessment in the elderly facilitated 
collection of data on dietary habits across a wide age range and within a limited time frame 
making it a suitable instrument for application in large-scale epidemiological studies in the 
elderly. 
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INTRODUCTION 
Diet is an important aspect of lifestyle and may affect life expectancy, morbidity and 
mortality of older adults. Data on the nutrient intake and the nutritional status of the 
elderly in large-scale studies are scarce, especially for those older than 75 years of age. 
So far, application of appropriate methods for dietary assessment in epidemiologic 
studies has been difficult in elderly populations. Limited recall due to fading memory or 
disabilities in sight or attention may require a more complicated dietary assessment and 
may result in a higher respondent burden 1,2 and low participation rate. To simplifY 
dietary assessment without loss of validity and precision, a semiquantitative food 
frequency questionnaire was adapted for use in an elderly popUlation. In this paper the 
method of dietary assessment will be introduced and nutrient intake in participants of the 
Rotterdam Study will be described. 
METHODS 
Study Design and Subjects 
The Rotterdam Study is a community based prospective cohort study among 7983 
subjects aged 55 years and over, living in Ommoord, an urban district in Rotterdam, the 
Netherlands. The rationale and design of the Rotterdam Study have been described 
previously3. In short, the Rotterdam Study is a large-scale prospective cohort study on 
prevalence, incidence, and determinants of cardiovascular, neurologic, locomotor, and 
ophthalmologic diseases. At baseline the study comprised an extensive general home 
interview (participation rate 78%) and two visits at a research center for a clinical 
examination (participation rate 69%). The study has been approved by the Medical 
Ethics Committee of Erasmus University, Rotterdam, and written consent was obtained 
from participants. Dietary assessment was undertaken to investigate the role of nutrition 
and nutrition-related factors in the development of chronic diseases. Dietary assessment 
was performed during the second visit of the participants (n = 7006) at the research 
center by trained dietitians. It was not performed in participants of the pilot study (n = 
277), in those living in nursing homes (n = 479), and in persons with known reduced 
cognitive function assessed by a neuropsychological test prior to dietary assessment (n = 
122). Due to logistic reasons (e.g. unavailability of a dietitian) no dietary assessment 
could be carried out in an additional 482 persons. A dietary interview was thus obtained 
in 5646 persons. 212 subjects were excluded from analysis because dietitians considered 
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their reported dietary intake unreliable, i.e because participants# answers during the 
dietaty interview were either too inconsistent or too incomplete. This resulied in 5434 
participants, 2225 men (41%) and 3209 women (59%), aged 55 to 95 years of age, for 
the present dietary analysis. 
Dietary Assessment by Semiquantitative Food Frequency Questionnaire (SFFQ) 
The instrument to assess nutrient intake in the Rotterdam Study is a modification of a 
self-administered mailed semiquantitative food frequency questionnaire (SFFQ) used in 
a large-scale prospective cohort study on diet and cancer in the Netherlands (NLCS)4. 
Data on the validity and reproducibility of the original questionnaire with 150 food items 
have been reporteds.6• Modification consisted mainly of a different mode of 
administration, collection of more detailed infonnation on vegetable, fruit, and meat 
consumption, and inclusion of some additional items. The modified SFFQ contained 170 
food items in 13 food groups and general questions about dietary habits (e.g. type of 
coffee, use ofmilklsugar in coffee, change in food habits) to assess habitual food intake 
during the past year. The dietary assessment was undertaken in two consecutive phases 
as outlined in figure I. First, participants were asked to report foods consumed regularly 
(at least twice a month) by use of a self-administered questionnaire consisting mainly of 
a meal-based checklist of foods. The questionnaire was explained to each participant 
during a home visit by a trained research assistant. It was filled in at home and collected 
at the research center. Participants had to mark the foods they had consumed at least 
twice a month in the preceeding year. Questions on fruit and vegetables were asked with 
respect to season (summer and winter), and preparation (raw, cooked). In addition, type 
and brand of dietary fats and oils used on bread, for cooking or as salad dressing were 
asked. Finally, subjects were asked whether additional foods not included in the 
questionnaire were consumed on a regular basis (frequency and amount specified). 
Average time for completion of the questionnaire was 20 minutes. The availability of the 
completed checklist of foods allowed for a more time-efficient dietary interview at the 
research center. The dietary interview was conducted by dietitians trained in the use of 
this method. The dietitians aimed at obtaining accurate infonnation on amount and 
consumption frequency of food items noted by participants as consumed frequently. For 
each item the frequency was recorded in times per day, week, or month. The number of 
servings per frequency was expressed in natural units (e.g. slice of bread, apple), 
household measures (e.g. cup, spoon) or grams (cooked vegetables, mixed dishes). 
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General questions to check the consistency of the completed dietary questionnaire were 
asked, such as for the total number of warm meals per week. 
Additional information about dietary habits and supplement use (e.g. type, amount, and 
frequency) during the past year was obtained, as well as comprehensive data on 
prescribed diets that were currently followed. The time allocated to the dietary interview 
was 20 minutes, thus, time needed to complete both parts of the dietary assessment was 
approximately 40 minutes. 
Figure 1: Dietary assessment in the Rotterdam Study 
Place of application 
Method of dietary 
assessment 
Phase 1: 
Selr~administered questionnaire 
at home 
meal· based checklist of foods 
Mode of application self-administered 
Type of information foods consumed at least twice a month 
collected over the past year 
in addition questions on 
• dietary fats/oils (type) 
• vegetables/fruits (season; preparation) 
• additional foods consumed regularly 
and not listed in the questionnaire 
Time for completion 20 min (average) 
Phase 2: 
Dietary interview 
at the study center 
structured interview 
by dietitian 
quantification (amount, 
frequency) of reported food 
items based on the self-
administered questionnaire over 
the past year 
in addition questions on 
• reliability 
• dietary habits 
• prescribed diets 
• supplements 
20 min (allocated) 
All data were entered into an interactive computer programme. Average time for data 
entry was 20 minutes. For calculation of frequency and amounts of foods consumed a 
computer application was developed. Questionnaires were checked for completeness by 
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an interactive data-entry programme and automatically coded for later conversion into 
nutrients. The program checked further for internal consistency, range, and other 
response errors. The conversion from foods to energy and nutrient intakes was 
established with a computerized version of the Dutch Food Composition Table7. Intake 
through dietetic products and nutritional supplements was not taken into account since 
brand labels were not recorded with sufficient accuracy. 
Validity of the modified SFFQ was assessed in a subsample of80 men and women aged 
55 to 75 years of the Rotterdam Study as previously described8• Multiple food records 
(FR) collected over a one year period served as reference method. 24-h urine urea was 
used as indirect marker for protein intake. Compared with FR, the SFFQ generally 
overestimated nutrient intake as reflected by difference in means and the ratio of SFFQ 
to FR. Energy adjustment reduced the observed overestimation. Validation of protein 
intake from SFFQ with estimated protein excretion from 24-h urea indicated 
overestimation of protein intake by SFFQ. The ability of the SFFQ to rank subjects 
adequately according to their dietary intake was reflected by Pearson's correlation 
coefficients varying from 0.44 to 0.85 adjusted for age, sex, total energy intake9 and 
within-person variability in daily intake 10 and by correct classification into the same or 
adjacent quintile (75.8 % of crude and 76.8% for energy-adjusted data). 
Data Analysis 
Nutrient intake was calculated for men and women in four age groups (55-64 years, 65-
74 years, 75-84 years, 85-95 years). Linear trend analysis for differences in mean 
nutrient intake across three age groups (55-64 years, 65-74 years, and 75-95 years) was 
carried out by regression analysis. Influence of baseline characteristics such as smoking 
status, body mass index (BMI), disability, and reported difficulty with food intake on 
energy and nutrient intakes adjusted by age and sex was investigated by one-way-
analysis of variance. When testing for statistical significance natural logarithm (energy, 
protein, vegetable protein, total fat, satured fat, monounsaturated fat, carbohydrates, 
mono/disaccharides, fiber, water, calcium, phosphor, potassium, iron, zinc, retinol, B 
vitamins, vitamin E, and B-carotene), respectively square root transformation 
(polyunsaturated fat, linoleic acid, polyssaccharides, cholesterol, sodium, magnesium, 
and vitamin C) was used for skewed nutrients to improve their distribution towards 
normality. 
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Me. Women 
Characteristic 55-64 years 65-74 years 75-84 years 85-95 years 55-64 years 65-74 years 75-84 years 85-95 years 
0=948 .=902 .=352 n=24 • = 1331 0=1193 0=612 0=73 
mea.(SD) 
Weight (kg) 80.7 (10.6) 78.6(10.1) 75.6 (9.7) 72.1 (8.2) 70.4 (11.3) 70.5 (10.9) 68.1 (10.9) 67.8 (9.0) 
Height (em) 176.4 (6.6) 174.7 (6.3) 172.2 (6.3) 171.1 (7.2) 163.7 (6.0) 161.7 (6.2) 158.6 (6.5) 157.3 (5.8) 
Body mass index (kg1m') 25.9 (2.9) 25.8 (2.8) 25.5 (3.0) 24.7 (2.6) 26.3 (4.0) 27.0 (4.0) 27.1 (4.4) 27.4 (3.2) 
Energy intakelbasal metabolic rate 1.36 (0.33) 1.36 (0.32) 1.47 (0.29) 1.S2 (0.34) 1.32 (0.33) 1.34 (0.31) 1.38 (0.33) 1.47 (0.42) 
Serum cholesterol (mmolll) 6.5 (1.2) 6.3 (1.1) 6.1 (1.1) 6.0 (0.8) 6.9 (1.1) 7.0 (1.2) 6.8 (1.2) 6.5 (1.3) 
Percentage 
Current cigarette smoking 33.7 25.8 25.6 33.3 25.7 18.2 9.5 2.7 
Alcohol drinking 88.8 86.5 83.5 79.2 78.2 72.3 64.1 63.0 
Diabetes 6.4 11.6 12.6 25.0 4.8 11.1 15.5 13.7 
Hypertension· 16.8 19.5 24.1 29.2 14.0 22.0 31.1 472 
Obesity (BM! ;" 30 kg1m') 7.6 7.4 5.7 0.0 16.2 20.8 23.4 16.7 
Poor performance~ 1.7 3.6 6.3 16.7 4.5 9.4 22.1 50.7 
Single household 9.3 8.8 . 17.1 50.0 19.8 39.4 63.3 83.6 
Difficulties with food intake 2.2 5.4 10.3 16.7 11.3 15.1 20.8 35.6 
Use ofprescnbed diet 9.8 12.2 9.7 12.5 12.0 16.9 18.6 13.7 
Use of supplements 25.8 23.9 25.5 25.0 39.7 37.2 37.8 34.2 
• Hypertension Systolic blood pressure O!: 160 rom Hg. diastolic blood pressure;:: 90 mm Hg or use of blood pressure lowering drugs 
t Poor performance High score on disability index: mean of ability to perfonn dressing, rising,. eating, walking, hygiene, reaching, griP. activity 
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For evaluation of plausibility of dietary intake data, the ratio of energy intake (EI) to 
basal metabolic rate (BMR) was calculated. EIIBMR is regarded to be a satisfactory 
independent validator of energy intakell ,12. BMR was predicted from standard equations 
based on age-specific formulae". 
RESULTS 
Descriptive Characteristics 
Table I summarizes selected characteristics of the study group. Mean age was 67 years 
(range 55-93) for men and 68 years (range 55-94) for women. Significant trends towards 
lower measured body weight and lower measured height at older age were observed. 
These changes with age were more. pronounced in men. Body Mass Index (BM!) 
decreased with age in men, whereas it increased slightly in women. Calculated basal 
metabolic rate averaged 6.9 MIld (SO 0.7) for men and 5.6 (SO 0.5) for women and 
declined significantly with age. Mean ratio of energy intake to basal metabolic rate 
(EIIBMR) was 1.38 (SO 0.32) for men and 1.34 (SO 0.33) for women. The ratio of 
energy intake to basal metabolic rate (EIIBMR) was significantly related to age. 
Indicators of activities of daily living as well as the percentage of those living 
independently decreased steadily with age. More women were living in a single 
household than men. Percentage with a low monthly equivalent household income 
«1500 Hfl [<680 EURO]) was higher for women (26.4%) than for men (12.6%). 
Education level was generally lower for women and decreased with age. A completed 
primary education as highest degree obtained was reported by 24.0% of men and 42.1 % 
of women, whereas 14.7% of men and 4.3% of women reported a college or university 
education. Comparison of baseline characteristics as given in table I for the study 
population undergoing dietary assessment with the total study population revealed no 
differences for the majority of characteristics. The prevalence of obesity was somewhat 
lower for women in the total study population, whereas the percentage of those with poor 
physical performance (activities of daily living), living alone, difficulties with food 
intake and a low income was higher in the total population. Stratification by age revealed 
that these differences were mainly due to aberrant values in the oldest age group (85 - 95 
years). 
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Table 2a: Mean daily intake of energy and selected nutrients, energy distribution and 
nutrient density for selected nutrients of men in the Rotterdam Study 
Men Test 
ror 
55-64 years 65-74 years 75-84 years 85-95 years trendt 
n~948 n~902 n~352 n~24 
mean (SD) mean (SD) mean (SD) mean (SD) 
Nutrient 
Energy (MJ) 9.7 (2.3) 9.3 (2.1) 8.9 (1.7) 9.1 (1.9) ... 
Protein 
total (g) 93.3 (22.1) 86.2 (18.4) 82.0 (19.1) 82.4 (17.4) ••• 
vegetable protein (g) 32.6 (9.3) 30.8 (8.4) 29.2 (7.2) 30.2 (7.0) ... 
Fat 
total (g) 94.6 (29.8) 90.9 (28.4) 87.6 (24.3) 90.6 (27.5) ••• 
saturated rat (g) 36.8 (13.0) 35.4 (12.4) 34.7 (10.6) 36.8 (12.2) • 
monounsaturated rat (g) 32.6 (11.7) 31.0 (10.8) 29.6 (9.7) 31.3 (13.2) ••• 
polyunsaturated rat (g) 18.3 (8.3) 17.9 (8.5) 16.9 (7.9) 16.2 (8.2) •• 
linoleic acid (g) 15.2 (8.1) 14.8 (8.2) 13.9 (7.8) 13.4 (8.1) •• 
Carbohydrates 
total (g) 243.3 (70.8) 233.1 (64.4) 228.8 (53.7) 229.5 (54.8) .. 
mono/disaccharides (g) 118.1 (50.4) 114.7 (46.1) 115.9 (39.8) 112.1 (43.6) ns 
polysaccharides (g) 124.1 (35.3) ll7.5 (30.9) 112.0 (26.8) 115.9 (30.4) ••• 
Cholesterol (mg) 268 (94) 254 (85) 247 (83) 254 (94) ... 
Dietary fiber (g) 18.6 (5.6) 17.6 (5.3) 16.9 (4.3) 16.7 (4.4) ••• 
Water(mI) 2543 (655) 2344 (538) 2279 (504) 2166 (441) ••• 
Alcohol (g)~ 19.9 (19.7) 18.8 (19.2) 16.0 (16.3) 18.5 (13.7) • 
Energy density 
Cholesterol (mg/MJ) 27.7 (7.2) 27.5 (7,0) 27.8 (7.8) 28.2 (7,0) ns 
Dietary fiber (g/MJ) 2.0 (0.5) 1.9 (0.5) 1.9 (0.5) 1.9 (0.5) ns 
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table 2 a continued 
Men Test 
for 
55-64 years 65-74 years 75-84 years 85-95 years trendt 
n~948 n~902 n~352 n~24 
mean (SD) mean (SD) mean (SD) mean (SD) 
Energy distribution 
Energy from: 
protein % 16.3 (2.8) 15.8 (2.8) 15.5 (2.8) 15.5 (2.9) ... 
fat % 36.3 (6.0) 36.7 (6.0) 36.8 (6.3) 37.3 (5.8) ns 
saturated fat % 14.1 (3.0) 14.3 (3,0) 14.6 (3.2) 15.1 (3.1) • 
carbohydrates % 41.9 (6.9) 42.2 (7.1) 43.2 (7.1) 42.6 (7.2) •• 
mono/disaccharides % 20.2 (6.3) 20.6 (6.2) 21.8 (6.3) 20.5 (6.0) ... 
t test for trend across age groups (55-64 years, 65-74 years, 74-95 years) 
os = not significant, • to '0, P <0.05, p<O.OOI, p<O.OOOI 
trnean alcohol consumption ofmeo drinking alcohol (87%) 
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Table 2b: Mean daily intake of energy and selected nutrients, energy distribution and 
nutrient density for selected nutrients of women in the Rotterdam Study 
Women Test 
for 
55-64 years 65-74 years 75-84 years 85-95 years trendt 
n = 1331 n = 1193 n=612 n=73 
mean (SD) mean (SD) mean (SD) mean (SD) 
Nutrients 
Energy(MJ) 7.5 (1.7) 7.4 (1.6) 7.4 (1.7) 7.9 (2.2) ns 
Protein 
total (g) 78.6 (16.8) 75.1 (16.3) 74.1 (17.4) 75.1 (22.4) ... 
vegetable protein (g) 26.7 (7.2) 25.7 (7.0) 24.4 (6.5) 25.2 (7.1) ... 
Fat 
total (g) 72.1 (23.4) 72.3 (22.8) 74.0 (23.2) 82.1 (29.3) • 
saturated fat (g) 28.3 (10.3) 29.0 (10.2) 30.5 (10.6) 33.5 (13.2) ... 
monounsaturated fat (g) 24.6 (8.5) 24.3 (8.6) 24.8 (8.6) 27.6 (11.1) ns 
polyunsaturated fat (g) 13.6 (6.7) 13.4 (6.7) 13.0 (7.0) 14.7 (7.3) • 
linoleic acid (g) 11.4 (6.5) 11.1 (6.4) 10.6 (6.6) 11.6 (6.7) •• 
Carbchydrates 
total (g) 195.4 (53.9) 195.5 (49.6) 195.6 (52.3) 207.8 (68.5) ns 
mono/disaccharides (g) 97.8 (36.6) 99.7 (35.0) 103.5 (38.6) 111.5 (47.4) ... 
polysaccharides (g) 96.9 (26.9) 95.2 (24.5) 91.5 (23.8) 94.7 (29.6) ... 
Cholesterol (mg) 217 (70) 214 (71) 219 (74.5) 243 (93) ns 
Dietary fiber (g) 16.5 (4.8) 15.8 (4.5) 15.3 (5.0) 16.0 (8.8) ... 
Water (ml) 2483 (614) 2391 (596) 2334 (554) 2216 (632) ••• 
Alcohol (g) t 9.4 (I 1.7) 8.4 (10.9) 5.8 (8.3) 5.4 (8.8) ••• 
Energy density 
Cholesterol (mg/MJ) 29.1 (7.6) 29.0 (7.7) 29.6 (7.6) 30.6 (7.0) liS 
Dietary fiber (g/MJ) 2.3 (0.6) 2.2 (0.6) 2.1 (0.7) 2.0 (0.7) ... 
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table 2b continued 
Women Test 
for 
55-64 years 65-74 years 75-84 years 85-95 years trendt 
n ~ 1331 n~1l93 n~612 n ~ 73 
mean (SO) mean (SO) mean (SO) mean (SO) 
Energy distribution 
Energy from: 
protein % 17.8 (3.2) 17.2 (3.0) 17.0 (3.1) 16.2 (3.2) ••• 
fat % 35.7 (6.3) 36.2 (6.19 37.2 (6.4) 38.6 (6.3) ... 
saturated fat % 14.0 (3.2) 14.5 (3.3) 15.4 (3.6) 15.7 (3.2) ... 
carbohydrates % 43.6 (6.9) 44.2 (6.6) 44.2 (6.7) 43.8 (5.8) • 
mono/disaccharides % 21.7 (6.2) 22.4 (5.8) 23.3 (6.3) 23.3 (5.3) ... 
t test for trend across age.groups (55.~~ years, 65·74 years:.?5-95 years) 
ns = not siginificanl; p<O.05; p<o.oOJ; p<O.OOOJ 
tmean alcohol consumption of women drinking alcohol (73%) 
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Energy and Nutrient Intake 
Men reported significantly higher mean intakes of energy and all nutrients from food 
intake compared compared to women except for water and calcium, which were similar, 
and vitamin C which was lower in men. Mean alcohol consumption among drinkers of 
any alcohol (men 87%; women 73%) was higher in men than in women with 18.9 gld 
compared to 8.3 gld. Linear trend analysis across age groups showed a general decline in 
energy and nutrient intake with advancing age in men which was significant for most 
nutrients (table 2a, 3a). However, percentage of energy from saturated fat, 
mono/disaccharides and carbohydrates increased whereas percentage of energy from 
protein decreased. In women, mean intake of most nutrients decreased (e.g. water, 
protein, magnesium, potassium, zinc, pyridoxine, Jl-carotene), but some increased (e.g 
total fat, saturated fat, mono/disaccharides, or the percentage of energy of these nutrients, 
respectively), and some showed no substantial changes (e.g. calcium, retinol) (table 2b, 
3b). 
Some baseline characteristics (age- and sex-adjusted) were related to energy and nutrient 
intake. A significant inverse relationship between BMI and reported energy intake was 
present for both men and women which was consistent over age groups. Current 
cigarette smokers had significantly higher intakes of macro nutrients (e.g. carbohydrates, 
mono/disaccharides, saturated fat) and significantly lower intakes of micronutrients (e.g. 
calcium, vitamin C) compared to nonsmokers and former smokers. Lower educational 
attainment was associated with a higher intake of macronutrients in general and a less 
favourable fat composition (van Rossum, unpublished observations). Disability and 
reported difficulty with food intake were associated with lower intakes of energy and 
most nutrients. Living independently compared to living in a service flat only marginally 
influenced energy and nutrient intakes. 
Dietary regimen 
A prescribed diet was reported by 231 men (10.4%) and 469 women (15.3%). Figure 2 
shows the percentage of men and women currently following different types of a diet. 
Only for women a significant increase with age in the percentage of prescribed diets was 
seen (ANOV A; p < 0.000 I) (table I). Of the 700 men and women reporting a prescribed 
diet, 153 followed a combined dietary regime. The most commonly used combinations 
were a sodium/fat-restricted diet, a fat/cholesterol-restricted diet, or a diabetes diet with 
41 
Chapter 2.2 
sodium or fat restriction. Subjects currently following a prescribed diet generally 
reported lower energy and nutrient intakes compared to subjects not on a dietary 
regimen. The observed decrease in energy and nutrient intake was more pronounced for 
macronutients tban for micronutrients witb the exception of sodium. The reported energy 
and nutrient intake between different dietary regimes differed according to the aim of the 
prescribed diet. 
Figure 2: Men and women following different types of prescribed diet 
in the Rotterdam Study 
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Supplementation 
aMen 
.Women 
Information on supplement use during the past year was obtained in 5334 persons (2183 
men, 3151 women). Of tbose, 1267 women (40.2%) and 580 men (26.6%) reported 
regular use of supplements. Consumption of more than two different supplements was 
reported by 4.8% of men and 9.3% of women. The type of supplements consumed 
included vitamins, minerals and a variety of preparations such as garlic, brewer's yeast, 
ginseng, and fish oil. Use of supplementation showed no clear trend with age (table I). 
The most popular supplement was garlic (n = 572), followed by tonicum supplement 
(n = 107) and brewer's yeast (n = 86). Use of vitamin/mineral supplementation was 
reported by 307 men (14.1%) and 793 women (25.2%). The most frequently consumed 
mineraVvitamin supplements Were multivitamins (n = 329), vitamin C (n = 309), calcium 
(n = 229), vitamin B preparations (n = 135), multiminerals (n = 123) and vitamin D 
(n = 83). 
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Table 30: Mean daily intake of selected vitamins and minerals of men in the Rotterdam 
Study 
Men Test 
for 
55-64 years 65-74 years 75-84 years 85-95 years trendt 
n=948 n=902 n=352 n=24 
mean (SO) mean (SO) mean (SO) mean (SO) 
Minerals 
Calcium (mg) 1205 (471) 1117 (414) 1081 (386) 1035 (297) ... 
Phosphor (mg)- 1843 (820) 1673 (802) 1604 (646) 1514 (432) ••• 
Iron (mg) 13.8 (3.2) 12.8 (2.9) 12.3 (2.8) 11.8 (2.5) ••• 
Sodium from food (mg) 2584 (761) 2385 (681) 2317 (628) 2408 (893) ••• 
Potassium (mg) 4083 (910) 3823 (817) 3653 (739) 3630 (743) ••• 
Magnesium (mg) 350.9 (86.3) 320.0 (74.5) 306.9 (68.1) 307.4 (68.4) ... 
Zinc (mg) 12.1 (3.0) 11.2 (2.5) 10.7 (2.6) 10.2 (2.3) ... 
Vitamins 
Vitamin A (mg RE) 0.93 (0.47) 0.87 (0.38) 0.88 (0.36) 0.78 (0.23) • 
6-carotene (mg) 1.66 (0.70) 1.49 (0.59) 1.42 (0.56) 1.19 (0.47) ••• 
TIliamin (mg) 1.27 (0.34) 1.17 (0.31) 1.13 (0.36) 1.09 (0.24) ... 
Riboflavin (mg) 1.72 (0.62) 1.58 (0.53) 1.57 (0.50) 1.57 (0.42) ••• 
Pyridoxine (mg) 1.84 (0.45) 1.71 (0.40) 1.63 (0.38) 1.63 (0.34) ... 
Niacin (mg) 12.9 (4.7) 11.0 (3.8) 9.9 (3.0) 10.1 (3.1) ... 
Tocopherol (mg eqv) 15.6 (6.6) 15.3 (6.9) 14.7 (6.3) 13.3 (6.8) •• 
Vitamin C (g) 116.6 (52.4) 114.8 (49.5) 112.8 (46.7) 92.5 (33.5) ns 
t test for trend across age groups (55-64 years, 65-74 years, 74-95 years) 
?s = not significant 
p <0.05 
P < 0.001 
... p<O.OOOI 
43 
Chapter 2.2 
Table 3b: Mean daily intake of select cd vitamins and minerals of women in the 
Rotterdam Study 
Women 
55·64 years 65-74 years 75-84 years 85-95 years 
n= i331 n= 1193 n=612 n=73 
mean (SD) mean (SD) mean (SD) mean (SD) 
Minerals 
Calcium (mg) 1125 (386) 1090 (349) 1115(381) 1134 (551) 
Phosphor (mg) 1697 (754) 1612 (727) 1610 (724) 1619 (820) 
Iron (mg) 11.5 (2.5) 11.0 (2.4) 10.4 (2.5) 10.8(3.5) 
Sodium from foed (mg) 2092 (582) 1993 (532) 1954 (564) 2061 (699) 
Potassium (mg) 3590 (765) 3469 (729) 3381 (798) 3450 (998) 
Magnesium (mg) 298 (66) 285 (62) 277 (65) 285 (80) 
Zinc (mg) 10.2 (2.3) 9.7 (2.3) 9.6 (2.5) 9.6 (2.9) 
Vitamins 
Vitamin A (mg RE) 0.76 (0.37) 0.76 (0.37) 0.77 (0.34) 0.89 (0.47) 
B-carotene (mg) 1.61 (0.79) 1.46 (0.79) 1.41 (0.94) 1.37 (0.53) 
Thiamin (mg) 1.07 (0.26) 1.02 (0.25) 0.99 (0.27) 1.00 (0.28) 
Rihoflavin (mg) 1.51 (0.48) 1.47 (0.46) 1.50 (0.50) 1.60 (0.74) 
Pyridoxine (mg) 1.50 (0.34) 1.46 (0.32) 1.42 (0.34) 1.40 (0.38) 
Niacin (mg) 9.7 (2.7) 8.9 (2.7) 8.1 (2.4) 8.0 (2.6) 
Tocopheroi (mg eqv) 12.8 (5.5) 12.8 (5.5) 12.5 (5.7) 13.9 (5.9) 
Vitamin C (g) 125.8 (55.0) 123.5 (2.7) 123.3 (64.2) 121.6 (47.7) 
t test for trend across age groups (55-64 years, 65-74 years, 75-95 years) 
?s = not siginificant; 
p <0.05 
p<O.OOI 
... p<O.OOOI 
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DISCUSSION 
In this paper we described a new approach to improve feasability of dietary assessment 
by SFFQ in the elderly. The assessment comprised a simple self-adminstered dietary 
questionnaire which formed the basis for an interview with a trained dietitian. Average 
time for completion of the self-administered questionnaire was 20 minutes, and a further 
20 minutes were allocated to conduct the dietary interview. Information concerning 
dietary intake was obtained in 5434 participants of the Rotterdam Study, and intake ofa 
variety of nutrients was calculated. In men, a general decline in intake of energy and 
most nutrients was observed with age. In women, the relation with age was not 
consistent: mean intake for most nutrients showed a significant decline, some showed an 
increase, and others showed no substantial change with age. Body mass index, smoking 
status, socioeconomic status, and activities of daily living were observed to influence 
reported nutrient intake. 
Before interpreting the results, some methodological aspects of the study need to be 
addressed. The Rotterdam Study is a community based prospective cohort study in 
Rotterdam. Baseline data were collected by means of an extensive general home 
interview and two visits at the research center. In general, relatively healthy community 
dwelling elderly are more likely to participate in a study such as the Rotterdam Study"l4. 
Application of exclusion criteria for dietary assessment analysis such as exclusion of 
nursing home residents and persons with a known reduced cognitive function may have 
further contributed to the formation of a relatively healthy cohort. Thus, we cannot 
exclude the possibility of an overrepresentation of persons with a dietary pattern similar 
to a healthier population, particularly in the older age groups. If this is true, the observed 
decreased intake of most nutrients with age, especially in men as compared to the general 
population ofthis age is probably underestimated. 
Efficiency in dietary assessment was aimed by conduct of two consecutive steps (figure 
I). A checklist of foods completed by the participants at home made the subjects aware 
of their food consumption and the items marked by the participants informed the dietitian 
about the meal pattern and the foods consumed regularly. This, subsequently, allowed 
the dietitian to focus during the interview only on specification of amounts and 
frequencies of reported items during the interview. Thus, respondent burden, which is 
seen as a specific problem of dietary assessment in the elderlyl,2, was kept low. Time for 
45 
Chapter 2.2 
completion of the self-administered questionnaire averaged 20 minutes and another 20 
minutes were allocated for the dietary interview. Thus, total time for dietary assessment 
was approximately 40 minutes. Combination of methods, use of memory strategies, or 
prior notification of a dietary interview have been shown previously to be useful in 
obtaining accurate and complete recalls in elderly people". 
Visual check of formal completeness of the self-administered questionnaire and by the 
dietitians, their professional judgement concerning unreliable dietary assessment (3.8% 
unreliable dietary assessments), and logical checks build in the interactive data entry 
progranune further ensured to obtain complete recalls in our study. 
The presence of over- and underreporting in dietary assessment has been extensively 
documented for various methods and for diverse populations and age groupsl2. Studies 
using the doubly labeled water method to assess total energy expenditure confirmed that 
self-reports of energy and food intake tend to be underestimatedJ6.J8. Underestimation of 
food intake may be due to the tendency of subjects to conceal their true dietary intake 
consiously or unconciously. Some authors suggested underreporting to be dependent on 
the degree of obesityJ9.2o and for elderly women adiposity WIIS shown to be a 
independent predictor of underreporting2o. In our study population of 5434 elderly 
subjects the ratio of energy intake to basal metabolic rate (EIIBMR) was significantly 
associated with age (table I) partially to be explained by the observed significant 
decrease of estimated BMR with age. EIIBMR was also found to be significantly inverse 
associated with BMI (Pearson's r = 0.36, p > 0.0001). Stratification by age strata «65, 
65-74, >74 years) revealed that EIIBMR significantly decreased across categories of 
BMI «25, 25-30, >30) suggesting underreporting of obese subjects independent of age. 
The results of this study are generally in accordance with other surveys of smaller size 
conducted in this age group in the Netherlands, despite the use of a different FFQ or a 
different methodology for dietary assessment"'''. However, some differences were 
observed. Intakes of protein and vitamin C intake were consistently lower, whereas 
intakes of fat, saturated fat, cholesterol, and dietary fiber were consistently higher in the 
present study. Differences may be partly attributable to the use of an updated food 
composition table in the present study. Changes in the composition of foods and 
improvements in the quality of data in the current food composition table were shown to 
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be the major cause for changes in dietary fiber and fat intake estimates in the Dutch 
National Food Consumption Survey in 1987/88 compared to 1992'6. 
Comparison with large-scale studies in the elderly conducted in the US revealed some 
differences"·29. Nutrient estimates derived in the Rotterdam Study showed good 
agreement on macronutrient level with nutrient estimates obtained by FFQ method in the 
Iowa's Women Study29. For calcium, however, the Dutch estimates were considerably 
higher (circa 300 mg/d), whereas for vitamin A (retinol and ll-carotene), vitamin C, and 
the B vitamins the estimates were lower. In the Beaver Dam Stud/' nutrient estimates 
obtained by diet history questionnaire (age group 65-84 years) were considerably lower 
compared to the Rotterdam Study except for vitamin B complex and vitamin C. Similar 
results were found for the Ross Laboratories Elderly Dietary Survey {RLEDSio, in 
which diet was assessed by 24-h recall and in the 1987 National Health Interview Survey 
(NHIS/7 using a 60-item FFQ. In summary, dietary intake of most nutrients in the 
elderly of the Rotterdam Study compared to the US studies cited has been found to be in 
general higher, except for vitamin C and B-vitamins (thiamin, riboflavin, pyridoxine, 
niacin). The widespread use of products fortified with vitamin B-complex and other 
vitamins/minerals in the USA may explain this observation. 
A substantial part of the subjects in our study followed a prescribed dietary regimen as is 
in accord with other studies in the elderl/4. Prescribed diets were more prevalent among 
women than among men. The number of persons reporting a prescribed diet increased 
significantly with age (table I). Because we assume that prescribed diets are consumed 
over a relatively long period and because we are interested in average dietary intake over 
a longer period (preceeding year) we did not exclude subjects following a prescribed diet 
from the analysis. 
Dietary supplements, especially vitamin and mineral preparations, are generally regarded 
as important sources of micronutrients. Supplement use in the Rotterdam Study was not 
recorded with sufficient accuracy to incorporate vitamin and mineral intake through 
supplements in the computation of nutrient intakes. However, data on supplement use as 
collected in our study provide enough precision to classifY individuals correctly as users 
or non-users of those supplements in the past year3l. In a validation study using the same 
method a sensitivity of 65.9% and a specificity of 98.5% were reported with a kappa 
statistic of 0.6931 for classification of users or non-users of the past year. The use of 
supplements respectively vitamin/mineral supplements in the Rotterdam Study was 
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somewhat higher than reported in the Dutch National Food Consumption Survey24,32 and 
and the National Diet and Nutrition Survey in the elderly in the UK33, but considerably 
lower than that observed in American elderly, where figures range from 28% in the 
NHIS26 to 60% in the Iowa's Women Study". 
CONCLUSION 
We described a novel two-step dietary assessment approach for use in epidemiological 
studies in the elderly, applied it across a wide age range in a large elderly population, and 
reported estimates of nutrient intake. We conclude that the adapted SFFQ facilitated 
collection of data on dietary habits in the elderly within a limited time frame and 
consider it to be a suitable instrument for dietary assessment in large scale epidemiologic 
studies. 
REFERENCES 
I. Kelsey JL, O'Brien LA, Grisso JA et al. Issues in carrying out epidemiologic research in the elderly. 
AIIIJ Epidemiol1989; 130:857-866 
2. Van StavereJ] WA, de Groot LCPGM et al. Assessing diets of elderly people: problems and 
approaches. Am J elill Nulr 1994; 59:22IS-223. 
3. Hofinan A, Grobbee DE, De Jong PTVM et a!. Determinants of disease and disability in the elderly: 
The Rotterdam Elderly Study. Eur J Epidemiol1991; 7:403-422. 
4. Van den Brandt PA, Goldbohm RAJ van't Veer P et al. A large~scale prospective cohort study on 
diet and cancer in the Netherlands. J Clill Epidemiol 1990; 121:783-790 
5. Goldbohm RA, van den Brandt PA, Brauts HAM et al. Validation of a dietary questionnaire used in 
a large-scale prospective cohort study on diet and cancer. Eur J Clill Nutr 1994; 48:253 M 265. 
6. Goldbohm RAJ van't Veer P, van den Brandt PA et al. Reproducibility ofa food frequency 
questionnaire and stability of dietary habits det~nnined from five annually repeated measurements. 
Ellr J eli" Nutr 1995; 49:420-429. 
7. Food and Nutrition Council. Dutch food composition table (NEVO). 1993. The Hague, Netherlands: 
Voorlichtingsbureau voor de Voeding (in Dutch). 
8. KlipsteinMGrobusch K, den Breeijen JHJ Goldhohm RA et al. Dietary assessment in the elderly: 
validation of a semiquantitative food frequency questionnaire. Eur J Clill Nutr 1998; 52:588-596. 
9. Willett we, Stampfer Ml. Total energy intake: implications for epidemiologic analysis. AmJ 
Epidellliol 1986; 124: 17-27. 
48 
Application of a semiquantitative food frequency questionnaire 
10. Beaton GH, Milner J, Corey P et al. Source of variance in 24M hour dietary recall data: implications 
for nutrition study design and interpretation. Am J CIiIJ NlItr 1979; 32:2546M2559. 
II. Garrow JS. Validation of methods for estimating habitual diet: proposed guidelines. Eur J Clill 
Nlltr 1995; 49:231-232. 
12. Black AE, Goldberg GR, Jebb, SA et al. Critical evaluation of energy intake data using principles of 
energy physiology: 2. Evaluating the results of published surveys. Elfr J Clill Nlltr 1991; 45:583-
599. 
13. Department of Health: Dietary reference values for food energy and nutrients for the United 
Kingdom. Annex 2. London, U.K. HMSO, 1994. 
14. Herzog AR, Rodgers WL. Age and response rates to interview sample surveys. JGerolllol1988; 
43:S2000-2005. 
15. Chiannetta MM, Head MK. Effect of prior notification on accuracy of dietary recall in the elderly. J 
Alii Diet Assoc 1992; 92:741-743. 
16. Black AE, Prentice AM, Goldberg OR et a!. Measurements of total energy expenditure provide 
insight into the validity of dietary measurements of energy intake. JAm Diet Assoc 1993, 93:572M 
579. 
17. Goran MI, Poehlman ET. Total energy expenditure and energy requirements in healthy elderly 
persons. MetabolisIII1992; 41:744-753. 
18. Livingstone MBE, Prentice AM, Strain JJ et a!. Accuracy of weighed dietary records in studies of 
diet and health. BMJ 1990; 300:708-712. 
19. De Vries JH, Zock PL, Mensink RP et a!. Underestimation of energy intake by 3-d records compared 
with energy intake to maintain body weight in 269 nonobese adults. Alii J Clill Nlltr 1994; 60:855-
860. 
20. Lichtman SW, Pisarska K, Berman ER et al. Discrepancy between self-reported and actual caloric 
intake and exercise in obese subjects. N ElIgl J Med 1992; 327: 1893-1898. 
21. Johnson RK, Goran MI, Poehlman ET. Correlates of over-and underreporting of energy intake in 
healthy older men and women. Alii J Clill Nlltr 1994; 59: 1286-1290. 
22. Grootenhuis PA, Westerbrink S, Sie CM et al. A semiquantitative food frequency questionnaire for 
use in epidemiologic research among the elderly: validation by comparison with dietaty history. J 
Clill Epidemiol1995; 48:859-868. 
23. Ulwik MRH, Westenbrink S, HulshofKFAM et al. Nutrition and aging: Dietary intake of 
"apparently healthy" elderly - The Dutch Nutrition Surveillance System. JAm Call Nutr 1990; 
8:347-356. 
24. Ulwik MRH, Brussaard JH, HulshofKFAM et al. Adequacy of the diet in the NetllCriands in 1987-
1988. Dutch Nutrition Surveillance System. lilt J Food Sclellces mId Nlltr 1994; 45:81-S62. 
25. MoreirasMVarela 0, van Staveren WA, Amorim Cruz JA et al. Intake of energy and nutrients. 
Euronut SENECA Investigators. Eur J Clill Nutr 1991: 45:S 105-120. 
26. HulshofKFAM, Lowik MRH, Kistemaker L. Changes in the composition ofthe Dutch diet. 
Abstract; Second International Conference on Dietary Assessment Methods. Boston 1995 
49 
Chapter 2.2 
27. Block 0, Suhar AF. Estimates of nutrient intake from a food frequency questiOimaire: The 1987 
National Health Interview Survey. J Alii Diet Assoc 1992; 92:969-977. 
28. Mares-Perlman JA, Klein BEK, Klein R et 81. Nutrient supplements contribute to the dietary intake 
of middle- and older-aged adult residents of Seaver Dam, Wiscollsirt J Nutr 1993; 123:176-188. 
29. Munger RGJ Folsom AR. Kushi LH et al. Dietary assessment of older Iowa women with a food 
frequency questionnaire: Nutrient intake, reproducibility, and comparison with 24-hour dietary recall 
interviews. Am J EpidelllioiI992; 136:192-200. 
30. Ryan AS, Craig LD, Finn SC: Nutrient intakes and dietary patterns of older Americans: A national 
study. JGerollloiogy 1992; 47:MI45-150. 
31. Dorant E, van den Brandt PAJ Goldbohm RA et al. Agreement between interview data and a self-
administered questionnaire on dietary supplement use. Eur J Cli" Null' 1994; 48: 180-188. 
32. Dorant E, van den Brandt PA, Hamstra AM et a!. The use of vitamins, minerals, and other dietary 
supplements in the Netherlands.lntemat J Vit Null' Research 1993; 63:4-10. 
33. Bates CJ, Prentice A, van der Pols Je et al. Estimation of the use of dietary supplements in the 
National Diet and Nutrition Survey: People aged 65 years and over. An observed paradox and a 
recommendation. EurJ eli" Nutr 1998; 52:917-923. 
50 
CHAPTER 3 
Prooxidants in coronary heart disease 
51 
I 
I 
I 
I 
I 
I 
3.1 
Serum ceruloplasmin as coronary risk factor in the elderly 
ABSTRACT 
Serum copper and ceruloplasmin have been suggested to be independent risk factors for 
coronary heart disease operating through oxidative modification of low-density lipoprotein. 
However, given its ftmction as an acute-phase protein, the question has been raised whether 
elevated ceruloplasmin is not merely an indicator of inflammation. In the current study, we 
investigated whether serum ceruloplasmin was associated with subsequent myocardial 
infarction taking into account indices ofinflarnmation. The study population consisted of21O 
cases of first myocardial infarction and controls, frequency-matched on age (5-year categories) 
and sex selected from the population-based cohort of the Rotterdam Study. Serum 
ceruloplasmin levels were significantly elevated in cases of myocardial infarction compared to 
controls (510 (SD 110) v. 470 (SD 100) mg/l; p=0.007). Risk of myocardial infarction for the 
highest compared to the lowest quartile of ceruloplasmin was 2.46 (95% CI 1.04-6.00; 
P","d=0.043) after adjustment for age, sex, body mass index, packyears smoked, serum 
cholesterol, systolic blood pressure, and income. The relative risk was most evident in current 
smokers. Adjustment for C-reactive protein and white blood cell count reduced the excess risk 
by 33%. This suggests that a substantial part of the observed association between serum 
ceruloplasmin and coronary heart disease may be attributed to inflammation processes rather 
than to the pro-oxidant activity of ceruloplasmin. 
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INTRODUCTION 
Elevated serum ceruloplasmin levels have been found in patients with cardiovascular 
disorders including arteriosclerosis, abdominal aneurysms, unstable angina, and 
vasculitis and peripheral artery disease'. Several prospective studies have indicated 
that serum copper or ceruloplasmin may be an independent risk factor for 
cardiovascular disease2•7• The increased risk has been attributed to pro-oxidant activity 
of ceruloplasmin and recent experimental studies demonstrating the ability of 
ceruloplasmin to oxidatively modifY low-density lipoprotein8•9 seem to underline this 
notion. However, the question has been raised whether elevated ceruloplasmin is not 
merely an indicator of inflammation given its acute-phase protein property. So far, 
most studies investigating the association between serum ceruloplasmin or copper 
lacked information on indicators of inflammation. In the current study we obtained 
information on C-reactive protein and white blood cell count as indicators of 
inflammation. We examined whether serum ceruloplasmin is associated with an 
increased risk of myocardial infarction taking into account possible markers of 
inflammation. 
SUBJECTS AND METHODS 
Study popUlation and case ascertainment 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78%) aged 55 years and over, living in Ommoord, an urban district in 
Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of and 
the risk factors for chronic and disabling diseases, as described elsewhere lO• The study 
was approved by the Medical Ethics Committee of the Erasmus University, and written 
informed consent was obtained from all participants. 
Follow-up for coronary heart disease started after the baseline survey in 1990, and until 
April 1996 (mean 4 years) follow-up information was available for 94% of the cohort. 
With respect to the vital status of participants, information was obtained at regular 
intervals from the municipal health service in Rotterdam. Information on fatal and non-
fatal endpoints was obtained from the general practitioners (GPs) working in the study 
district of Ommoord. All possible events reported by the GPs were verified by research 
physicians from the Rotterdam Study through records of the participating GPs and 
medical specialists. Cause and circumstances of death were obtained by questionnaire 
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from the GP and by scrutinising infonnation from hospital discharge records in case of 
admittance or referral, shortly after reporting of death by the municipal health service or 
the GP. Classification of fatal and non-fatal events was based on the International 
Classification of Diseases, 10th edition ". For the present analysis only cases of first 
myocardial infarction (ICD-IO codes 121-124) were selected. All events were classified 
independently by two research physicians. If there was disagreement, a consensus was 
reached in a special session. Finally, all these events were verified by a cardiovascular 
disease expert. In case of discrepancies, the judgement by this expert was considered 
definite. 
The association between serum ceruloplasmin and risk of myocardial infarction was 
examined by use of a nested case-control design. Cases and controls were drawn from 
the population-based Rotterdam Study. For every subject with a myocardial infarction 
during follow-up (n= 202) a control without a myocardial infarction was selected. Age 
strata (5-year interval) and sex were used as matching variables. For detennination of 
serum ceruloplasmin and C-reactive protein frozen sera were available for 255 subjects, 
III myocardial infarction cases and 144 controls. Availability of blood samples of cases 
and matched controls in this project depended on the date of the event and were not 
related to serum ceruloplasmin levels. Exclusion of subjects with history of myocardial 
infarction at baseline resulted in a study population of 210 subjects (83 cases and 127 
controls) for the present analysis. 
Measurements 
Baseline infonnation on current health status, medical history, drug use, education, 
income, and smoking behaviour was obtained with a computerised questionnaire during 
a home interview. Height and weight were measured, and body mass index (weight in 
kglheight in m2) was calculated as a measure of obesity. Sitting blood pressure was 
measured on the right upper ann with a random-zero sphygmomanometer. The average 
of two measurements was used in the analysis. A venepuncture was perfonned and 
haematological parameters were obtained by standard clinical laboratory procedures. 
Serum total and high density lipoprotein (HDL) cholesterol concentrations were 
detennined by an automated enzymatic procedure. Alcohol intake was estimated by use 
of a semiquantiative food frequency questioilllaire assessing habitual food intake during 
the past yearl2. Frozen sera, preserved at -20°C, and collected from the cases and the 
controls simultaneously at study baseline were used to detennine serum concentrations 
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of ceruloplasmin and C-reactive protein. Sera from cases and controls were analysed in 
the same run. Serum ceruloplasmin concentrations and C-reactive protein were 
determined by kinetic nephelometry by use of a Beckman-Array system (Munich, 
Germany). For five subjects (cases/controls) C-reactive protein could not be determined 
due to insufficient serum for analysis. Interassay coefficients of variation were 4.6% for 
ceruloplasmin and 3.8% for C-reactive protein. 
Data Analysis 
Associations between serum ceruloplasmin concentrations and risk factors for ischemic 
heart disease were estimated by use of Pearson's correlation coefficient (continous 
variables) and analysis of variance (categorical variables) adjusted for age and sex. The 
association between quartiles of serum ceruloplasmin and risk of myocardial infarction 
was investigated by multiple logistic regression comparing risk of myocardial infarction 
in the upper quartiles to the lowest quartile of serum ceruloplasmin. Analyses were 
initially adjusted for age and sex and subsequently for body mass index, packyears 
smoked, equivalent household income (five categories), serum cholesterol, and systolic 
blood pressure. Stratification procedures were used to evaluate whether smoking 
status, hypertension (systolic blood pressure ;;, 140 mm Hg andlor diastolic blood 
pressure ;;,90 mm Hg andlor use of antihypertensive medication), 
hypercholesterolemia (serum cholesterol levels ;;,6.5 mmolll), or high-density 
lipoprotein cholesterol levels below the median modified the association between 
serum ceruloplasmin and myocardial infarction. We next examined to which extent 
ceruloplasmin reflects increased inflammation. First we included measures of 
inflammation in our multivariate logistic regression model - white blood cell count as 
continous, and C-reactive protein as a categorised variable using a cut-off point of 6 
gil. Second, we assessed whether exclusion of subjects with C-reactive protein levels 
above 6 gil modified the serum ceruloplasmin - myocardial infarction association. 
Associations are expressed as odds ratios with 95% confidence interval (CI). Results 
were considered statistically significant at the two-sided 0.-05 alpha level. Statistical 
analysis was performed using SAS® statistical software package version 6.11 (SAS 
Institute, Cary, NC, USA). 
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RESULTS 
Baseline characteristics of cases and controls of myocardial infarction are shown in 
table I. Significant differences were seen for white blood cell count, percentage of 
subjects with C-reactive protein levels above 6 gil, and income of at least 3000 Hfl 
(about £900)/month. Compared to controls cases of myocardial infarction had non-
significantly higher serum levels of cholesterol, have more packyears smoked, and 
were more often current smokers. 
Serum ceruloplasmin levels in the case-control population ranged from 220 to 790 
mgll with averages of 370, 460, 520, and 640 mgll in subsequent quartiles. 
Ceruloplasmin was significantly higher in cases than controls of myocardial infarction 
(510 (SD 110) v. 470 (SD 100) mgll; p=0.007). The distribution of serum 
ceruloplasmin for cases and controls is shown in figure I indicating a shift towards 
higher serum ceruloplasmin levels for incident cases of myocardial infarction 
compared to controls. 
Figure 1: Serum ceruloplasmin levels among myocardial infarction 
cases and controls 
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Serum ceruloplasmin adjusted for age and sex correlated significantly with serum 
cholesterol (r=0.25; p=0.0002), white blood cell count (r=0.24, p=0.0004), and 
packyears smoked (r=0.24; p=0.0004), and was significantly inverse associated with 
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serum HDL-cholesterol (r=O.l7, p=0.0170). No correlations were observed between 
ceruloplasmin and age, body mass index, waist-to-hip ratio, diastolic and systolic 
blood pressure, and alcohol intake. Mean ceruloplasmin was observed to be 
significantly higher (572 (SD 85) v. 470 (SD 94) mgll; p < 0.0001) for subjects with C-
reactive protein of at least 6 gil. These subjects also reported to have more packyears 
smoked and they were more likely to be current smokers. No correlation between 
white blood cell count and packyears smoked was seen. 
Table 1: Baseline characteristics of cases of myocardial infarction and controls 
(Mean values and standard deviations or percentage distribution) 
Variables 
Men(%) 
Age (years) 
Body mass index (kg/m') 
Waist-to-hip ratio 
Ceruloplasmin (mg/I) 
White blood cell count (lO'/I) 
Serum cholesterol (mmoUI) 
HDL-serum cholesterol (mmol/l) 
Systolic blood pressure (mm Hg) 
Diastolic blood pressure (mmHg) 
Packyears smoked (%) 
Current smokers(%) 
C-reactive protein above 6 g/I (%) 
High income§ (%) 
Cases of myocardial 
Infarction 
n=83 
45.8 
76.4 (8.7) 
26.2 (2.8) 
0.94 (0.09) 
510 (110) 
7.34 (2.20) 
6.67 (1.37) 
1.22 (0.26) 
148 (22) 
73 (14) 
17.9 (26.6) 
24.1 
21.3 
1.2 
Controls 
II = 127 
44.1 
76.8 (9.0) 
25.9 (3.5) 
0.92 (0.08) 
470 (100) 
6.70 (1.73) 
6.46 (1.37) 
1.28 (0.32) 
143 (23) 
74 (12.2) 
12.9 (27.0) 
17.3 
9.9 
9.5 
p. 
n.s. 
n.s. 
n,s. 
n.s. 
0.007 
0.020 
II,S. 
n.s, 
I1.S. 
I1.S. 
n,s. 
n,s. 
0.019 
0.013 
• for continous variables: analysis of variance adjusted for age and sex; for categorical variables: Mantel-
Haenszel Chi-square test adjusted for age and sex 
§ equivalent household income> 3000 Hfl (around £900) 
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When adjusted for age and sex, serum ceruloplasmin levels were significantly 
associated with increased risk of myocardial infarction (table 2). The odds ratio for the 
highest compared to the lowest quartile of ceruloplasmin was 2.96 (95% CI, 1.29-
6.84; P","d =0.0 I 0). The association remained statistically significant after adjustment 
for BMI, packyears smoked, income (five categories), serum cholesterol, and 
systolicblood pressure (table 2). Figure 2 depicts graphically a trend of increasing 
myocardial infarction risk across the quartiles of serum ceruloplasmin. We next 
stratified by smoking status, hypertension, hypercholesterolemia, and low high-density 
lipoprotein cholesterol levels. Results showed a significantly increased risk of 
myocardial infarction with elevated ceruloplasmin in current smokers compared to 
Table 2: Risk of myocardial infarction according to quartiles of serum ceruloplasmin 
concentration in the Rotterdam Study 
(Values are odds ratios (OR) and 95% confidence intervals) 
Variable Quartiles 
If 2 3 4 
(Lowest) (Higbest) 
No.ofM! 20 16 20 27 
serum level (mg/I) < 0.420 0.420 - 0.489 0.490 - 0.560 > 0.560 
Odds ratio (95% CI) 
age and sex adjusted 1.07 (0.47 - 2.42) 1,45 (0.65 - 3.25) 2.96 (1.29 - 6.84) 
multivariate adjusted· 0.97 (0.42 - 2.22) 1.31 (0.58 - 2.98) 2.59 (1.10 - 6.24) 
multivariate adjusted·· 0.99 (0.43 - 2.27) 1.28 (0.57 - 2.93) 2.46 (1.04 - 6.00) 
adjusted for CRP" 0.96 (0.41 - 2.22) 1.15 (0.49 - 2.68) 1.97 (0.76 - 5.18) 
adjusted for white 0.91 (0.39 - 2.11) 1.15 (0.50 - 2.66) 2.02 (0.82 - 5.06) 
blood cell count" 
f reference category 
, adjusted for age, sex, body mass index, packyears smoked, and equivalent houshold income (five 
categories) 
.. additonally adjusted for serum cholesterol and systolic blood pressure. 
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trend 
0.010 
0.029 
0.043 
0.189 
0.127 
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former and non-smokers. Risk estimates for quartiles of serum ceruloplasmin in 
smokers were I, 2.08 (0.29-19.81), 3.54 (0.43-38.81), and 9.12 (1.41-88.09), 
respectively with 95% CI in parentheses and a p-value for trend of 0.021. For 
hypertension, hypercholesterolemia, and low high-density lipoprotein cholesterol 
levels no risk modifications were observed (data not shown). 
Figure 2: Odds ratio and 95% confidence interval for myocardial 
infarction according to quartiles of serum ceruloplasmin 
multivariate adjustment* 
OR 
7 
6 
6 
4 
3 
+ 2 -+ 1 0 
II III IV 
Quarfiles or serum ceruloplasmin 
• adjusted for age, sex, body mass index, packyears smoked, equivalent household income (5 categories), 
alcohol intake (4 categories), serum cholesterol, and hypertension 
The excess risk of myocardial infarction for the highest compared to the lowest 
quartile of serum ceruloplasmin was reduced by 33% when white blood cell count was 
taken into account or when C-reactive protein was included in the model (table 2). For 
both, white blood cell count and C-reactive protein, a non-significant increased risk of 
myocardial infarction was observed in the multivariate models. Exclusion of subjects 
with C-reactive protein above 6 gil (28 subjects) resulted in an age- and sex-adjusted 
odds ratio of 2.18 (95% CI 0.88-5.49; Plnmd=0.107) for the highest compared to the 
lowest quartile of serum ceruloplasmin. In the multivariate adjusted model, an odds 
ratio of 1.73 (95% CI 0.65-4.73, Ptrcod=0.300) was observed. 
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DISCUSSION 
In the prospective cohort of the Rotterdam Study we observed a significant association 
between high baseline levels of serum ceruloplasmin and the subsequent risk for a first 
myocardial infarction. The association was most evident in current smokers. Serum 
ceruloplasmin was observed to be highly correlated with indices of inflammation. 
Exclusion of subjects with elevated C-reactive protein levels reduced the excess risk of 
myocardial infarction associated with high serum ceruloplasmin levels by 33%. For 
each 100 mg/I increase in serum ceruloplasmin we observed an increment of 41 % in 
myocardial infarction risk. Comparable findings of an elevated risk of myocardial 
infarctionS and incidence of coronary heart disease6 among persons with high levels of 
serum ceruloplasmin have been previously reported. Several other studies reported 
associations of high levels of serum copper to elevated risk of increased carotid intima-
media thickness3, myocardial infarction', and mortality from coronary heart disease or 
cardiovascular disease"'. 
Ceruloplasmin in which 90-95% of serum copper is bound, is considered a physiologic 
inhibitor of lipid peroxidation. However, besides its antioxidant properties such as its 
ability to scavenge superoxide and other reactive species and the inhibition of the 
Fenton reaction by conversion ofFe'+ to Fe3+ through ferroxidase activity, pro-oxidant 
activities of ceruloplasmin have been proposed8• To explain the pro-oxidant activity of 
ceruloplasmin a pathway involving lipid and lipoprotein oxidation has been suggested. 
Recent data indicate that ceruloplasmin by itself can oxidise LDL in vitro and possibly 
in viv08.'3. However, accessory factors derived from vascular cells may be modulatory 
or requisite during lipoprotein oxidation within the vessel wall'. 
An alternative explanation for the association between elevated serum ceruloplasmin 
levels and increased incidence of CHD is its property as acute-phase protein. Since an 
increase of ceruloplasmin can be mediated by many unspecific factors causing tissue 
injury, a high ceruloplasmin level may reflect response to injury or inflammation. 
Endothelial injury and inflammatory processes are thought to be involved in the 
pathogenesis of atherosclerosis and markers of inflammation and infection, such as 
white blood cell count, fibrinogen, and C-reactive protein have been shown to be 
independent risk factors for coronary heart disease14·'8. Most previous studies have not 
taken into account markers of inflammation. We investigated whether the observed 
61 
Chapter 3.1 
associations in our study may have been due to the presence of inflammation. 
Including white blood cell count or C·reactive protein in the multivariate logistic 
regression model substantially reduced the risk estimate. We next excluded subjects 
with clinically elevated C·reactive protein from the analysis. Risk of myocardial 
infarction with serum ceruloplasmin levels was considerably decreased but still 
present. This suggests that a substantial part of the increased risk associated with high 
levels of serum ceruloplasmin may be attributed to inflammation processes. The 
remaining elevated risk may be due to other properties of ceruloplasmin, like its pro· 
oxidant activity or it may reflect low·level inflammation being involved in the 
cardiovascular disease process. 
In summary, we observed an elevated risk of myocardial infarction with high serum 
ceruloplasmin levels in the elderly population of the Rotterdam Study. Adjustment of 
markers of inflammation substantially reduced the association between serum 
ceruloplasmin and myocardial infarction. This results suggest that at least part of the 
observed risk association with high levels of ceruloplasmin can be attributed to it's 
property as acute phase protein. 
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Serum ferritin and risk of myocardial infarction in the elderly 
ABSTRACT 
Background: Elevated body iron stores have been suggested to be an ischemic heart disease 
risk factor. 
Objective: To examine whether elevated senun ferritin levels, other parameters of iron status, 
and dietary iron affect the incidence of myocardial infarction (MI) in an elderly population. 
Design: A nested case-control study of 60 cases of first MI and 112 controls frequency-
matched on age (5-year categories) and sex embedded in the population-based cohort of the 
Rotterdam Study. 
Results: Age- and sex-adjusted risk of MI for subjects with serum ferritin levels above 200 
fig/I was 1.82 (95% CI, 0.90-3.69; p=0.096). The odds ratio (OR) was 1.26 (95% CI 
0.98-1.64; p=0.078) for the highest compared to the lowest tertile of serum ferritin and was 
slightly altered in a multivariate model. Risk of MI associated with the highest compared to 
the lowest tertile of ferritin was found to be most evident in current or former smokers 
(OR=1.68; 95% CI 1.17-2.47; PU,"d=0.008) and in subjects with hypercholesterolemia 
(OR= 1.43; 95% CI 0.99-2.11; P","d=0.056) or diabetes (OR=2.50; 95% CI 1.15-8.05; 
PU,"d=0.020). No association with risk of MI was observed for tertiles of serum iron, serum 
transferrin, or total dietary iron. For dietary heme iron risk of MI was significantly increased 
in a multivariate model, additionally adjusted for categories of dietary energy, fat, saturated 
fat, and cholesterol (OR= 4.01; 95% CI 1.17-15.87; PU,"d=0.031). 
Conclusion: The observed association of elevated serum ferritin levels with myocardial 
infarction in high risk strata in an elderly population suggests that ferritin may adversely 
affect coronary heart disease risk in the presence of other risk factors. 
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INTRODUCTION 
Free iron - a catalyst of the production of free radicals - has been implicated in 
ischemic myocardial damage and lipid peroxidation. Plausible hypotheses as to how 
free iron may accelerate the progression of atherosclerosis or contribute to myocardial 
injury after an ischemic event have been generated from basic research. Direct 
evidence that high stored iron levels or high iron intake increase the incidence of 
coronary heart disease in humans, however, is limited. So far the strongest supporting 
evidence for iron as a coronary heart disease risk factor stems from a cohort study of 
Eastern Finnish men, where high levels of serum ferritin and dietary iron were 
positively associated with incidence of myocardial infarction!. Furthermore, serum 
ferritin was observed to be one of the strongest indicators of presence and progression 
of carotid artery disease2•3, and blood donation, depleting iron stores in blood donors, 
was associated with reduced risk of myocardial infarction 4 and cardiovascular disease5• 
However, most subsequent studies investigating whether iron status or dietary iron 
intake are associated with increased risk of myocardial infarction or coronary heart 
disease have not provided consistent results6.!4. Using a nested case-control approach, 
we studied whether serum ferritin and other parameters of iron status are associated 
with the incidence of myocardial infarction in the elderly population of the Rotterdam 
Study. 
SUBJECTS AND METHODS 
Study population and case ascertainment 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78%) aged 55 years and over, living in Ommoord, an urban district in 
Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of and 
the risk factors for chronic and disabling cardiovascular, neurodegenerative, locomotor, 
and ophthalmic diseases as described elsewherel5• The study was approved by the 
Medical Ethics Committee of the Erasmus University, and written informed consent was 
obtained from all participants. 
Follow-up for coronary heart disease started after the baseline survey in 1990. Until 
April 1996 (mean 4 years) follow-up infonnation was available for 94% of the cohort. 
With respect to the vital status of participants, information was obtained at regular 
intervals from the municipal health service in Rotterdam. Information on fatal and non-
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fatal endpoints was obtained from the general practitioners (GPs) working in the study 
district of Ommoord. All possible events reported by the GPs were verified by research 
physicians from the Rotterdam Study through records of the participating GPs and 
medical specialists. Cause and circumstances of death were obtained from the GP and 
from hospital discharge records in case of admittance or referral, shortly after reporting 
of death by the municipal health service or the GP. Classification of fatal and non-fatal 
events was based on the International Classification of Diseases, 10th editionl6• For the 
present analysis cases of first myocardial infarction (ICD-IO:I21-I24) were used. All 
events were classified independently by two research physicians. If there was 
disagreement about case status, a consensus was reached in a special session. Finally, all 
these events were verified by a cardiovascular disease expert. In case of discrepancies, 
the judgment by this expert was considered definite. 
The association between serum ferritin and risk of fatal and non-fatal myocardial 
infarction was examined by use of a nested case-control approach. For every subject with 
a first myocardial infarction during follow-up (n = 202) a control without a cardiac end-
point was selected. Age strata (5-year intervals) and sex were used as matching variables. 
Frozen sera, stored at -20°C for determination of serum ferritin were available for 255 
subjects (Ill myocardial infarction cases and 144 controls). Blood samples were not 
available for all cases and controls allocated to this study due to multiple use of blood 
samples in the Rotterdam Study. Subjects with C-reactive protein values above 6 gil or in 
case data for C-reactive protein were missing, erythrocyte sedimentation rate above 20 
nun/h (cases n = 25, controls n = 15) indicating presence of inflammation or infection 
that could potentially lead to elevated ferritin values were excluded from analysis. 
Further exclusion of subjects with a verified history of myocardial infarction resulted in 
172 subjects, 60 cases (35 nonfatal and 25 fatal) and 112 controls for analysis of serum 
ferritin and risk of myocardial infarction. 
Baseline measurements 
Information on current health status, medical history, drug use, education, income, and 
smoking behaviour was obtained with a computerized questionnaire during a home 
interview. Height and weight were measured, and body mass index (weight in kglheight 
in m2) was calculated as a measure of obesity. Sitting blood pressure was measured on 
the right upper arm with a random-zero sphygmomanometer. The average of two 
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measurements was used in the analysis. A venepuncture was performed and 
hematological parameters were obtained by standard clinical laboratory procedures. 
Serum total and high density lipoprotein (HDL) cholesterol concentrations were 
determined at baseline by an automated enzymatic procedure. Serum samples were 
collected from case and control subjects simultaneously at study baseline and frozen at 
-20°C until used to determine serum concentrations of ferritin, iron, transferrin, 
ceruloplasmin, and C-reactive protein. Sera from cases and controls were analyzed in the 
same run. Serum ferritin concentrations were determined by ELISA (Boehringer 
Mannheim, Germany). The coefficient of variation was 2.8%, 4.0%, and 10.4% for 
ferritin levels of 389, 139 and 27 IlglI, respectively. Serum transferrin and C-reactive 
protein (CRP) were measured by kinetic nephelometry by use of a Beckman-Array 
system (Munich, Gennany) and serum iron was detemlined by photometry on EPOS 
(Boehringer Mannheim, Germany). Coefficients of variation were 4%, 2%, 4.6%, and 
3.8% for transferrin, iron, ceruloplasmin, and C-reactive protein, respectively. 
Dietary assessment 
The semiquantitative food frequency questionnaire (SFFQ) completed during baseline 
aimed at assessing habitual food intake during the past year and included 170 food items 
in 13 food groups and questions about dietary habits, supplementation, and prescribed 
diets. SFFQ data were converted to nutrient intake using the computerized Dutch Food 
Composition Table17• Heme iron intake was estimated to account for 40% of the total 
iron found in meat, poultry, and fisht'. Data for fi-carotene, retinol, and tocopherol were 
updated by use of an additional database by the Netherlands Institute of Public Health 
and Environmental Protection (YCJ Vollebregt, EJM Feskens, unpublished observations, 
1993). Nutrient intake through nutritional supplements was not considered since brand 
labels, dose, and duration were not recorded with sufficient accuracy. The validity of the 
SFFQ was assessed in a subsample of 80 men and women aged 55 to 75 years. Nutrient 
intake estimated from the SFFQ was compared with estimated nutrient intake of in total 
15 days of food records collected over a one-year periodt9. The ability of the SFFQ to 
adequately rank subjects according to their dietary intake was demonstrated by Pearson's 
correlation coefficients (0.5 to 0.9 for crude data) and a high degree of classification into 
the same or adjacent quintile (75.8 percent for crude data). Pearson's con'e1ation 
coefficient between food records and SFFQ for iron was 0.67. 
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Data Analysis 
Associations between serum ferritin and risk factors for ischemic heart disease were 
investigated by use of Pearson's correlation coefficient and for categorical variables by 
chi-square statistics. Analysis of variance was used to test for differences in baseline 
characteristics between cases and controls of myocardial infarction. All analyses were 
adjusted for age and sex. Serum ferritin was categorized equal or below/above 200 Ilgl1 
ferritin and risk of nonfatal and fatal myocardial infarction was investigated by 
multivariate logistic regression. To evaluate whether there was a graded association 
between serum ferritin levels and risk of myocardial infarction, analysis was perforrued 
for tertiles of serum ferritin. Analyses were initially adjusted for age and sex and 
subsequently for body mass index (BMI), packyears smoked, equivalent household 
income (five categories), and alcohol intake (five categories). To evaluate whether 
smoking status, hypertension, hypercholesterolemia, or diabetes modified the 
association between serum ferritin and myocardial infarction, stratified analyses were 
conducted. In addition, the association of other measures of iron status (serum iron and 
transferrin) and dietary iron intake (total iron and heme iron) to risk of myocardial 
infarction was evaluated. 
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Figure 1: Serum ferritin levels among cases and controls 
of myocardial infarction 
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For dietary intake of total and heme iron the multivariate model was furthermore 
adjusted for categories of energy, fat, saturated fat, and cholesterol. Associations are 
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Table 1: Means (SD) and distribution (%) of baseline characteristics for cases and 
controls of myocardial infarction 
Cases of myocardial Controls pt 
infarction 
Variables 11=60 II = 112 
Men (%) 44.6 45.0 n,s. 
Age (years) 75.9 (8.5) 76.4 (8.9) 11.5. 
Body mass index (kglm') 26.2 (2.8) 26.0 (3.5) n,s, 
Waist-to-hip ratio 0.93 (0.09) 0.92 (0.08) n.s, 
Diastolic blood pressure (mmHg) 75 (12) 74 (12) 11.5. 
Systolic blood pressure (mm Hg) 148 (21) 143 (23) n,s. 
Ferritin (l'gll) 183 (168) 144 (142) n,s, 
Transferrin (gil) 2.52 (0.45) 2.59 (0.42) n.s. 
Serum iron (I'mol/l) 16.4 (5.0) 16.9 (5.2) n,s. 
Serum cholesterol (mmolll) 6.80 (1.22) 6.53 (1.33) n.s. 
HDL-serum cholesterol (mmolll) 1.26 (0.28) 1.27 (0.32) n.s. 
Obesity (%) 10.0 13.4 n.s, 
Hypertension (%n 36.7 32.1 n,s, 
Hypercholesterolemia (%)/ 55.0 44.6 n.s. 
Diabetes (%) 20.3 20.6 n.s. 
Current smokers (%) 18.3 16.1 1),5. 
High alcohol intake¥ 3.3 5.4 I1.S. 
Dietary iron (gld)§ 12.1 (2.7) 12.5 (3.5) n.s. 
Dietary heme iron (gld)§ 1.14 (0.46) 0.95 (0.36) 0.016 
t for continous variables: ANOVA adjusted for age and sex 
for categorical variables: Mantel-Haenszel Chi-square test adjusted for age and sex 
i systolic blood pressure ~ 160 mm Hg andlor diastolic blood pressure <?: 95 mOl Hg andlor use of medication 
f serum cholesterol> 6.5 mmoln 
¥ alcohol intake> 20 gld for females and> 30 gld for males 
§ dietary data available for 37 cases of myocardial infarction and 66 controls 
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Table 2: Odds ratio and 95% confidence intervals (CI) for myocardial infarction for 
tertiles of iron parameters 
Variable Tertlles P value tor 
I (Lowest)! 2 3 (Highest) trend 
serum ferritin 
No. ofMI Icontrols 17/41 17/40 26/31 
serum level (~gll) <77 77 -171 > 171 
Odds ratio (95% el) 
age and sex adjusted 1.00 1.0 I (0.67 - 1.51) 1.26 (0.98 - 1.64) 0.070 
multivariate adjustedt 1.00 1.08 (0.71 - 1.64) 1.28 (0.98 - 1.67) 0.066 
serum iron 
No. of MUcontrols 23/35 16/42 21/35 
serum level (pmolll) < 14.1 14.1- 18.9 > 18.9 
Odds ratio (95% CI) 
age and sex adjusted 1.00 0.75 (0.50 - 1.11) 0.95 (0.72 - 1.24) 0.699 
multivariate adjustedt 1.00 0.77 (0.51-1.15) 0.97 (0.73 - 1.28) 0.788 
serum transterrln 
No.ofMI 25149 20/31 15/32 
serum level (gil) <2.5 2.5 - 2.7 >2.7 
Odds ratio (95% CI) 
age and sex adjusted 1.00 1.12 (0.77 - 1.63) 0.97 (0.75 - 1.26) 0.909 
multivariate adjustedt 1.00 1.15 (0.78 - 1.68) 0.96 (0.73 - 1.25) 0.624 
dietary Iron§ 
No.orMI 12123 14120 11123 
dietary intake (gld) < 11.1 11.1 - 13.1 > 13.1 
Odds ratio (95% CI) 
age and sex adjusted 1.00 1.73 (0.61 - 5.09) 1.33 (0.43 - 4.26) 0.641 
multivariate adjustedt 1.00 1.49 (0.50 - 4.62) 1.35 (0.41 - 4.62) 0.606 
multivariate adjusted* 1.00 2.12 (0.57 - 8.45) 3.02 (0.50 - 20.52) 0.274 
dietary heme tron§ 
No.orMI 9126 12122 16/18 
dietary heme iron intake (gld) <2.16 2.16 - 2.76 >2.76 
Odds ratio (95% el) 
age and sex adjusted 1.00 1.68 (0.59 - 4.96) 2.79 (1.01 - 8.13) 0.047 
multivariate adjustedt 1.00 1.66 (0.56 - 5.08) 2.75 (0.92 - 8.64) 0.069 
multivariate adjustedt 1.00 1.85 (0.61 - 5.91) 4.01 (1.17 - 15.87) 0.031 
I reference category 
§ dietary data available for 37 cases of myocardial infarction and 66 controls 
t adjusted for age. sex, OM!, packyears smoked. equivalent household income (five categories), alcohol Intake (five 
categories.) 
t additonally adjusted for categories of dietary energy, lotal fat, saturated fat, and cholesterol 
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expressed as an odds ratio with 95% confidence interval (CI). Two-sided p-values were 
calculated. Statistical analysis was perfonned using SAS® statistical software package 
version 6.11 (SAS Institute, Cary, NC, USA). 
RESULTS 
Serum ferritin levels in the case-control population ranged from 10 to 1221 I-Igll and 
averaged 47, 119, and 309 I-Igll per tertile. Median levels of serum ferritin were 129 
I-Igli for men and 10 1 I-Igll for women. Serum ferritin was significantly inversely 
associated with serum transferrin (r = -0.28, P = 0.002) and was directly associated 
with serum iron, hemoglobin, and alcohol intake. For serum ferritin and heme iron 
intake a weak association was noted (r = 0.14; P = 0.17). 
Figure 1 shows the distribution of serum ferritin for cases and controls indicating a 
shift towards higher serum ferritin levels for cases of myocardial infarction. 
Correspondingly, more cases of myocardial infarction had levels above the cut-off of 
200 I-Igli (33.3%) than controls (21.4%). Cases and controls of myocardial infarction 
differed significantly for heme iron intake (table 1) and percentage of high equivalent 
income. 
When adjusted for age and sex, subjects with a serum ferritin level above 200 I-Igll 
tended to have a risk of 1.82 (95% CI, 0.90 - 3.69; P = 0.096) for myocardial infarction 
compared to those with serum ferritin levels equal or below 200 I-Igli. Further 
adjustment for body mass index, packyears smoked, income, and alcohol intake only 
marginally altered the risk of myocardial infarction (OR = 1.81,95% CI 0.88 - 3.74, P 
= 0.108). To evaluate whether there was a graded association between serum ferritin 
levels and risk of myocardial infarction, serum ferritin tertiles were examined. Age- and 
sex-adjusted odds ratio (OR) for the highest compared to the lowest tertile was 1.26 
(95% CI 0.98 - 1.64; Pu"d = 0.070) and was 1.28 (95% CI 0.98 - 1.67; Pu"d = 0.066) 
in the multivariate adjusted model (table 2). Inclusion of subjects with elevated CRP or 
erythrocyte sedimentation rate gave smaller estimates for subjects with ferritin levels 
above 200 I-Igll (age- and sex-adjusted OR = 1.46; 95% CI 0.75-2.80) indicating 
misclassification of iron status when subjects with signs of inflanunation were not 
excluded from analysis. No association with risk of myocardial infarction was 
observed for tertiles of serum iron, serum transferrin, or total dietary iron (table 2). For 
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Table 3: Odds ratio and 95% confidence intervals (CI) for myocardial infarction for 
tertiles of serum ferritin! 
No No Tertiles P value 
MI controls 
1 2 3 (IIlgbest) for trend 
(Lowest)t 
smoking statust 
current II 18 1.00 0.39 (0.07-1.66) 2.62 (1.12-9.10) 0.047 
fonner 29 46 1.00 1.63 (0.88-3.13) 1.56 (1.01-2.48) 0.046 
non-smoker 20 48 1.00 0.80 (0.36-1.70) 1.00 (0.65-1.54) 0.975 
bypertenslon~ 
present 42 68 1.00 0.96 (0.55-1.66) 1.23 (0.88-1.74) 0.219 
not present 18 44 1.00 1.02 (0.46-2.31) 1.26 (0.76-2.12) 0.353 
hypercholesterolemia). 
present 33 50 1.00 1.17 (0.65-2.10) 1.43 (0.99-2.11) 0.056 
not present 27 62 1.00 1.03 (0.56-1.90) 1.17 (0.80-1.74) 0.410 
diabetes 
present 12 22 1.00 3.35 (0.91-19.92) 2.41 (1.12-7.67) 0.027 
not present 47 85 1.00 0.95 (0.60-1.49) 1.11 (0.81-1.50) 0.541 
f adjusted for age, sex, body mass index, packyears smoked, equivalent household income (five categories), and 
alcohol intake (five categories) 
t reference category 
* adjusted for age, sex, body mass index, equivalent household income (five categories), and alcohol intake (five 
categories) 
~ systolic blood pressure;;:: 140 mmHg amI/or diastolic blood pressure;;:: 90 and/or use of antihypertensive 
medication 
). serum cholesterol;;:: 6.5 mmolfl 
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dietary heme iron a significantly increased risk of myocardial infarction was observed 
for the highest compared to the lowest tertile of heme iron intake in an age- and sex-
adjusted model (OR = 2.79; 95% CI 1.01- 8.13, P","d = 0.047). Multivariate adjustment 
including dietary variables that could potentially confound the association between 
heme iron and myocardial infarction resulted in an OR of 4.01 (95% CI 1.17 - 15.87; 
P.,"d = 0.031). Further adjustment by dietary antioxidants (ll-carotene, vitamin C, and 
vitamin E) did not materially alter the risk estimate. 
Stratification by smoking status, hypercholesterolemia, and diabetes showed 
modification of the association between serum ferritin and myocardial infarction (table 
3). Risk of myocardial infarction was more pronounced in the case of 
hypercholesterolemia (OR = 1.43; 95% CI 0.99 - 2.11; P.,"d = 0.056 for the highest 
versus lowest tertile of serum ferritin) or diabetes (OR = 2.50; 95% CI 1.15 - 8.05; 
P","d = 0.020). Both, current and former smoking considerably increased the risk of 
myocardial infarction in association with elevated serum ferritin concentrations 
(table 3). 
DISCUSSION 
In this study in an elderly Dutch population, elevated serum ferritin levels were 
associated with increased risk of myocardial infarction. It was most pronounced in 
current and former smokers and in those with diabetes. Serum iron, transferrin, and 
dietary total iron were not associated with myocardial infarction. High heme iron 
intake, however, was significantly associated with increased myocardial infarction 
risk. 
Studies investigating whether iron status can be considered a cardiovascular risk factor 
presented conflicting results as recently reviewed2o,21. This is not unexpected as none 
of the parameters advocated - hemoglobin, hematocrit, serum iron, transferrin, 
transferrin saturation, total iron binding capacity, or ferritin - accurately reflects body 
iron22• Because serum ferritin concentrations are directly proportional to intracellular 
ferritin concentrations, it is considered to be the best clinical measure of body iron 
stores22 and the most feasible to use in epidemiological studies23• 
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However, so far only few studies used serum ferritin levels to examine whether body 
iron stores are associated with cardiovascular disease. Serum ferritin levels are known 
to increase in response to inflammation. To circumvent a confounding effect of 
inflammation on serum ferritin levels we excluded subjects with C-reactive protein 
levels greater 6 gil from analysis. 
Previous evidence for an increased risk of myocardial infarction with elevated serum 
ferritin levels has come from the Kuopio Ischemic Heart Disease Study following 1931 
men for on average three yearsl. Men with serum ferritin levels <! 200 Ilgl1 had a 2.2-
fold (95% CI 1.2 - 4.0; P <0.01) risk of myocardial infarction compared with men with 
lower serum ferritin levels after adjustment for other risk factors. This association was 
stronger in men with serum low density lipoprotein concentrations of 5.0 mmolll or 
more than in others. Extendend follow-up after a mean follow-up period of.five years 
confirmed these previous findings2'. In 847 Austrian men and women aged 40 to 79 
years, Kiechl et al.2 examined the relation between sonographically assessed carotid 
atherosclerosis and body iron stores. Ferritin was observed to be one of the strongest 
indicators of presence of carotid artery disease (OR = 1.54 per 100 Ilgl1 serum ferritin; 
p<O.OOI) in men and women aged 40 to 59. Again, a synergistic effect between 
hypercholesterolemia and serum ferritin levels was observed. Five-year follow-up 
showed that serum ferritin was also a strong risk predictor of overall progression of 
atherosclerosis and of incident cardiovascular disease and death. Risk of 
atherosclerosis and cardiovascular disease was modified by serum low-density 
lipoprotein cholesterol. Changes in iron stores during the follow-up period modified 
the atherosclerosis risk in that a lowering was beneficial and further iron accumulation 
unfavourable3. Further studies relating serum ferritin levels to carotid intima media 
h· kn • f hi' 26 d' 1 . c. • 67 h t IC ess, presence 0 at erose erOSIS , myocar la 1ll1arctlOn', or coronary eart 
d· 827 t . f .. f b d . . h Isease . were no supportive 0 an aSSOCiatIOn 0 0 y Iron stores Wit 
cardiovascular disease. However, studies investigating the effect of blood donation or 
phlebotomy, resulting in a considerable decrease of serum ferritin levels, on 
cardiovascular disease risk corroborate the finding of decreased risk. Meyers et al.s, 
comparing cardiovascular event rates in whole blood donors to non-donors, 
demonstrated blood donation to be associated with reduced risk of cardiovascular 
events (crude OR = 0.50, 95% CI 0.38 - 0.66) after 5-8 years offollow-up. Benefit of 
donation was confined to non-smoking males (adjusted OR 0.67; 95% CI 0.45 - 0.99), 
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limited to blood donation in the most recent three years, and was observed to be greater 
in non-smoking men with serum LDL cholesterol levels> 160 mgldl. Among 2682 
Finnish men blood donation was prospectively associated with a risk reduction of 
myocardial infarction by 86%4. However, a likely self-selection of healthier persons as 
blood donors should be considered. Examination of the effect of phlebotomy on the 
oxidation resistance of serum lipoproteins in 14 men with raised serum ferritin 
concentrations demonstrated significantly decreased maximal oxidation and increased 
lag time to start of oxidation28• 
We observed risk of myocardial infarction to be confined to current and former 
smokers and to be more pronounced in subjects with diabetes or serum cholesterol 
above 6.5 nunolll (table 4). The effects of iron stores on atherogenesis were found to 
be more pronounced in smokers3 and synergistic effects between serum ferritin and 
serum cholesterol or low-density lipoprotein cholesterol have been reported as 
discussed abovel•3• This indicates that ferritin may adversely affect coronary heart 
disease risk in the presence of other risk factors that may increase the fonnation of free 
radicals thus accelerating atherogenesis by stimulation of low-density lipoprotein 
oxidation29,Jo. Basic research has provided strong evidence that low-density lipoprotein 
(LDL) oxidation plays an important role in the pathogenesis of atherosclerosis and 
cardiovascular disease. Oxidized LDL causes lipid accumulation in macrophages and 
foam cell formation3l ,32 and has been shown to be cytotoxic to many cell types and 
chemotactic for monocyte macrophages. Lipid peroxidation of LDL can be enhanced 
by metal-catalyzed reactions resulting in highly reactive hydroxyl radicals. Superoxide 
anions produced by oxidative stress and reducing agents have been found to be capable 
of mobilizing iron from ferritin29,3o. 
In the cun'ent study we observed dietary heme iron to be associated with increased risk 
of myocardial infarction. Increased risk of non-fatal myocardial infarction or fatal 
coronary heart disease with heme iron intake has also been reported in the Health 
Professional Study3J. Observations among Seventh Day Adventists in whom meat 
consumption 6 or more times per week was associated with increased risk of fatal 
ischemic heart disease34 are furthermore supportive of a possible role of heme iron in 
coronary heart disease. Results suggestive of a role of heme iron in lipid peroxidation 
come furthermore from a nested case-control study showing a positive association 
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between blood hemoglobin concentration and the titer of autoantibodies against 
malondialdehyde-modified LOes and from the ability of hemin to very efficiently 
promote LOL oxidation in vitro36• 
In conclusion, we observed elevated serum ferritin levels to be associated with 
increased risk of myocardial infarction in our elderly population. Elevated risk was 
most evident in current or former smokers and diabetic subjects suggesting that ferritin 
may adversely affect coronary heart disease risk in the presence of other risk factors. 
Possibly those factors in interaction with elevated body iron stores may accelerate 
atherogenesis by stimulating oxidation oflow-density lipoproteins. 
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3.3 
Dietary iron and risk of myocardial infarction 
ABSTRACT 
Free iron has been implicated in lipid peroxidation and ischemic myocardial damage, and it 
has been suggested that iron is an independent risk factor for myocardial infarction (MI). The 
authors investigated whether dietary iron is associated with increased risk of fatal and nonfatal 
MI in the Rotterdam Study, a community-based prospective cohort study among 7983 elderly 
subjects in Rotterdam, The Netherlands. The study sample consisted of 4802 participants who 
at baseline had no known history of myocardial infarction and for whom dietary data were 
available. From 1990 to 1996 124 subjects experienced MI. No association was observed 
between total iron intake and risk of MI adjusted for age and sex (relative risk highest versus 
lowest tertile 0.89; 95 percent confidence interval 0.55-1.45; P",.d 0.640). Heme iron intake 
was positively associated with risk of MI (RR highest versus lowest tertile 1.83; 95 percent 
confidence interval 1.16-2.91; Po"d 0.008) after adjustment for age and sex and persisted after 
multivariate adjustment (RR 1.86; 95 percent confidence interval 1.14-3.09; P"',d 0.010). 
Distinction between fatal and non-fatal cases of MI indicated that the association of heme iron 
to MI was more pronounced in fatal cases. The results suggest that high dietary heme iron 
intake is related to increased risk of myocardial infarction and that it may specifically affect 
the rate of fatality of myocardial infarction. 
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INTRODUCTION 
Because of the importance of oxidized low density lipoprotein in atherosclerosis 1", the 
potential for iron to act as catalyst in biological oxidative damage3,4, and ecological 
observations of coronary artery disease and iron status', a potential role of iron in 
coronary heart disease seems plausible. So far the strongest supporting evidence for 
iron as a coronary heart disease risk factor stems from a cohort study of eastern Fimlish 
men
6
,7, where high levels of serum ferritin and dietary iron were positively associated 
with incidence of myocardial infarction. Most subsequent prospective studies 
investigating whether iron status or dietary iron intake are associated with increased 
risk of myocardial infarction or coronary heart disease could not support the hypothesis 
that high body iron stores increase the risk of coronary heart disease8•13, though 
Ascherio et a1.4, reported an increased risk of non-fatal myocardial infarction or fatal 
coronary heart disease with intake of heme iron. However, measures of iron status such 
as serum iron or transferrin saturation as applied in most of these studies are generally 
not considered to accurately reflect body iron stores IS. Most studies did not 
discriminate between non-fatal and fatal myocardial infarction, although iron may be 
directly involved in the myocardial injury caused by ischemia and reperfusion. Indirect 
evidence that iron is involved in reperfusion injury after an ischemic event has been 
provided by results of animal experiments showing that free radicals are generated 
after restoration of blood flow to ischemic myocardium 16, contributing to the 
subsequent myocardial injuryl7. Experiments with an iron chelatorl8,19 or iron-
overloading20 in animals emphasize this notion. It has subsequently been suggested 
that elevated iron stores may have an adverse effect on the survival after a myocardial 
infarction". ill the current study we investigated whether dietary iron and heme iron 
are associated with the incidence and case fatality of myocardial infarction in the 
cohort oflhe Rotterdam Study. 
MATERIAL AND METHODS 
Study popUlation 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78 percent) aged 55 years and over, living in Onunoord, an urban district 
in Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of 
and the risk factors for chronic and disabling cardiovascular, neurodegenerative, 
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locomotor, and ophthalmic diseases as described elsewhere". The study was approved 
by the Medical Ethics Committee of the Erasmus University, and written informed 
consent was obtained from all participants. Follow-up for coronary heart disease 
mortality started after the baseline survey in 1990. For the present analysis follow-up 
information until April 1996 was available. Of the 5159 subjects with dietary data, 173 
subjects experienced a myocardial infarction during the follow-up period. Because of 
possible changes in dietary pattern, subjects with history of myocardial infarction at 
baseline (n = 357) were excluded from analysis. This resulted in 4802 subjects for the 
current analysis. Of these, 124 cases of first fatal or non-fatal myocardial infarction 
occurred. 
Case ascertainment 
The follow-up period comprised 3 to 7 (mean 4) years. With respect to the vital status of 
participants, information was obtained at regular intervals from the municipal health 
service in Rotterdam. Information on fatal and non-fatal endpoints was obtained from the 
general practitioners working in the study district of Omrnoord. All possible events 
reported by the generai practitioners were verified by research physicians from the 
Rotterdam Study through records of the participating general practitioners and medical 
specialists. Cause and circumstances of death were obtained by using a questionnaire for 
general practitioners and by scrutinizing information from hospital discharge records in 
cases of admittance or referral, shortly after a death was reported by the municipal health 
service or the general practitioner. Overall, follow-up information was available for 94 
percent of the cohort. 
Classification of fatal and non-fatal events was based on the International Classification 
of Diseases (lCD), 10th edition23• For the present analysis c~ses of first non-fatal 
myocardial infarction or fatal myocardial infarction (lCD-1O codes 121-124) were 
selected. All events were independently classified by two research physicians. If there 
was disagreement, a consensus was reached in a special session. Finally, all these events 
were verified by a cardiovascular disease expert. In case of discrepancies, the judgment 
by this expert was considered definite. 
Measurements 
Information on current health status, medical history, drug use, education, income, and 
smoking behavior was obtained with a computerized questiOlUlaire during a home 
83 
Chapter 3.3 
interview. Height and weight were measured, and body mass index (weight in kglheight 
in m') was calculated as a measure of obesity. Sitting blood pressure was measured on 
the right upper arm with a random-zero sphygmomanometer. The average of two 
measurements was used in the analysis. Hypertension was defined as a systolic blood 
pressure of at least 140 mm Hg and/or diastolic blood pressure of at least 90 mm Hg 
and/or current use of antihypertensive drugs for indication of hypertension. A 
venepuncture was performed and serum total and high density lipoprotein (HDL) 
cholesterol concentrations were determined by an automated enzymatic procedure. If 
serum cholesterol levels were at least 6.5 mmoVI or higher, subjects were considered to 
be hypercholesterolemic. All participants except for those using antidiabetic medication, 
were given a 37.5 percent oral glucose solution (75 g of glucose) in a nonfasting state. 
Venous glucose levels were measured before and after two hours. Non-insulin-dependent 
diabetes was diagnosed if at least one measurement was 11.1 mmoVI or more or if the 
participant used antidiabetic medication. 
Dietary assessment 
A semiquantitative food frequency questionnaire (SFFQ) completed during baseline 
aimed at assessing habitual food intake during the past year. The questionnaire included 
170 food items in 13 food groups and questions about dietary habits, supplementation, 
and prescribed diets. SFFQ data were converted to nutrient intake using the 
computerized Dutch food composition table'·. Heme iron intake was estimated to be 
equal to 40% of the iron found in meat, fish, and poultry". Data for Il-carotene and 
tocopherol were updated by use of an additional database by the Netherlands Institute of 
Public Health and Environmental Protection (YCJ Vollebregt, EJM Feskens, 
unpublished observations, 1993). Intake through nutritional supplements was not 
considered since information from brand labels were not recorded with sufficient 
accuracy. The validity of the SFFQ was assessed in a subsample of 80 men and women 
aged 55 to 75 years. Nutrient intakes estimated from the SFFQ were compared with 
estimated nutrient intakes of 15 days of food records collected over a one-year period'6. 
The ability of the SFFQ to adequately rank subjects according to their dietary intake was 
demonstrated by Pearson's correlation coefficients (0.5 to 0.9 for crude data) and a high 
degree of classification into the same or adjacent quintile (75.8 percent for crude data). 
Pearson's correlation coefficient between food records and SFFQ for iron was 0.67. 
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Table 1: Association of various baseline factors adjusted for age and sex to energy-adjusted total and heme iron intake for the cohort of 
the Rotterdam Study, Rotterdam, the Netherlands, from 1990-1996 
TertiIe of energy adjusted iron intake 
Mean body mass index (kg/m2) 
Current smokers (%) 
Hypertension'" (%) 
Hypercholesteremiat (%) 
Diabetes (%) 
Mean alcohol intake (gId) 
Antioxidative vitamin supplements~ (%) 
Mean energy-adjusted 
Jl-earotene (mg/d) 
Vitamin C (rog/d) 
Vitamin E (mg/d) 
Total fat (g/d) 
Saturated fat (gId) 
Cholesterol (mg/d) 
I (Lowest) 
25.9 
28.5 
48.3 
51.7 
9.0 
13.1 
11.1 
1.16 
97 
12.3 
81.9 
32.9 
228 
2 3 (Highest) 
26.3 26.4 
24.7 21.9 
49.8 47.7 
492 48.9 
8.9 9.7 
1I.8 9.5 
10.9 11.6 
1.39 1.70 
III 125 
13.0 13.6 
79.7 77.3 
30.9 29.3 
227 227 
III systolic blood pressure 2: 140 and/or diastolic blood pressure 2: 90 and/or use of antihype11ensive medication 
t serum cholesterol;;: 6.5 mmolll 
::: use of either BooCarotene. vitamine E, vitamin C, or multivitamin supplements 
Tertile of energy adjusted heme iron intake 
I (Lowest) 2 3 (Highest) 
25.4 26.3 26.9 
23.0 23.0 28.1 
46.1 49.0 50.0 
45.6 502 53.0 
7.2 8.9 1I.5 
10.1 11.1 12.7 
13.0 102 10.7 
1.43 1.43 1.46 
112 112 1I2 
13.2 13.3 12.6 
77.2 79.4 81.6 
30.2 30.8 31.7 
203 224 251 
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Table 2: Relative risk of myocardial infarction and 95 percent confidence intervals 
according to intake of energy-adjusted tertiles of iron and heme iron for the cohort of 
the Rotterdam Study, Rotterdam, the Netherlands, 1990-1996 
Variable 
iron 
No.ofM! 
iron intake (mg/d) 
Relative risk (95% CI") 
age and sex adjusted 
multivariate adjustedt 
heme iron 
No.ofM! 
heme iron intake (mg/d) 
Relative risk (95% CI") 
age and sex adjusted 
multivariate adjustedt 
§ reference category 
• confidence interval 
Tertiles of energy-adjusted intake 
I (Lowest)§ 
38 
< 10.6 
29 
<0.70 
2 
40 
10.6 - 12.4 
0.97 (0.61 - 1.54) 
1.05 (0.66 - 1.68) 
37 
0.70 - 1.00 
1.23 (0.75 - 2.03) 
1.23 (0.75 - 2.06) 
3 (Highest) 
46 
>12.4 
0.89 (0.55 - 1.45) 
I.lI (0.67 (1.87) 
58 
> 1.00 
1.83 (1.16 - 2.91) 
1.86 (1.l4 - 3.09) 
P value for 
trend 
0.640 
0.787 
0.008 
0.010 
t adjusted for age, sex, body mass index. packyears smoked, equivalent houshold income (five categories), 
education (five categories) and alcohol intake (five categories), categories of energy-adjusted a·carotene, 
vitamin C, vitamin E, use of anti oxidative vitamin supplements 
t additionally adjusted for categories of energy-adjusted fat, saturated fat, and cholesterol. 
Adjustment for sex, age, total energy intake27, and for within-person variability in daily 
intake28 resulted in a correlation coefficient for iron of 0.44. 
Data Analysis 
The association between energy-adjusted dietary iron and heme iron intake and risk of 
myocardial infarction was examined by multivariate logistic regression. Energy-adjusted 
dietary intake of iron and heme iron was categorized into tertiles, and risk of myocardial 
infarction in the middle and highest tertile was compared to risk in the lowest tertile. The 
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initial analysis was adjusted for age and sex. The analyses were subsequently adjusted 
for body mass index, pack-years smoked, equivalent household income (five 
categories), highest education attained (five categories), and alcohol intake (five 
categories). In addition, dietary energy-adjusted intake of B-carotene, vitamin E, 
vitamin C, total fat, saturated fat, and cholesterol were considered. Use of 
anti oxidative vitamin supplements defmed as use of either B-carotene, vitamin C, 
vitamin E, or multivitamin supplements was also taken into account. Each association 
was expressed as a relative risk with 95 percent confidence interval (CI). Results were 
considered statistically different at the two-sided 0.05 alpha-level. Two-sided p-values 
were calculated. Statistical analysis was performed using SAS® (Release 6.11; SAS 
Institute, Cary, NC, USA). 
RESULTS 
The mean intake of energy-adjusted total iron was 9.3 mg/d in the lowest and 14.3 
mg/d in the highest tertile. For energy-adjusted heme iron, figures were 0.48 mg/d in 
the lowest and 1.36 mg/d in the highest tertile. Since sex and age were not equally 
distributed across tertiles of total and heme iron intake, baseline factors and selected 
nutrient intakes presented in table I were adjusted for sex and age. Percentage of 
current smokers decreased across tertiles of iron, whereas intake of B-carotene and 
vitamin C increased and total fat and alcohol intake decreased. For heme iron intake an 
increase in the prevalence of hypercholesterolemia and total fat and cholesterol intake 
across tertiles was observed. The percentage of current smokers was considerably 
higher in the highest tertile of heme iron intake. Iron supplementation was negligible in 
this elderly cohort (0.2 percent) and was not related to dietary iron intake. 
When adjusted for age and sex, intake of total iron was not associated with risk of 
myocardial infarction. Intake of heme iron was significantly associated with an 
increased risk of myocardial infarction (table 2). The relative risk for the highest 
compared to the lowest tertile was 1.83 (95 percent confidence interval 1.16-2.91; 
P",nd 0.008). After adjustment for body mass index, pack-years smoked, equivalent 
household income, education, and alcohol intake the observed association with heme 
iron remained (relative risk 1.84, 95 percent confidence interval 1.16-3.00; 
POend 0.008). Adjustment by dietary factors and cholesterol and subsequently for intake 
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of Table 3: Relative risk of myocardial infarction and 95 percent confidence intervals 
according to intake of energy-adjusted tertiIes of heme iron for the cohort of the 
Rotterdam Study, Rotterdam, the Netherlands, 1990-1996 
Variable Tertiles of energy-adjusted heme iron intake P value for 
trend 
I (Lowest)' 2 3 (Highest) 
Hypercholesterolemia 
multivariate adjustedt 
present (cases = 74) 1.59 (0.82 - 3.21) 2.39 (1.26 - 4.75) 0.008 
absent (cases = 50) 0.89 (0.41 - 1.91) 1.27 (0.64 - 2.61) 0.060 
Hypertension 
multivariate adjustedt 
present (cases = 77) 1.34 (0.71 - 2.56) 2.10 (1.16 - 3.92) 0.014 
absent (cases"" 47) 1.10 (0.49 - 3.53) 1.51 (0.71 - 3.38) 0.260 
Smoking status 
multivariate adjusted t 
current (cases = 40) 0.81 (0.26 - 2.47) 2.67 (1.17 - 6.86) 0.008 
ex/non-smoker (cases = 84) 1.38 (0.79 - 2.45) 1.45 (0.82 - 2.62) 0.216 
Diabetes 
multivariate adjustedt 
present (cases = 21) 1.81 (0.34 - 13.37) 5.40 (1.41 - 35.55) 0.012 
absent (cases = 100) 1.18 (0.70 - 2.00) 1.46 (0.87 - 2.48) 0.148 
* reference category 
t adjusted for age, sex, body mass index, packyears smoked, equivalent houshold income (five categories), 
education (five categories) and alcohol intake (five categories). 
t adjusted for age, sex, body mass index, equivalent houshold income (five categories), education (five 
categories), and alcohol intake (five categories). 
ll-carotene, vitamin E, vitamin C, and use of antioxidative vitamin supplements did not 
materially alter the risk estimate (table 2). On repeat of the analysis without applying 
any exclusion criteria, the relative risk was somewhat attenuated but still significantly 
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elevated with 1.68 (95 percent confidence interval 1.l0-2.60; P""nd 0.017) for the 
highest compared to the lowest tertile of heme iron intake. 
Table 3 presents the multivariate adjusted relative risks of myocardial infarction 
according to presence of other risk factors for myocardial infarction - hypertension, 
hypercholesterolemia, cigarette smoking, diabetes - and heme iron intake. For all risk 
factors investigated the increased risk of myocardial infarction was primarily observed 
in the presence of these risk factors. Relative risk estimates for falal (n = 30) and non-
fatal (n = 94) cases of first myocardial infarction and heme iron intake are presented in 
table 4. Multivariate age- and sex-adjusted risk for the top compared to the bottom 
tertile of heme iron was considerably elevated for fatal cases with 3.77 (95 percent 
confidence interval 1.22-14.20; P""nd 0.033). For non-fatal cases relative risk was 1.59 
(95 percent confidence interval 0.93-2.76; P""nd 0.064). 
Table 4: Relative risk of fatal and non-fatal myocardial infarction and 95 percent 
confidence intervals according to intake of energy-adjusted tertiles of heme iron for the 
cohort of the Rotterdam Study, Rotterdam, the Netherlands, from 1990·1996 
Variable 
No. ofnon~fatal MI 
Relative risk (95% CI) 
age and sex adjusted 
multivariate adjustedt 
No. offatal MI 
Relative risk (95% CI) 
age and sex adjusted 
multivariate adjustedt 
.. reference category 
I (Lowest)-
25 
4 
Tertiles of energy-adjusted P value for 
heme iron intake trend 
2 3 (Highest) 
23 46 
0.86 (0.48 - 1.53) 1.57 (0.95 - 2.65) 0.053 
0.86 (0.48 - 1.55) 1.59 (0.93 - 2.76) 0.064 
13 13 
3.41 (1.20.12.19) 3.56 (1.23· 12.99) 0.029 
3.66 (1.26 - 13.25) 3.77 (1.22· 14.20) 0.033 
t adjusted for age, sex, body mass index, packyears smoked, equivalent houshold income (five), education (five 
categories), alcohol intake (five categories), categories ofenergy~adjusted 6·carotene, vitamin C, vitamin E, 
fat, saturated fat, and cholesterol, and use of antioxidative vitamin supplements 
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DISCUSSION 
In the prospective cohort of the Rotterdam Study, we found no evidence for a positive 
association between total iron intake and risk of myocardial infarction. Heme iron 
intake, however, was positively associated with risk of myocardial infarction. 
Associations were strongest in those with presence of other risk factors for myocardial 
infarction. The results indicated that the association of heme iron to myocardial 
infarction was more pronounced in fatal than non-fatal cases of first myocardial 
infarction. 
Prior to interpretation of these results some methodological issues should be 
considered. Potential bias due to incomplete follow-up was unlikely to occur due to the 
high follow-up rate (94 percent) achieved. Case ascertainment was facilitated because 
general practitioners working in the study district of Ommoord covered 85% of the 
cohort and records were linked to the municipal health service in Rotterdam. Since all 
events were classified independently by two research physicians and in the case of 
disagreement by a medical expert in the field of cardiovascular disease, inaccuracies of 
coding of diagnosis was minimized. Because subjects with a previous diagnosis of 
myocardial infarction may have altered their diet as a consequence of disease, those 
reporting at baseline that they had been hospitalized for myocardial infarction were 
excluded from analysis. 
Confounding by dietary fats and cholesterol is of particular concern since these factors 
are likely to be correlated with heme iron (age- and sex-adjusted Spearman 
correlation's between heme iron and total fat, saturated fat, and cholesterol were 0.14, 
0.10, and 0.34 [for all p < 0.0001], respectively). We attempted to address this point by 
inclusion of these variables in the multivariate model. However, adjustment for these 
factors did not materially alter the risk estimate. Since heme iron is largely derived 
from meat and meat products, the observed association between heme iron intake and 
myocardial infarction may be attributed to other factors from meat apart from fat or 
cholesterol or to unidentified lifestyle habits associated with meat intake. We 
attempted to adjust for lifestyle factors such as smoking and alcohol intake, but we 
cannot exclude presence of residual confounding. However, it seems unlikely that a 
confounder could explain that the observed association between heme iron and 
myocardial infarction was most marked in the presence of hypertension, 
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hypercholesterolemia, diabetes, or cigarette smoking. In fact, this is highly compatible 
with the hypothesis of a promoting role of iron on LDL cholesterol oxidation. 
Furthermore, a confounder could not explain the difference in findings with respect to 
fatal and non-fatal events. Considering this, it seems unlikely that confounding 
accounts for the observed association between heme iron and myocardial infarction, 
although we cannot conclusively dismiss presence of residual confounding. 
We found heme and not total iron intake associated with myocardial infarction. There 
are several reasons to separate dietary heme iron from nonheme iron as a potential risk 
factor for coronary diseases. Iron status is regulated as a result of both absorption and 
bioavailability. Absorption of dietary iron is in general determined by two major 
factors, the rate of erythropoiesis and the size of the body's iron stores. Bioavailability 
is dependent both on the amount of meat in the diet since heme iron is well absorbed, 
and on the balance in the diet between promoters of nonheme iron absorption (e.g. 
ascorbic acid, meat, fish) and inhibitors of iron absorption (e.g. phytates, soy protein, 
polyphenols)29. The mechanisms of absorption of non-heme and heme iron differ 
markedly. At physiological levels, iron uptake is mediated by a series of receptors and 
binding proteins, whereas heme iron is taken up by the mucosal cells as such, therefore 
the iron in these cells is not exposed to the effects of the many ligands in the diet that 
inhibits iron absorption. For this reasons, only a slight association of total iron with 
risk of coronary heart disease would be expected in a generally well nourished 
population. 
Studies investigating the association between dietary iron and coronary heart disease 
have yielded inconsistent results. Whereas some researchers observed no association 
between dietary iron intake and coronary heart disease9,\3, Ascherio et a1. 14 reported a 
decreased risk of non-fatal myocardial infarction or fatal coronary heart disease with 
total dietary iron intake. Intake of heme iron, however, was, as in the present analysis, 
associated with an increased risk of non-fatal myocardial infarction or fatal coronary 
heart disease. After multivariate adjustment the inverse association with total iron and 
the direct association of heme iron intake were attenuated, though the association of 
heme iron of non-fatal myocardial infarction or fatal coronary heart disease remained 
statistically significant. Among Eastern Finnish men, in contrast, a direct association 
of total iron with risk of myocardial infarction was observed6• For each milligram of 
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daily iron intake, the authors reported an increment of 5% in the myocardial infarction 
risk. They also reported a weak association of meat intake with risk of myocardial 
infarction. Since men in the Kuopio study reported on average a daily meat intake of 
150 g29 the reported observation probably reflects the predominant contribution of 
heme iron to total iron intake in the population under study. Observations among 
Seventh Day Adventists in whom frequency of meat consumption (6 or more times 
compared to less than once per week) was associated with increased risk of fatal 
ischemic heart disease3! are furthermore supportive of a possible role of heme iron in 
coronary heart disease. 
A plausible explanation for an effect of iron is by stimulating oxidation of LDL 
cholesterol through catalyzing production of tissue-damaging free radicals3.4. Basic 
research has provided strong evidence that LDL cholesterol oxidation plays an 
important role in the pathogenesis of atherosclerosis and cardiovascular disease. 
Oxidized LDL cholesterol causes lipid accumulation in macrophages and foam cell 
formation!,32 and has been shown to be cytotoxic to many cell types and chemotactic 
for monocyte macrophages. Lipid peroxidation ofLDL cholesterol can be enhanced by 
metal-catalyzed reactions resulting in highly reactive hydroxyl radicals. Because of the 
considerable iron-binding capacity of the carrier protein transferrin, free low molecular 
weight iron cannot be detected in plasma under physiologic conditions. Iron is stored 
in the ferrite form that is bound to apoferritin, a protein widely distributed throughout 
the body. To exert its catalyzing activity, the ferrite ion must first be released from the 
protein moeity and reduced to the ferrous form. Superoxide anions produced by 
oxidative stress and reducing agents have been found to be capable of mobilizing iron 
from ferritin3.4. Recently hemin has also been shown to very efficiently promote LDL 
cholesterol oxidation in vitro33. Lack of an amplifYing effect of lipid-peroxidation on 
iron-deficient 'heme' (protoporphyrin IX) in vitro underlines this finding. Further 
results suggesting that heme iron plays a role in lipid peroxidation comes furthermore 
from the results of a nested case-control study showing a positive association between 
blood hemoglobin concentration and the titer of autoantibodies against 
malondialdehyde-modified LDL cholesterol34. The promoting effect of hemin on LDL 
cholesterol oxidation may thus be an additional plausible explanation for observed 
association of heme iron intake with risk of myocardial infarction in the current study. 
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Stratification by risk factors for myocardial infarction such as hypercholesterolemia, 
hypertension, cigarette smoking, and diabetes showed that the risk was most marked 
when any of these risk factors was present (table 3). This indicates that iron may 
adversely affect coronary heart disease risk only in the presence of other risk factors. 
Previous observations stress this view: relative risk for myocardial infarction 
associated with dietary heme iron intake was found to be stronger in subjects with 
history of diabetes or smokingl4 and synergistic associations of serum ferritin and 
elevated serum LDL cholesterol concentrations with myocardial infarction6 or carotid 
atherosclerosis35 were observed. 
Experiments with iron-chelators 18 or iron-overloading in animals20 provided indirect 
evidence that iron is involved in reperfusion injury after an ischemic insult. During 
ischaemia the amount of iron in the low molecular weight pool was observed to 
increase36 and iron accumulated in the perfusate when the circulation was restored37• 
Possibly entailed iron-catalyzed redox reactions within the cardiomyocyte are 
sufficient to elicit contractile dysfunction and lethal cell disruption38• This possibility 
suggests that iron-catalyzed reactions involving partially reduced oxygen might 
exacerbate reperfusion injury, which would imply that high iron stores may affect the 
fatality rate of myocardial infarction apart from an effect on the incidence of 
myocardial infarction2l . The more pronounced association between heme iron intake 
and risk of myocardial infarction observed in fatal than non-fatal cases of first 
myocardial infarction support this hypothesis, even though the number of fatal cases 
in the current study was small. 
In summary, our results suggest that high dietary heme iron intake increases the risk of 
myocardial infarction in the presence of other risk factors and may specifically affect 
its fatality. 
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CHAPTER 4 
Antioxidants in coronary heart disease 
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Serum carotenoids and atherosclerosis. 
The Rotterdam Study 
ABSTRACT 
4.1 
High circulating levels of carotenoids have been thought to exhibit a protective function in the 
development of atherosclerosis. We investigated whether aortic atherosclerosis was associated 
with lower levels of the major serum carotenoids in senun - a-carotene, p-carotcllc, 
Jl-cryptoxanthin, lutein, Iycopene, and zeaxanthin - in a subsample of the elderly population 
of the Rotterdam Study. Aortic atherosclerosis was assessed by presence of calcified plaques 
of the abdominal aorta. The case-control analysis comprised 108 subjects with aortic 
atherosclerosis and 109 age- and sex-matched controls. 
In an age- and sex-adjusted logistic regression model, serum lycopene was inversely 
associated with the risk of atherosclerosis. The odds ratio for the highest compared to the 
lowest quartile of serum Iycopene was 0.55 (95% CI 0.25 - 1.22; P'",d ~ 0.13). Multivariate 
adjustment did not appreciably alter these results. Stratification by smoking status indicated 
that the inverse association between lycopene and aortic calcification was most evident in 
current and former smokers (OR ~ 0.35; 0.13 - 0.94; P""d ~ 0.04). No association with 
atherosclerosis was observed for quartiles of serum concentrations of a-carotene, p-carotene, 
p-cryptoxanthin, lutein, and zeaxanthin. 
In conclusion, this study provides evidence for a modest inverse association between levels of 
serum lycopene and presence of atherosclerosis, the association being most pronounced in 
current and former smokers. Our findings suggest that lycopene may playa protective role in 
the development of atherosclerosis. 
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INTRODUCTION 
As reviewed by Steinberg et al.I the oxidation of LDL may be an important step in 
atherogenesis, promoting the development of foam cells and endothelial injury that 
lead to the formation of organized arterial plaques, Evidence that LDL oxidation 
occurs in vivo and contributes to the clinical manifestations of atherosclerosis supports 
the oxidative modification hypothesis, The link between oxidation of LDL and 
atherogenesis is hypothesized to be the basis for a beneficial effect of antioxidants on 
the incidence of subclinical and clinical coronary artery disease', Observational stndies 
suggest that dietary carotenoids exert a protective effect on incidence and mortality of 
I d' 3,7 h I ft I ' " I 8," h coronary leart Isease ,W ereas reSl1 ts om supp ement mtervention tna save 
shown few beneficial and some deleterious effects of 6-carotene supplementation with 
respect to cardiovascular disease, Stndies focusing on carotenoids in serum, plasma, or 
adipose tissue yielded, in general, consistent results concerning a protective effect of 
carotenoids on risk of coronary heart disease13 '19, The antioxidant potential of 6-
ft d' I '0 d' b'l' 'nh'b' LDL 'd' 'I" carotene to scavenge ee ra Ica s an Its a I Ity to I I It OXI allon ' support 
this hypothesis, Observations that other carotenoids, namely lycopene, lutein" and 
zeaxanthin, can also quench singlet oxygen, a potential initiator of lipid peroxidation 
give further support'O,,,, Data on carotenoids and atherosclerosis are scarce, In the 
ARIC-Study dietary provitamin A carotenoids were observed to be inversely related to 
carotid intima-media thickness in older male participants" and subsequently to the 
presence of carotid artery plaques", High 6-cryptoxanthin and luteinlzeaxanthin serum 
levels were both associated with lower odds of asymptomatic atherosclerosis", 
whereas, in contrast, no association between carotenoid plasma concentrations and 
carotid intima media thickness and presence of plaques in the common carotides in an 
elderly population was found'6, 
In the current study we investigated whether atherosclerosis as assessed by presence of 
calcified plaques in the abdominal aorta was associated with levels of the major 
carotenoids in senun - a-carotene, p-carotene, p-cryptoxanthin, lutein, lycopene, and 
zeaxanthin - in the population-based Rotterdam Stndy, 
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SUBJECTS & METHODS 
Stlldy poplIlation 
Serum carotenoids and atherosclerosis 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78%) aged 55 years and over, living in Ommoord, an urban district in 
Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of and 
the risk factors for chronic and disabling diseases as described previously'? The study 
was approved by the Medical Ethics Committee of Erasmus University, and written 
informed consent was obtained from all participants. The present case-control analysis 
comprised a sample of the Rotterdam Study without a self-reported history of myocardial 
infarction, stroke, percutaneous transluminal coronary angioplasty, or coronary bypass 
operation at baseline. Hundred and nine subjects with moderate/severe atherosclerosis 
measured by presence of plaque of the abdominal aorta and 109 controls without 
atherosclerosis frequency-matched on age (5-year categories) and sex were selected. For 
one subject serum for analysis of carotenoids was missing, resulting in a final sample of 
108 cases and 109 controls. 
Measuremellis 
Information on current health status, medical history, drug use, education, income, and 
smoking behaviour was obtained with a computerized questionnaire during a home 
interview. Height and weight were measured, and body mass index (weight in kglheight 
in m') was calculated as a measure of obesity. Sitting blood pressure was measured on 
the right upper arm with a random-zero sphygmomanometer. The average of two 
measurements was used in the analysis. A venepuncture was performed and serum total 
and high density lipoprotein (HDL) cholesterol concentrations were determined by an 
automated enzymatic procedure. Use of supplement preparations was ascertained during 
the home interview. None of the subjects reported use of ll-carotene supplements, but 
some reported use of vitamin A (n = I), vitamin E (n = 2), vitamin C (n = 6) , or 
multivitamins (n = 8). Since taking these supplements increases the serum concentrations 
of any of these antioxidants", we combined use of any of these supplements for data 
analysis. 
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Assessmellt of atherosclerosis 
A lateral radiographic film of the abdomen was made from a fixed distance while the 
participant was seated. Atherosclerosis was diagnosed off-line by detecting calcified 
deposits in the abdominal aorta, as described previously29. Calcification was judged 
present when linear densities were seen in an area parallel and interior to the lumbar 
spine (LI-L4). Atherosclerosis was classified as no, mild, moderate, or severe 
calcification, according to the length of the involved area « 1,2.5 - 4.9 cm, 5 - 9.9 cm, 
~ 10 cm, respectively). These calcified deposits have been shown to represent intimal 
atherosclerosis3o and have been associated with cardiovascular risk factors29,31 and 
d' I d' I ' 32·34 C 'h I ' . d car IOvascu ar Isease at severa sItes , ases lor t e current ana YSls compnse 
subjects with moderate and severe atherosclerosis, controls comprised subjects without 
atherosclerosis, 
Serum carotelloids 
Frozen sera collected at baseline examination and preserved at _80°C for on average 5.7 
years for cases and 5,8 years for controls were used to determine serum concentrations of 
a-carotene, p-carotene, P-cryptoxanthin, lutein, Iycopene, and zeaxanthin. Serum 
carotenoids appeared to be stable during long-tenn freezer storage at _70°C35• Sera fi'om 
cases and controls were analyzed in the same run, For carotenoid analyses one volume of 
sample was mixed with one volume of a-tocopheryl acetate (0.1 mg/ml in ethanol) as 
internal standard, and deproteinized. Carotenoids were then extracted with two volumes 
of n-hexane, Half of the hexane layer was evaporated to dryness under nitrogen and 
redissolved in 0.2 to 1.0 of solvent (acetonitrile/methanollmethylenchloride, 90;5;5, 
v/v/v). Fifty fll were then injected onto a Hyperchrome stainless steel column filled with 
Nucleosill20 3Cl8 (Applied Science Group, Emnlen, The Netherlands), and eluted with 
acetonitrile/methanollmethylenchloride/anuuonium acetate 0,05 molll (900:50:40: 10, 
v/v/v/v). Carotenoids were detected by abSOl]ltion at 450 mn and a-tocopheryl acetate at 
286 mn, Peak areas were calibrated against standard solution of the respective 
carotenoids. The procedure was carried out in a room with special yellow light, fi:ee from 
daylight. 
Data allalysis 
Associations of the serum carotenoids with risk factors for atherosclerosis were 
evaluated by use of Spearman's correlation coefficient and for categorical variables by 
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Table 1: Spearman correlation coefficients between serum carotenoids and age, waist-to-hip ratio, serum cholesterol, cigarette 
packyears smoked and alcohol intake for 217 subjects of the Rotterdam Study, the Netherlands 
Serum 
a-carotene p-carotene ,8-cryptoxaothin lutein lycopene zeaxanthin 
(pmolll) (pmolll) (pmolll) (pmolll) (pmolll) (pmolll) 
r p r p r p r p r p r p 
Variables 
Age (years) 0.15 (0.023) 0.10 (0.128) 0.05 (0.482) 0.17 (0.012) -0.32 « 0.001) -0.13 (0.041) 
Waist-to-hip ratio -023 « 0.001) -0.31 «0.001) -0.28 « 0.001) -026 (0.007) -0.18 (0.007) -0.17 (0.014) 
Serum cholesterol (mmolll) 0.11 (0.102) 0.12 (0.089) 0.14 (0.039) 0.24 « 0.001) -0.08 (0225) 0.14 (0.030) 
Cigarette packyears smoked -0.17 (0.012) -0.14 (0.037) -024 « 0.001) -0.15 (0.032) -0.11 (0.093) -0.06 (0368) 
Alcohol intake (g/d) -0.19 (0.006) -0.22 (0.001) -0.26 « 0.001) -0.09 (0.200) 0.11 (0.101) -0.13 (0.050) 
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chi-square statistics. Student's t-test was used to assess whether cases and controls of 
atherosclerosis differed by mean levels of serum a-carotene, p-carotene, cryptoxanthin, 
lutein, Iycopene, and zeaxanthin. Serum carotenoids were categorized into quartiles; the 
risk of atherosclerosis according to quartile of serum carotenoids was assessed with 
multivariate logistic regession. Analyses were initially adjusted for age, sex, serum 
cholesterol level, and season of blood draw, and were subsequently adjusted for pack-
years smoked, waist-to-hip ratio, and alcohol intake. Stratified analysis was perfonned to 
evaluate whether risk estimates were modified by smoking status as suggested by other 
studies!5,,,. Associations are expressed as odds ratios with 95% confidence interval (CI). 
Results were considered statistically different at the two-tailed alpha-level of 0.05. 
Statistical analysis was perfonned using SAS® release 6.12 (SAS Institute, Inc, Cary, 
North Carolina, USA). 
RESULTS 
Correlation coefficients between serum carotenoids and age, waist-to-hip ratio, serum 
cholesterol, cigarette packyears smoked, and alcohol intake are shown in table I. Age 
was significantly associated with all serum carotenoids except p-cryptoxanthin and 
p-carotene. Except for Iycopene, serum carotenoid levels were significantly higher in 
women compared to men. Serum concentrations of a-carotene, p-carotene, zeaxanthin, 
and lutein differed significantly across seasons. Supplement users had significantly 
higher mean serum concentration levels of a-carotene, p-carotene, and zeaxanthin than 
subjects who did not use supplements. All carotenoids except lutein with Iycopene were 
significantly correlated with each other. Correlation coefficients were mostly between 
0.3 and 0.5; stronger correlations were found between P-cryploxanthin and zeaxanthin 
(r ~ 0.52, P < 0.0001), lutein and zeaxanthin (r ~ 0.56, P < 0.0001) and a-carotene and p-
carotene (r ~ 0.72, P < 0.0001). 
Subjects with and without atherosclerosis differed significantly by body mass index, 
systolic blood pressure, presence of hypertension and diabetes (table 2). Among cases of 
atherosclerosis, more subjects currently smoked. Lycopene, a-carotene, p-carotene, and 
p-cryptoxanthin levels were observed to be lower in cases than controls <if 
atherosclerosis. 
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Table 2: Means (SD) and distribution (%) of baseline characteristics between subjects 
with and without calcified aortic atherosclerosis; the Rotterdam Study 
Atherosclerosis 
................................... ....................................................................................... 
no 
Variables n= 109 
Men (%) 43.1 
Age (years) 66.3 
Serum a-carotene (umolll) 0.052 
Serum jl-carotene (umoUI) 0.301 
Serum cryptoxanthin (umolll) 0.477 
Serum lutein (umol/I) 0.390 
Serum Iycopene (umoUI) 0.134 
Serum zeaxanthin (umol/I) 0.066 
Body mass index (kgim') 25.9 
Waist-to-hip ratio 0.90 
Serum cholesterol (mmoUI) 6.65 
HDL-serum cholesterol (mmoUI) 1.37 
Diastolic blood pressure (mmHg) 74 
Systolic blood pressure (mm Hg) 135 
Hypertension" (%) 14.7 
Diabetes (%) 1.9 
Current smokers (%) 24.8 
High alcohol intaket (%) 20.2 
Values are means (standard error) unless otherwise indicated 
I p~O.05 
2 p~o.o05 
yes 
n= 108 
40.7 
(7.4) 67.3 (7.1) 
(0.039) 0.047 (0.030) 
(0.216) 0.290 (0.152) 
(0.426) 0.469 (0.333) 
(0.180) 0.393 (0.178) 
(0.094) 0.119 (0.092) 
(0.036) 0.065 (0.036) 
(3.9) 26.9 (3.4)' 
(0.08) 0.91 (0.08) 
(1.17) 6.90 (1.18) 
(0.41) 1.36 (0.37) 
(II) 75 (11) 
(21) 143 (20)' 
30.6' 
7.4' 
28.7 
19.4 
+ systolic blood pressure ~ 160 mm Hg andlor diastolic blood pressure ~ 95 mm Hg andlor use of 
antihypertensive medication 
t alcohol intake> 20gld in women or >30 gld in men 
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Table 3: Odds ratio and 95% confidence intervals (el) for atherosclerosis according to qnartiles of serum carotenoids, the Rotterdam 
Stndy, The Netherlands 
Quartiles Pvalue for 
Variable 1 (Lowest)' 2 3 4 (Highest) trend 
cx~carotene 
mean level (lUllol/l) <0.028 0.028 - 0.039 0.040 - 0.063 > 0.063 
No cases of atherosclerosis 27 28 31 22 
OR(95%CI) 
adjusted for age and sex 1.00 1.41 (0.66 - 3.03) 1.31 (0.62 - 2.75) 0.80 (0.36 - 1.73) 0.616 
multivariate adjusted§ 1.00 156 (0.71 - 3.47) 1.49 (0.69 - 3.24) 0.90 (0040- 2.04) 0.843 
I3-carotene 
mean level (lUllol/l) <0.184 0.184 - 0.263 0.264 - 0.367 > 0.367 
No cases of atherosclerosis 27 27 28 26 
OR(95%CI) 
adjusted for age and sex 1.00 0.96 (0045 - 2.04) 1.10 (051 - 2.36) 0.90 (0041 - 1.95) 0.906 
multivariate adjusted§ ·1.00 1.06 (0047 - 2.37) 1.24 (056 - 2.78) 1.00 (0043 - 2.32) 0.899 
cryptoxanthin 
mean level (lUllolll) < 0.214 0.214 - 0.364 0.365 - 0583 > 0583 
No cases of atherosclerosis 21 31 31 25 
OR(95%CI) 
adjusted for age and sex 1.00 2.02 (0.94 - 4040) 2041 (1.08 - 5049) 1.40 (0.63 - 3.1 1) 00413 
multivariate adjusted§ 1.00 2.17 (0.99 - 4.89) 2.69 (1.17 - 6.37) 1047 (0.63 - 3049) 0.334 
table 3 continued 
Quartiles Pvalue for 
Variable 1 (Lowest)- 2 3 4 (Highest) trend 
lutein 
mean level (J.lIDolll) < 0.281 0.281 - 0.380 0.381 - 0.505 > 0.505 
No cases of atherosclerosis 26 27 29 26 
OR(95%CI) 
adjusted for age and sex 1.00 1.08 (0.51 - 2.32) 1.22 (0.57 - 2.63) 0.93 (0.42 - 2.03) 0.938 
multivariate adjusted§ 1.00 1.09 (0.50 - 2.37) 1.30 (0.58 - 2.91) 0.96 (0.42 - 2.20) 0.964 
Iycopene 
mean level (J.lIDolll) <0.058 0.058 - 0.103 0.104 - 0.166 > 0.166 
No cases of atherosclerosis 32 28 25 23 
OR (95% CI) 
adjusted for age and sex 1.00 0.79 (0.37 - 1.69) 0.65 (0.30 - 1.42) 0.55 (0.25 - 1.22) 0.126 
multivariate adjusted§ 1.00 0.89 (0.41 - 1.95) 0.78 (0.33 - 1.71) 0.66 (0.29 - 1.49) 0.284 
zeaxanthin 
mean level (J.lIDolll) <0.046 0.046 - 0.062 0.063 - 0.084 > 0.084 
No cases of atherosclerosis 29 31 24 24 
OR(95%CI) 
adjusted for age and sex 1.00 1.16 (0.55 - 2.46) 0.73 (0.34 - 1.55) 0.88 (0.41 - 1.90) 0.493 
multivariate adjusted§ 1.00 1.15 (0.54 - 2.47) 0.75 (0.34 - 1.65) 0.80 (0.35 - 1.78) 0,400 
"'reference category 
§ multivariate adjusted: adjusted for age. sex, serum cholesterol, season, waist-te-hip rario, pack~years smoked, alcohol intake 
Table 4: Odds ratio and 95% confidence intervals (CI) for atherosclerosis for quartiJes of serum Iycopene stratified by 
smoking status, the Rotterdam Study, the Netherlands 
Quartiles P value for 
Variable 1 (Lowest)' 2 3 4 (Highest) trend 
smoking status 
non-snwkers (30 casesl39 controls) 
OR (95% CI) 
adjusted for age and sex 1.00 0.92 (0.22 - 3.81) 1.02 (0.21 - 4.96) 1.48 (0.36 - 6.35) 0.543 
multivariate adjusted§ 1.00 0.95 (0.20 - 4.52) 1.04 (0.17 - 6.53) 1.19 (0.23 - 6.34) 0.798 
ever snwkers (78 cases/70 controls) 
OR(95%CI) 
adjusted for age and sex 1.00 0.34 (0.12 - 0.91) 0.29 (0.11 - 0.73) 0.35 (0.13 - 0.94) 0.036 
multivariate adjusted§ 1.00 0.32 (0. I I - 0.89) 0.34 (0.12 - 0.91) 0.43 (0.14 - 1.25) 0.139 
• reference category 
§ multivariate adjusted: adjusted for age, sex, season, serum cholesterol, waisHo--hip ratio, pack-years smoked and alcohol intake 
Serum carotenoids and atherosclerosis 
In a logistic regression model adjusted for age and sex there was a non-significant 
inverse association of quartiles of serum lycopene to risk of atherosclerosis. The odds 
ratio for the highest compared to the lowest level of serum lycopene was 0.55 (95% CI 
0.25 - 1.22; P""d = 0.13). Quartiles of serum concentrations of a-carotene, p-carotene, 
lutein, and zeaxanthin were not associated with atherosclerosis (table 3). For the second 
and third quartile of serum p-cryptoxanthin, an increased risk of aortic calcification was 
observed (table 3). Further adjustment for season and serum cholesterol, and 
subsequently waist-to-hip ratio, pack-years smoked, and alcohol intake did not 
appreciably alter these results (table 3). 
Stratification by smoking status indicated that the inverse association observed for 
serum lycopene with aortic calcification was most evident in ever smokers. The age-
and sex-adjusted odds ratio for the highest compared to the lowest quartile of serum 
lycopene was 0.35 (0.13 - 0.94; Plreod = 0.04) for ever smokers. Multivariate adjustment 
only slightly altered the risk estimates (table 4). 
DISCUSSION 
High circulating levels of carotenoids have been presumed to protect against 
atherosclerosis before its clinical manifestation'4. We tested this hypothesis by 
investigating whether high levels of the major carotenoids in serum - a-carotene, p-
carotene, p-cryptoxanthin, lutein, lycopene, and zeaxanthin - were associated with 
decreased risk of aortic atherosclerosis assessed by presence of calcified plaques of the 
abdominal aorta. Serum levels of lycopene were inversely associated with aortic 
calcification. The association was most pronounced in current and former smokers. No 
association with risk of aortic calcification for the serum carotenoids a-carotene, p-
carotene, p-cryptoxanthin, lutein, and zeaxanlhin was observed. 
We recognize that there are some sources of potential bias in our study. Presence of 
calcifications in the abdominal aorta was' used as a proxy for generalized 
atherosclerosis in the current study. These calcifications have been shown previously 
to be associated with atherosclerosis in other arterial vessels36 and with cardiovascular 
disease risk factors29•3'. They have been shown to predict coronary heart disease34 and 
cardiovascular mortality32.33. Validity of roentgenographic assessment of aortic 
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calcification for assessment of atherosclerosis was demonstrated by comparison with 
necropsy materiatl° and comparison of radiographs with CT images of calcified aortas 
showed that calcifications seen on the radiographs were within the vascular wall of the 
aorta in almost all cases'9. 
We used single blood specimen to determine serum carotenoids. Given the biologic 
variation of the actual carotenoid concentration, possibly reflecting variations in 
dietary intake and imprecision in the measurement technique, a single serum specimen 
may not be able to provide a precise estimate of typical serum carotenoid 
concentrations over time3'. This could potentially attenuate the relationship between 
carotenoid concentrations and presence of atherosclerosis towards the null. To 
compensate for the reduction in statistical power resulting from intrasubject variability 
in serum carotenoids our sample size (n = 217) may have been too small. However, 
lack of power does not explain why the observed association between serum Iycopene 
concentrations and aortic atherosclerosis turns out to be stronger than those for the 
other carotenoids. 
Looking at atherosclerosis adds to previous studies on coronary heart disease with 
respect to asymptomatic disease. We observed a consistent trend of a decreased risk for 
aortic calcification with elevated serum Iycopene levels, but no association for u-
carotene, p-carotene, lutein, or zeaxanthin. The observed positive association of the 
second and third quartile of p-cryptoxanthin with atherosclerosis was unexpected and 
cannot be explained. Few other studies have focused on carotenoids and 
atherosclerosis and so far results are inconsistent. Provitamin A carotenoid intake has 
been reported to be inversely associated with presence of carotid intima media 
thickness in men aged 55 years and 0lder'3 and in a subsequent analysis with carotid 
artery plaquel4. In an elderly French population no association of plasma carotenoids 
with common carotid intima media thickness or with presence of carotid plaques was 
observed'6. Iribarren et al.'5, however, observed serum ll-cryptoxanthin and 
lutein/zeaxanthin levels to be inversely related to the extent of asymptomatic carotid 
atherosclerosis, and increases of serum a-carotene and Iycopene to be associated with 
nonsignificantly lower odds of being a case. In our study on serum carotenoids and 
atherosclerosis only elevated serum Iycopene levels were nonsignificantly associated 
with decreased risk of aortic atherosclerosis. Supportive of a beneficial effect of 
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lycopene in cardiovascular disease are furthermore results from the EURAMIC study, 
where elevated adipose tissue levels oflycopene were associated with decreased risk of 
myocardial infarction'8,'9, 
The observed association with lycopene in the current study was most evident in 
current and former smokers. Interaction between carotenoids and cardiovascular 
disease was reported in several epidemiologic studies3"s,'7,2s. Street et al.'s observed 
low serum lycopene levels to be associated with subsequent myocardial infarction only 
in smokers and Kritchevsky et a!. 24 observed the strongest evidence for a protective 
effect of dietary provitamin A carotenoids in female smokers. In both studies the 
carotenoid effect on smoking did not seem to depend on the intensity of smoking, In 
contrast, the effect observed for lycopene in EURAMIC was strongest among non-
smokers, though it was also evident in former and current smokers'8. Cigarette smoke 
contains an abundance of free radical species which could be expected to deplete lipid-
phase micronutrients such as carotenoids. Exposing human plasma to the gas phase of 
cigarette smoke led to depletion of most of the lipophilic antioxidants. The most 
susceptible of the carotenoids to cigarette smoke-induced depletion were lycopene 
followed by lutein + zeaxanthin and B-carotene38. This might explain the observed 
increased risk of cardiovascular diseases with low carotenoid levels in ever smokers in 
this and other studies,s,'7. 
In the current study only serum lycopene but not B-carotene was inversely associated 
with a decreased risk of atherosclerosis. Factors related to measurement and the 
interaction between different foodstuffs or nutrients may explain why we see an effect 
only in lycopene, but additional studies on carotenoids are needed to further clarifY 
this. For instance, some variability in antioxidant activity among the carotenoids has 
been observed in vitro; e.g, lycopene exhibits superior antioxidant capability compared 
with B-carotene and lutein39, Given its ability to quench singlet oxygen and scavenge 
peroxyl radicals, lycopene is considered to be among the most efficient single oxygen 
quenchers of the natural carotenoids39,40, In addition, tomato lycopene has been shown 
to inhibit low density lipoprotein oxidation in vitr04', a finding supporting its possible 
role in the prevention of cardiovascular disease. However, whether the observed 
association between serum lycopene and atherosclerosis can be attributed to lycopene 
itself or whether lycopene is merely a marker of active phytochemicals found in 
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lycopene-rich foods such as tomatoes and tomato products remains to be elucidated. 
In conclusion, this study provides evidence for a modest inverse association between 
levels of serum lycopene levels and presence of aortic atherosclerosis in a population-
based study. The associations were most pronounced in former and current smokers. 
Our findings suggest that serum carotenoids with a strong antioxidant activity such as 
lycopene may be important in the prevention of atherosclerosis. 
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Dietary antioxidants and peripheral artery disease. 
The Rotterdam Study 
ABSTRACT 
4.2 
The aim of this study was to examine cross-sectionally whether energy-adjusted dietary 
antioxidant intake - 13-carotene, vitamin C, and vitamin E - was associated with peripheral 
artery disease in the Rotterdam Study. The study population consisted of 4460 subjects aged 
55-94 years without previous cardiovascular disease at baseline for whom dietary data 
assessed by a semiquaotitative food frequency questionnaire were available. Peripheral artery 
disease was defined as a right or left ankle-arm pressure index lower thao or equal to 0.9 and 
was present in 626 subjects (228 men, 398 women). In age-adjusted logistic regression aoalyses, 
vitamin C intake was significaotly inversely associated with peripheral artery disease in women 
(relative risk ~ 0.65; 95 percent confidence interval 0.45-0.84; P"',d 0.001; highest versus lowest 
quartile of vitamin C intake), whereas in men Jl-carotene (relative risk ~ 0.68; 95% CI 0.45-1.02; 
P"',d 0.054; highest versus lowest quartile of Jl-carotene intake) aod vitamin E intake (relative 
risk ~ 0.61, 95% CI 0.40-0.92; P"',d 0.0\ 7; highest versus lowest quartile of vitamin E intake) 
were inversely associated with peripheral artery disease. After adjustment by body mass index, 
smoking status, education, income, and alcohol intake the significantly inverse association of 
vitamin C in women with peripheral artery disease remained (relative risk ~ 0.66, 95% CI 0.48 -
0.91, PO,"d 0.007 highest versus lowest quartile of vitamin C intake). Stratification by smoking 
status indicated that current or former smokers benefit most of elevated dietary antioxidant 
intake suggesting that a diet high in fruit and vegetables may be in particular beneficial in the 
prevention of peripheral atherosclerosis in ever smokers. 
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INTRODUCTION 
Observational studies have indicated that dietary antioxidants may exert a protective 
effect on incidence and mortality of cardiovascular disease!·9 and suggest that 
antioxidative vitamins may be associated with reduced atherosclerosis lO.". Peripheral 
artery disease, reflecting the presence of atherosclerotic vessel wall abnormalities of the 
arteries of the lower extremities, is considered to be a good indicator of asymptomatic 
atherosclerosis lJ•1 •. Peripheral artery disease occurs commonly in the elderly'··16 and 
presence of peripheral artery disease has been shown to be a strong predictor of 
subsequent morbidity and mortalityI5.17.18. The aim of the present study was to 
investigate whether dietary antioxidants are associated with presence of peripheral 
artery disease. 
SUBJECTS AND METHODS 
Study popUlation 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78%) aged 55 years and over, living in Ommoord, an urban district in 
Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of and 
the risk factors for chronic and disabling diseases as described previously'9. The study 
was approved by the Medical Ethics Committee of the Erasmus University, and written 
infonned consent was obtained from all participants. Dietary assessment was conducted 
in 5646 participants. Two hundred and twelve subjects were excluded because they did 
not fully cooperate during the interview and the dietitian considered their reported diets 
unreliable. This resulted in 5434 subjects (2225 men and 3209 women) with dietary data. 
Blood pressure of the lower extremities was measured in 4900 subjects with complete 
dietary data. A total of 733 subjects (288 men, 445 women) had peripheral artery disease 
in one or both extremities. Among subjects with peripheral artery disease were 107 
subjects with a self-report of myocardial infarction, cerebrovascular accident, bypass 
surgery, or percutaneous transluminal coronary angioplasty and among those without 
peripheral artery disease were 333 subjects with any of these conditions. Because they 
might intentionally have changed their diets after having experienced a cardiovascular 
event, they were not included in the analysis. This resulted in a study sample of 4460 
subjects (626 subjects with and 3834 subjects without peripheral artery disease) for the 
current analysis. 
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Measurements 
All subjects were first visited at their home. Information on current health status, medical 
history, drug use, education, income, and smoking behaviour was obtained by a 
computerized questionnaire, which included the Dutch version of the Rose 
cardiovascular questionnaire2o• The home visit was followed by two visits at the research 
centre. During those visits several cardiovascular risk factors were determined. Height 
and weight were measured, and body mass index (weight in kglheight in m2) was 
calculated as a measure of obesity. Sitting blood pressure was measured twice at the right 
upper arm with a random-zero sphygmomanometer; the average of two measurements 
was used. Systolic blood pressure at the ankles (posterior tibial artery) was measured in 
supine position with an adult size cuff just above the malleoli, and a 8 Mhz Doppler 
transducer2'. The ankle-arm pressure index (ABPI) is the ratio of the systolic blood 
pressure at the ankle to the systolic blood pressure at the arm. Peripheral artery disease 
was defined as a right or left ankle-arm pressure index lower than or equal to 0.922• A 
venepuncture was performed and serum total and high density lipoprotein (HDL) 
cholesterol concentrations were determined by an automated enzymatic procedure. 
Dietary assessment 
The semiquantitative food frequency questionnaire (SFFQ) completed during baseline 
aimed at assessing habitual food intake during the past year and included 170 food items 
in 13 food groups and questions about dietary habits, supplementation, and prescribed 
diets. SFFQ data were converted to nutrient intake using the computerized Dutch Food 
Composition Table23 • Data for B-carotene, retinol, and tocopherol were updated by use of 
an additional database by the Netherlands Institute of Public Health and Enviromnental 
Protection (Vollebregts & Feskens, unpublished observations, 1993). Nutrient intake 
through nutritional supplements was not considered since brand labels were not recorded 
with sufficient accuracy. 
The validity of the SFFQ was assessed in a subsample of 80 men and women aged 55 to 
75 years. Nutrient intake estimated from the SFFQ was compared with estimated nutrient 
intake of in total 15 days offood records collected over a one-year period24 • The ability 
of the SFFQ to rank subjects adequately according to their dietary intake was 
demonstrated by Pearson's correlation coefficients of 0.4 to 0.8 adjusted for sex, age, 
total energy intake, and for wiihin-person variability in daily intake25, and a high degree 
of classification into the same or adjacent quintile (76.8% for energy-adjusted data). 
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Data Analysis 
Differences in mean levels of dietary antioxidants and risk factors for peripheral artery 
disease between subjects with and without peripheral artery disease were assessed by 
analysis of variance, respectively by chi-square statistics for categorical variables. The 
association between dietary antioxidant intake and peripheral artery disease was 
examined primarily by multivariate logistic regression. Energy-adjusted nutrient intakes 
were derived by adding the median nutrient intake to the residuals from regression 
analysis of nutrient intake on energy2'. Energy-adjusted dietary antioxidant intake from 
food sources was categorized into quartiles, and risk of peripheral artery disease of the 
upper quartiles was compared to risk in the lowest quartile. The initial analysis examined 
associations adjusted for age and was furthermore adjusted for body mass index, 
smoking status, equivalent household income (five categories), highest education 
attained (five categories), and alcohol intake (five categories). The models were fit 
separately for men and women. The associations between qual1iles of energy-adjusted 
intake of Il-carotene, vitamin C, and vitamin E and risk of peripheral artery disease were 
expressed as relative risk with 95% confidence intervals. Results were considered 
statistically different at the two-tailed 0.05 alpha-level. Statistical analysis was performed 
using SAS® (Release 6.11; SAS Institute, Cary, NC, USA). 
RESULTS 
Mean age of the 1720 men and 2740 women was 66.6 years (SO 7.3) and 67.5 years 
(7.9 SO), respectively. Compared to the total population of the Rotterdam Study for 
whom dietary data were available (n = 5434) the study population did not differ in 
characteristics such as age, body mass index, blood pressure, income, level of 
education, or nutrient intake. Vitamin supplements containing either Il-carotene, 
vitamin C, or vitamin E were used by 9.0% of the male and 13.8% of the female study 
population. 
Peripheral artery disease was present in 13.3% of the men and 14.5% of the women. 
Subjects with peripheral artery disease were on average significantly older than those 
without peripheral artery disease. Analysis was thus subsequently adjusted for age. 
Table I depicts differences between subjects with and without peripheral artery disease 
stratified by sex. Risk factors for peripheral artery disease - smoking, elevated blood 
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Table 1: Age-adjusted means (SE) and distributions (%) of baseline characteristics for men and women with and without peripheral 
artery disease* 
Men Women 
PAD not present PAD present pt PAD not present PAD present pt 
n = 1492 n=228 n=2342 n=398 
Variables 
Age (years) 66.0 0.18 70.7 0.56 < 0.001 66.8 0.16 71.3 0.45 < 0.001 
Body mass index (kg/m') 25.8 0.07 25.3 0.19 0.028 26.7 0.08 26.7 0.20 0.848 
Waist-to-hip ratio 0.95 0.002 0.96 0.004 0.245 0.86 0.002 0.86 0.004 0.874 
Systolic blood pressure (mm Hg) 137 0.55 145 1.42 < 0.001 137 0.42 147 1.04 < 0.001 
Diastolic blood pressure (mmHg) 75 0.29 75 0.77 0.845 7.3 0.23 75 0.56 0.006 
Serum cholesterol (mmoIlI) 6.32 0.03 6.42 0.07 0.232 6.84 0.02 7.05 0.06 0.001 
HDL-serum cholesterol (mmoIlI) 1.24 om 1.20 0.02 0.133 1.46 0.01 1.41 0.02 0.006 
Packyears smoked 1.88 9.6 225 11.9 0.004 68.3 2.55 95.6 6.20 < 0.001 
Obesity (%) 6.7 7.3 0.804 19.2 18.1 0.845 
Hypertension! (%) 21.1 33.0 0.001 22.6 36.0 0.001 
Hyperchoiesterolemiat (%) 38.5 46.1 0.043 58.7 64.2 0.023 
Diabetes (%) 7.5 14.2 0.001 8.0 13.5 0.001 
Current smokers (%) 27.2 50.1 0.001 17.1 28.8 0.001 
High alcohol intake¥ (%) 32.1 37.3 0.100 10.4 11.5 0.462 
University education (%) 15.2 19.2 0.187 4.4 5.0 0.888 
Higher income). (%) 13.7 15.! 0.993 8.7 8.0 0.310 
Antioxidative supplementation (%) 8.5 11.7 0.122 13.2 16.9 0.072 
Diet (%) 8.2 13.7 0.007 13.3 19.8 0.001 
• •• table 1 continued 
Men Women 
PAD not present PAD present pt PAD not present PAD present pt 
n = 1492 n=228 n=2342 n=398 
Variables 
Energy-adjusted intake of 
B-carotene (mg/d) 1.50 0.02 1.43 0.04 0.143 1.41 0.02 1.37 0.04 0.367 
vitamin C (mg/d) 108 1.32 106 3.43 0.494 117 1.13 109 2.78 0.006 
vitamin E (mg/d) 14.3 0.15 13.2 0.40 0.014 11.9 0.10 12.2 024 0202 
total fat (g/d) 88.6 0.39 88.2 1.00 0.744 70.2 025 71.0 0.61 0.208 
saturated fat (g/d) 33.8 020 34.3 0.51 0.423 27.9 0.13 27.9 0.33 0.970 
cholesterol (mg/d) 246 1.77 252 4.61 0210 208 1.14 211 2.81 0.290 
• subjects with self-reports of myocardial infarction, cerebrovascular accident, bypass operation, or percutaneous transluminal angiopJasty were excluded from analysis 
~ if serum cholesterol:?: 6.5 mmolll 
f if systolic blood pressure ~ 160 rom Hg and/or diastolic blood pressure ~ 95 mm Hg andlor use of antihypertensive medication 
¥ alcohol intake> 20 gld 
').. equivalent household income> 3000 Hfl 
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pressure, elevated serum cholesterol levels, and presence of diabetes were significantly 
more pronounced in males and females with peripheral artery disease than in those 
without peripheral artery disease (table I). In female subjects a significantly lower 
intake of dietary vitamin C with presence of peripheral artery disease was seen, in male 
cases intake of vitamin E was significantly lower. 
In men and women B-carotene intake was inversely associated with age (men r = -0.13, 
P < 0.001; women r = -0.12, p < 0.001). In addition, a weak inverse correlation of 
vitamin C with age ( r = -0.05, P = 0.036) was observed in men. Vitamin C and 
B-carotene intake were highly correlated in both sexes (men r = 0.39, p < 0.001; 
women r = 0.36, P < 0.001), whereas correlations between B-carotene and vitamin E, 
and between vitamin C and vitamin E were rather modest (range 0.12 - 0.19; p < 
0.00 I). Dietary fat and cholesterol intake were inversely associated with B-carotene, 
vitamin C and vitamin E with the exception of total fat and polynnsatnred fat that were 
positively correlated with vitamin E intake. Only weak associations of antioxidative 
vitamins with measures of body composition, blood pressure, and serum cholesterol 
were seen for both sexes. Current smoking was associated with lower dietary intake of 
energy-adjusted B-carotene (both sexes p < 0.0001), vitamin C (both sexes p < 0.0001) 
and vitamin E (men p < 0.000 I). 
In women, dietary vitamin C was inversely associated with age-adjusted risk of 
peripheral artery disease. The relative risk for the highest compared to the lowest 
quartile was 0.65 (95% CI 0.45-0.84, P""d 0.001). Multivariate adjustment did not 
change risk estimates and further adjustment by B-carotene and vitamin E intake and 
use of anti oxidative vitamin supplements only slightly altered risk estimates (data not 
shown). Dietary intake of B-carotene or vitamin E was not associated with risk of 
peripheral artery disease in women. In men, dietary B-carotene and vitamin E were 
inversely associated with age-adjusted risk of peripheral artery disease. The relative 
risk for the highest compared to the lowest quartile was 0.68 (95% CI 0.45-1.02, Ptre"d 
0.054) for B-carotene and 0.61 (95% CI 0.40-0.92, P"eod 0.017) for vitamin E. After 
adjustment for body mass index, smoking statns, education, income, and alcohol 
intake, point estimates were considerably decreased (table 2). 
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Table 2: Relative risk and 95% CI for peripheral artery disease according to quartiJes of energy-adjusted dietary antioxidants> 
among 1720 men and 2740 women ofthe Rotterdam Study 
Dietary intake of 
energy-adjusted 
fl-carotene (mgld) 
< 1.10 
1.10 - 1.41 
1.41 -1.77 
>1.77 
p""" 
vitamin C (mgld) 
<73 
73 - 100 
100-132 
> 132 
p""" 
vitamin E (mgld) 
< 10.0 
10.0 - 13.3 
13.3 -17.2 
> 17.2 
p.." 
Men (22811492) 
RRI RRl 
1.00 
0.97 (1.07 - 1.11) 
0.68 (0.45 - 1.14) 
0.68 (0.45 - 1.02) 
0.054 
1.00 
0.76 (0.51 -1.14) 
0.83 (0.56 - 1.24) 
0.86 (0.57 - 1.28) 
0.536 
1.00 
0.80 (0.54 - 1.17) 
0.73 (0.49 - 1.08) 
0.61 (0.40 - 0.92) 
0.017 
1.00 
1.03 (0.70 - 1.52) 
0.73 (0.48 - 1.11) 
0.79 (0.51 - 1.14) 
0.137 
1.00 
0.82 (0.55 - 1.24) 
1.00 (0.66 - 1.52) 
1.09 (0.71 - 1.67) 
0.548 
1.00 
0.85 (0.57 - 1.26) 
0.84 (0.56 - 1.26) 
0.70 (0.46 - 1.06) 
0.110 
Peripheral artery disease 
Dietary intake of 
energy-adjusted 
fl-carotene (mglel) 
<0.98 
0.98 - 1.30 
1.30 - 1.67 
> 1.67 
p""" 
vitamin C (mgld) 
<80 
80 - !O8 
108 - 142 
> 142 
p""" 
vitamin E (mgld) 
<8.7 
8.7-11.4 
11.4 - 14.5 
> 14.5 
p""" 
Women (39812342) 
RR' 
1.00 
0.79 (0.59 - 1.07) 
0.72 (0.53 - 0.98) 
0.81 (0.59 -1.10) 
0.106 
1.00 
0.80 (0.60 - 1.07) 
0.72 (0.53 - 0.97) 
0.65 (0.45 - 0.84) 
. 0.002 
1.00 
1.33 (0.98 - 1.81) 
1.06 (0.77 - 1.45) 
1.28 (0.84 - 1.74) 
0.319 
subjects with a self-reported history ofM!, cerebrovascular accident, coronary bypass operation. and PTCA are excluded from the analyses 
t reference category 
RR 1 adjusted for age 
RR' 
1.00 
0.85 (0.57 - 1.15) 
0.78 (0.66 - 1.07) 
0.92 (0.065 - 1.28) 
0.427 
1.00 
0.85 (0.60 -1.15) 
0.80 (0.58 - 1.09) 
0.67 (0.48 - 0.93) 
0.017 
1.00 
1.42 (1.04 - 1.95) 
1.13 (0.81 - 1.57) 
1.41 (1.03 - 1.95) 
0.122 
RRz adjusted for age. BMI. number ofpackyears smoked, education. income. alcohol intake. and energy-adjusted 6-carotene. vitamin C. and vitamin E: use of 
antioxidative vitamin supplements 
Dietary antioxidants and peripheral artery disease 
Risk of peripheral artery disease was significantly increased in men and women 
following a prescribed diet. Multivariate adjusted risk estimates were 1.88 (95% CI 
1.19-2.91, p= 0.006) for men and 1.62 (95% CI 1.22-2.13, p<O.OOI) for women. 
Subsequent exclusion of subjects reporting a precribed diet (n = 544), however, only 
marginally altered risk estimates (data not shown). 
Risk of peripheral artery disease was considerably modified by smoking status (tables 
3,4). In general, inverse associations were stronger among smokers compared to never 
smokers. In men high levels of dietary Il-carotene were significantly (relative risk = 
0.59,95% CI 0.29-1.17; P'"nd 0.042; highest versus lowest quartile) and high levels of 
vitamin C and vitamin E were nonsignificantly associated with age-adjusted risk of 
peripheral artery in current smokers. Multivariate adjustment only slightly altered risk 
estimates. For men who never smoked increased risk of PAD was observed with 
vitamin C intake (table 3), but numbers were small and confidence limits were wide. In 
women, this association was significant for vitamin C intake among former (relative 
risk = 0.54, 95% CI 0.29-0.99; PIT,nd 0.029 for the highest versus the lowest quartile) 
and among current female smokers (relative risk = 0.48, 95% CI 0.23-0.95; P'rend 0.039 
for the highest versus the lowest quartile) in a multivariate adjusted model (table 4) .. 
DISCUSSION 
In the present cross-sectional study we investigated whether energy-adjusted dietary 
Il-carotene, vitamin C, and vitamin E were associated with peripheral artery disease in 
the elderly cohort of the Rotterdam Study. In women, we observed vitamin C to be 
inversely associated with risk of peripheral artery disease, whereas in men Il-carotene 
and vitamin E were inversely associated with risk of peripheral artery disease. 
Stratification by smoking status indicated that current or former smokers benefit most 
of elevated dieiary antioxidant intake. 
Interpretation of our findings should be preceeded by methodological considerations. 
Since our results are based on cross-sectional analysis, the basis for causal inference is 
inherently limited. Timing of dietary intake with respect to the development of peripheral 
artery disease is not known, but one might expect that recent dietary changes would not 
reflect the dietary milieu under which peripheral artery disease developed. For most 
subjects peripheral artery disease is asymptomatic, therefore we do not expect changes as 
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Table 3: Relative risk and 95% confidence intervals for peripheral artery disease for quartiles of energy-adjnsted antioxidant intake 
stratified by smoking status among 1720 men of the Rotterdam Study 
8-carotene vitamin C vitamin E 
Intake quartile RR' RR2 RR' ~ RR' RR2 
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) 
Never smoked 
I 1.00 1.00 1.00 
-f 1.00 1.00 
2 0.83 (0.09 - 7.86) 0.90 (0.09 - 9.82) 1.63 (0.21- 12.86) 1.26 (0.18 - 11.05) 1.51 (0.19 - 14.67) 
3 1.60 (0.23 - 14.49) 1.08 (0.12 - 12.31) 1.55 (0.23- 10.52) 0.64 (0.07 - 6.07) 0.47 (0.04 - 4.79) 
4 2.43 (0.32 - 24.45) 1.71 (0.18-20.30) 3.10 (0.33- 29.38) 1.08 (0.15 - 9.81) 1.22 (0.16 - 11.60) 
Pt=' 0.316 0.592 0.032 0.895 0.890 
Former smokers 
1 1.00 1.00 1.00 1.00 1.00 1.00 
2 1.57 (0.88 - 2.82) 1.04 (0.57 - 1.92) 1.03 (0.56 - 1.90) 1.04 (0.57 - 1.92) 0.88 (0.48 - 1.61) 0.86 (0.47 - 1.57) 
3 1.02 (0.56 - 1.88) 0.95 (0.51 - 1.78) 0.92 (0.50 - 1.72) 0.95 (0.51-1.78) i.IO (0.63 - 1.94) 1.08 (0.61 - 1.92) 
4 1.22 (0.68 - 222) 1.45 (0.81 - 2.67) 1.39 (0.78 - 2.51) 1.45 (0.81- 2.67) 0.82 (0.45 - 1.48) 0.79 (0.43 - 1.44) 
Ptrend 0.895 0.240 0.304 0.240· 0.680 0.621 
Current smokers 
I 1.00 1.00 1.00 1.00 1.00 1.00 
2 0.74 (0.42 - 1.29) 0.75 (0.43 - 1.32) 0.66 (0.36 - 1.17) 0.65 (0.35 - 1.17) 0.80 (0.45 - 1.40) 0.82 (0.46 - 1.43) 
3 0.53 (0.28 - 0.97) 0.50 (0.27 - 0.92) 1.07 (0.60 - 1.90) 1.12 (0.62 - 2.01) 0.62 (0.33 - 1.15) 0.63 (0.33 - 1.17) 
4 0.59 (0.29 - 1.17) 0.56 (0.27 - 1.12) 0.51 (0.25 - 0.99) 0.51 (0.25 - 1.00) 0.59 (0.30 - 1.12) 0.62(0.31-1.18) 
Ptrend 0.042 0.027 0.185 0.210 0.060 0.090 
subjects with a se1f~reported history of MI. cerebrovascular accident, coronary bypass operation. and PTCA were excluded from the analyses 
t reference category 
RR 1 adjusted for age 
RR2 adjusted for age. body mass index. smoking status (two variables), education (five categories). income (five categories). alcohol intake (five categories) 
f because of an empty cell in the reference category no risk estimates are given 
Table 4: Relative risk and 95% confidence intervals for peripberal artery disease for quartiles of energy-adjusted antioxidant intake 
stratified by smoking status among 2740 women oftbe Rotterdam Study 
8-carotene vitamin C vitaminE 
Intake quartile RR' RR' RR' 1m' 1m' 1m' 
(95% CI) (95% CI) (95%CI) (95% CI) (95% CI) (95% CI) 
Never smoked 
I 1.00 1.00 1.00 1.00 1.00 1.00 
2 0.80 (0.52 - 1.21) 0.80 (0.52 - 1.22) 0.73 (0.48 - 1.13) 0.73 (0.48 - 1.13) 1.60 (1.01·- 2.55) 1.59 (1.01 - 2.54) 
3 0.85 (0.56 - 1.30) 0.85 (0.55 - 1.30) 0.75 (0.48 - 1.16) 0.76 (0.49 - 1.17) 1.23 (0.77 - 1.98) 1.20 (0.75 - 1.93) 
4 0.84 (0.53 - 1.31) 0.82 (0.52 - 1.29) 0.74 (0.48 -1.16) 0.76 (0.49-1.18) 1.72 (1.11 - 2.71) 1.70 (1.09 - 2.67) 
J'tre", 0.472 0.430 0.225 0.270 0.056 0.068 
Former smokers 
1 1.00 1.00 1.00 1.00 1.00 1.00 
2 0.63 (0.35 - 1.12) 0.63 (0.35 - 1.12) 0.92 (0.52 - 1.62) 0.95 (0.53 - 1.69) 0.82 (0.46 - 1.45) 0.80 (0.45 - 1.43) 
3 0.46 (024 - 0.85) 0.45 (023 - 0.83) 0.70 (038 - 1.29) 0.69 (037 - 127) 0.66 (036 - 1.21) 0.65 (035 - 120) 
4 0.72(0.40-1.29) 0.71 (0.39 - 1.28) 0.55 (0.29 - 1.00) 0.54 (0.29 - 0.99) 0.73 (0.40 - 1.33) 0.73 (0.39 - 1.32) 
Ptrend 0.142 0.131 0.036 0.029 0.887 0220 
Current smokers 
1 1.00 1.00 1.00 1.00 1.00 1.00 
2 1.09 (0.60 - 2.00) 1.05 (0.57 - 1.93) 1.06 (0.59 - 1.18) 1.08 (0.60 - 1.94) 1.74 (0.93 - 3.30) 1.79 (0.95 - 3.43) 
3 0.91 (0.48 - 1.69) 0.91 (0.48 - 1.71) 0.85 (0.47 - 1.52) 0.78 (0.42 - 1.42) 1.46 (0.77 - 2.80) 1.49 (0.77 - 2.89) 
4 1.08 (0.57 - 2.02) 1.11 (0.58 - 2.11) 0.59 (0.29 - 1.14) 0.48 (0.23 - 0.95) 1.46 (0.76 - 2.82) 1.04 (0.98 - 1.10) 
p""" 0.980 0.890 0.127 0.039 0.362 0.323 
subjects with a self~reported history of ?ill, cerebrovascular accident. coronary bypass operation, and PTCA were excluded from the analyses 
t reference category 
RR' adjusted for age 
RR' adjusted for age, body mass index, smoking status (two variables), education (five categOries), income (fiVe. categories), a1cobol intake (five categories) 
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a result of the presence of disease. We excluded subjects with symptomatic disease 
assuming that they might intentionally have changed their diets after having experienced 
a cardiovascular event. In addition, we evaluated whether exclusion of subjects reporting 
a prescribed diet modified risk estimates. However, only minor alterations were 
observed, suggesting that recent dietary changes were not a major source of bias in the 
present study. 
Few other studies have focused on the association of dietary antioxidants and 
peripheral artery disease. In a cross-sectional analysis of dietary antioxidants with 
peripheral atherosclerosis lower dietary intakes of vitamins E, C, and A were observed 
to be significantly associated with lower ankle-arm index in men but not in women in 
the ARIC Stud/9• Cross-sectional data from the Edinburgh Artery Study showed 
lower vitamin E intake to be associated with decreased ankle-arm index3o, whereas 
case-control data from the same study showed no association of alpha-tocopherol and 
beta-carotene with intermittent claudication. Among cases of intermittent claudication, 
however, a lower intake of vitamin C was observed31 • In the current study we found 
dietary vitamin C to be significantly inversely associated with peripheral artery disease 
in women and B-carotene and vitamin E nonsignificantly inversely associated with 
peripheral artery disease in men in a multivariate model. Whether this may be partly 
attributable to a different food pattern compared to women remains to be elucidated. 
Smokers are at a high risk of developing atherosclerosis, though the mechanisms are 
not yet fully understood. Cigarette smoke contains vast amounts of free radicals that 
could directly initiate and propagate the process of lipid peroxidation. An imbalance 
between prooxidants and antioxidants, linked to decreased smoke related anti oxidative 
capacity and increased free radical generation, might render smokers more prone to 
peroxidative stress32• Several studies examining antioxidants and cardiovascular 
disease observed an interaction between dietary antioxidants and smoking. This 
interaction has not been observed uniformly in epidemiological studies, but several 
studies have seen fairly strong associations in current or former smokers 1o,14.33. In the 
current study we observed that among men current smokers benefit most of elevated 
dietary antioxidant intake. Among women this was less clear for current smokers 
which might be due to relatively small numbers. Differences in smoking history 
between men and women might be a possible explanation for these observations. In 
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conclusion, our results suggest that a diet high in fruit and vegetables may be 
beneficial in the prevention of peripheral atherosclerosis in particular in ever smokers. 
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Dietary antioxidants and risk of myocardial infarction in the 
elderly. The Rotterdam Study 
ABSTRACT 
4.3 
Epidemiological studies have shown dietary antioxidants to be inversely correlated with 
coronary heart disease (CHD). In the current observational study we investigated whether B-
carotene, vitamin C, and vitamin E from food sources and supplements were related to risk of 
myocardial infarction (MI) in an elderly population. The study sample consisted of 4802 
participants of the Rotterdam Study free ofMI at baseline for whom dietary data assessed by a 
semiquantitative food frequency questionnaire were available. During a four year follow-up 
period 124 subjects had a first MI. The association between energy-adjusted B-carotene, 
vitamin C, and vitamin E and risk of MI was examined by multivariate logistic regression. 
Risk of MI for the highest compared to the lowest tertile of B-carotene intake was 0.55 (95% 
CI: 0.34,0.83; P"',d 0.013) adjusted for age, sex, body mass index, packyears smoked, income, 
education, alcohol intake, intakes of energy-adjusted vitamin C and vitamin E, and use of 
anti oxidative vitamin supplements. If B-carotene intake from food sources and supplements 
was combined, the inverse relation with risk of MI was slightly more pronounced. 
Stratification by smoking status indicated that the association was most evident in current and 
former smokers. No association with risk of MI was observed for dietary vitamin C and 
vitamin E. 
In conclusion, the results of this observational study in the elderly population of the 
Rotterdam Study are supportive of the hypothesis that high levels of dietary B-carotene may 
protect against CHD. We did not observe an association between vitamin C or vitamin E and 
myocardial infarction. 
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INTRODUCTION 
Several epidemiological studies have shown dietary antioxidants to be inversely 
associated with coronary heart disease'-9. The antioxidants B-carotene, tocopherol, and 
vitamin C have been implicated to prevent or slow down the atherosclerotic process by 
inhibiting low-density-lipoprotein (LDL) oxidation. The most consistent and reliable 
association has been seen with vitamin E, either with supplementation or with 
relatively high levels of dietary intake. Beta-carotene and vitamin C intake have been 
less clearly associated with a reduced risk lO_ Most epidemiological studies on dietary 
antioxidants and risk of CHD focused on middle-aged populations. In the current study 
we investigated whether dietary intake of the antioxidants B-carotene, vitamin C, and 
vitamin E from food and supplemental sources was related to risk of myocardial 
infarction in an elderly population. 
SUBJECTS AND METHODS 
Study population 
The Rotterdam Study is a community based prospective cohort study of 7983 persons 
(response rate 78%) aged 55 years and over, living in Ommoord, an urban district in 
Rotterdam, the Netherlands. The aim of the study is to investigate the incidence of and 
the risk factors for chronic and disabling cardiovascular, neurodegenerative, locomotor, 
and ophthalmic diseases as described elsewhere". The study was approved by the 
Medical Ethics Committee of the Erasmus University, and written informed consent was 
obtained from all participants. Follow-up for coronary heart disease mortality started 
after the baseline survey in 1990, and until April 1996 follow-up information was 
available for 94% of the cohort. Ofthe 5159 subjects with dietary data, 173 subjects had 
a myocardial infarction (MI) during the follow-up period. Because of possible changes in 
dietary pattern, subjects with a previously known MI at baseline (n ~ 357) were 
excluded from analysis. This resulted in 4802 subjects for the current analysis. During 
an average follow-up time of 4 years, 124 cases of first fatal or non-fatal myocardial 
. infarction occurred. 
Case Ascertainment 
The follow-up period, starting at the baseline examination and lasting until April 1996 
for the present analysis, comprised 3 to 7 (mean 4) years. With respect to the vital status 
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of participants infonnation was obtained at regular intervals from the municipal health 
service in Rotterdam. Infonnation on fatal and non-fatal endpoints was obtained from the 
general practitioners (OPs) working in the study district of Ommoord. Information on 
fatal and non-fatal endpoints for 85% of the cohort was obtained from OPs in the study 
district of OmnlOord, who regularly report such information to the data center of the 
Rotterdam Study. All possible events reported by the OPs were verified by research 
physicians from the Rotterdam Study through records of the participating practitioners 
and medical specialists. In April 1996, the medical records of participants with OPs from 
outside the Onunoord area, contributing around 15% of the cohort, were checked by 
research physicians and of all possible events additional infonnation for coding was 
collected. Cause and circumstances of death were obtained by questionnaire from the OP 
and by scrutinizing infonnation from hospital discharge records in case of admittance or 
referral shortly after reporting of death by the municipal health service or the OP. 
Overall, follow-up infonnation was available for 94% of the cohort. 
Classification of fatal and non-fatal events was based on the International Classification 
of Diseases, 10th editionl2. For the present analysis cases of first non-fatal myocardial 
infarction or fatal myocardial infarction (ICD-IO:I21-124) were selected. All events were 
classified independently by two research physicians. If there was disagreement, a 
consensus was reached in a special session. Finally, all these events were verified by a 
medical expert in the field of cardiovascular disease. In case of discrepancies the 
judgment by this expert was considered definite. 
Measurements 
Infonnation on current health status, medical history, drug use, education, income, and 
smoking behaviour was obtained with a computerized questionnaire during a home 
interview. Height and weight were measured, and body mass index (weight in kg/height 
in m2) was calculated as a measure of obesity. Sitting blood pressure was measured in 
the right upper ann with a random-zero sphygmomanometer; the average of two 
measurements was used. Hypertension was defined as a systolic blood pressure of at 
least 140 mm Hg andlor diastolic blood pressure of at least 90 mm Hg, andlor current use 
of antihypertensive drugs. A venepuncture was perfornled and serum total and high 
density lipoprotein (HDL) cholesterol concentrations were determined by an automated 
enzymatic procedure. Subjects were classified as hypercholesteremic if serum 
cholesterol levels were at least 6.5 mmolll or higher. 
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Dietary assessment 
The semiquantitative food frequency questionnaire (SFFQ) completed during baseline 
aimed at assessing habitual food intake during the past year and included 170 food items 
in 13 food groups and questions about dietary habits, supplementation, and prescribed 
diets. The dietary assessment consisted of a simple self-administered questionnaire that 
was completed at home (completion time < 20 min) and a subsequent structured 
interview with a trained dietitian (allocated time < 20 min). The structured interview was 
based on the contents of the completed questionnaire and was conducted during the 
subjects' second visit at the study center. SFFQ data were converted to nutrient intake 
using the computerized Dutch Food Composition Tablel3. Data for B-carotene, retinol, 
and tocopherol were updated by use of an additional database by the Netherlands 
Institute of Public Health and Environmental Protection (unpublished observation, 1993). 
Intake through nutritional supplements was not considered since brand labels were not 
recorded with sufficient accuracy. 
The validity of the SFFQ was assessed in a subsample of SO men and women aged 55 to 
75 years. Nutrient intake estimated from the SFFQ was compared with estimated nutrient 
intake of in total 15 days of food records collected over a one-year periodl4• The ability 
of the SFFQ to rank subjects adequately according to their dietary intake was 
demonstrated by Pearson's correlation coefficients of 0.4 to O.S adjusted for sex, age, 
total energy intakel5 and for within-person variability in daily intakel6, and a high degree 
of classification into the same or adjacent quintile (76.S % for energy-adjusted data). 
Data Analysis 
All analyses were performed for men and women combined. The association between 
dietary antioxidants and risk of myocardial infarction was examined primarily by 
multivariate logistic regression. Because vitamins can be ingested from both foods and 
supplements, exposure to each vitamin was studied in two ways: first, dietary antioxidant 
intake from food sources was categorized into tertiles, and risk of myocardial infarction 
in the highest and middle tertile was compared to risk in the lowest tertile. The initial 
analysis examined associations adjusted for age and sex. The analyses were furthermore 
adjusted for body mass index, packyears smoked, equivalent household income (five 
categories), highest education attained (five categories), and alcohol intake (five 
categories). Supplement preparations containing B-carotene, vitamin C or vitamin E 
were combined and added to the model as separate variable. This allowed investigation 
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of the relation between dietary antioxidants and the risk of MI unconfounded by 
supplemental antioxidant vitamin intake. Second, in order to study the effects of 
combined intakes of antioxidants from food sources and supplement preparations, 
users of B-carotene, vitamin C, vitamin E, or multivitamin supplements were 
categorized into the highest tertile of the correspondent dietary intake. Age- and sex-
adjusted risk of MI according to tertile of intake was investigated and the models were 
subsequently adjusted for the above mentioned factors except for supplemental 
antioxidant intake. 
The associations between tertiles of energy-adjusted B-carotene, vitamin E, and 
vitamin C with and without supplemental intake and risk of MI were expressed as odds 
ratio with 95% confidence intervals. Results were considered statistically different at the 
two-sided 0.05 alpha-level. Statistical analysis was performed using SAS® (Release 
6.11; SAS Institute, Cary, NC, USA). 
RESULTS 
Mean age of the 1856 men and 2946 women was 67.0 years (SO 7.3) and 67.9 years 
(SO 8.0), respectively. Compared to the general population of the Rotterdam Study for 
whom dietary data were available (n=5434) the study population for the present 
analysis did not differ in characteristics such as age, BMI, blood pressure, income, 
level of education or nutrient intake. Vitamin supplements containing either B-
carotene, vitamin C, or vitamin E were used by 11.8% of the study population. 
Details of the association between the intake of energy-adjusted antioxidants and 
selected baseline factors are presented in table I. Since sex and age were not equally 
distributed across tertiles of dietary antioxidant intake, adjustment for age and sex was 
performed. Mean energy-adjusted dietary intakes of B-carotene were 0.84 mg/d in the 
lowest and 2.11 mg/d in the highest teltile, of vitamin C 63 mg/d in the bottom tertile 
and 170 mg/d in the top tertile and of vitamin E 18.5 mg/d and 7.8 mg/d, respectively. 
The percentage of hypercholesterolemic subjects was higher in the lowest tertile 
compared to the upper two tertiles of B-carotene intake. Percentage of current smokers 
declined across tertiles of B-carotene. A similar decline was observed for percentage of 
current smokers across tertiles of vitamin C and vitamin E (table I). In addition, mean 
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Talile 1: Levels of various baseline factors in tertiles of energy-adjusted 8-carotene, 
vitamin C, and vitamin E from food intake (adjusted for age and sex) 
Tertilc of energy adjusted dietary "-carotene intake 
1 (Lowest) 2 3 (Highest) p-value 
(n = 1601) (n = 1601) (n = 1600) for 
Energy-adjusted 8-carotene intake < 1.13 1.13 - 1.57 > 1.57 trend 
(mg/d) 
Body mass index (kg/m') 26.0 26.4 26.3 0.011 
Current smokers (%) 29.1 25.9 19.5 0.015 
Hypertension' (%) 48.4 48.3 49.0 0.610 
Hypercholesteremia} (%) 52.5 48.0 49.0 0.063 
Diabetes (%) 9.5 9.33 9.0 0.631 
Alcohol intake (mg/d) 12.1 10.9 10.9 0.021 
Antioxidative vitamin supplementl (%) 11.0 11.5 11.3 0.651 
Energy-adjusted vitamin C intake (mg/d) 93.8 108.7 132.8 <0.001 
Energy-adjusted vitamin E intake (mg/d) 11.8 13,0 14.2 <0.001 
Tertile of energy adjusted vitamin E intake 
1 (Lowest) 2 3 (Highest) p-value 
(n = 1601) (n = 1601) (n = 1600) for 
Energy-adjusted vitamin E intake (mg/d) < 10.2 10.2 - 14.2 > 14.2 trend 
Body mass index (kg/m') 26.3 26.3 26.1 0.323 
Current smokers (%) 27.6 25.4 21.7 0.007 
Hypertension l (%) 48.6 48.5 48.6 0.330 
Hypercholesteremia' (%) 51.3 48.8 49.5 0.212 
Diabetes (%) 8.0 9.8 9.7 0.170 
Alcohol intake (g/d) 14.1 10.5 9.7 <0.001 
Antioxidative vitamin supplements3 (%) 10.3 11.9 11.5 0.577 
Energy-adjusted n·carotene intake (rog/d) 1.27 1.45 1.59 <0.001 
Energy-adjusted vitamin C intake (mg/d) 104.6 112.3 118.6 <0.001 
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table J continued 
Tertile of energy adjusted dietary vitamin C intake 
1 (Lowest) 2 3 (Highest) 
(n = 1601) (n = 1601) (n = 1600) 
Energy-adjusted vitamin C intake (mg/d) <87 87 - 126 > 126 
Body mass index (kg/m' ) 26.0 26.2 26.5 
Current smokers (%) 31.4 22.8 20.0 
Hypertension l (%) 47.3 49.9 48.5 
Hypercholesteremia] (%) 52.0 49.9 47.5 
Diabetes (%) 10.2 9.6 7.9 
Alcohol intake (g/d) 12.0 11.6 10.3 
Antioxidative vitamin supplementl (%) 11.6 10.9 11.3 
Energy-adjusted B·carotene intake (mg/d) 1.19 1.44 1.71 
Energy-adjusted vitamin E intake (mg/d) 12.3 13.0 13.7 
J systolic blood pressure ~ 140 andlor diastolic blood pressure ~ 90 andlor use of antihypertensive medication 
1 serum cholesterol ~ 6.5 mmoVl 
J use of either 3·carotene, vitamin E, vitamin C, or multivitamin supplements 
p-value 
for 
trend 
0.003 
0.001 
0.381 
0.786 
0.052 
0.002 
0.482 
<0.001 
<0.001 
alcohol intake was highest for the lowest tertiles of dietary antioxidant intake. 
Although dietary antioxidant intake generally increased across tertiles of the other 
antioxidants, the increase of B-carotene and vitamin C with tertiles of vitamin E was 
very modest. Spearman correlation coefficient was highest between B-carotene and 
vitamin C (r = 0.36, P < 0.0001) and lowest between vitamin C and vitamin E (r = 
0.12, P < 0.0001). 
Beta-carotene from food sources was inversely related to risk of myocardial infarction 
after adjustment for age and sex (table 2). The relative risk for the highest compared to 
the lowest tertile was 0.59 (95% CI: 0.34,0.86, P",nd 0.009). After additional 
adjustment for body mass index, packyears smoked, equivalent household income, 
education, and alcohol intake, the observed association remained (table 2). Further 
adjustment for vitamin E and vitamin C did not alter the observed association. To 
evaluate whether the observed association of B-carotene from food sources was 
independent of anti oxidative vitamin supplements, antioxidant vitamin supplement use 
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Table 2: Risk of myocardial infarction and 95% confidence intervals according to 
energy-adjusted tcrtiles of dietary fl-carotene, vitamin C, and vitamin E 
Variable Tertiles of energy-adjusted dietary intake P value 
for trend 
1 (Lowest)' 2 3 (Highest) 
(n ~ 1601) (n ~ 1601) (n ~ 1600) 
"-carotene level 
No.ofMI 53 41 30 
energy-adjusted 
n·carotene intake (mg/d) < 1.13 1.13· 1.57 > 1.57 
Relative risk (95% CI) 
age and sex adjusted 1.00 0.74 (0.48· 1.12) 0.55 (0.34· 0.86) 0.009 
multivariate adjusted I I 1.00 0.74 (0.48· 1.12) 0.57 (0.36·0.91) 0.017 
multivariate adjusted 112 1.00 0.72 (0.47 - 1.10) 0.55 (0.34 - 0.83) 0.013 
vitamin C level 
No.ofMI 47 41 36 
energy-adjusted 
vitamin C intake (mg/d) < 87 87 - 126 > 126 
Relative risk (95% CI) 
age and sex adjusted 1.00 0.89 (0.58· 1.37) 0.84 (0.54 - 1.30) 0.446 
multivariate adjusted II 1.00 0.94 (0.58· 1.37) 0.88 (0.56 - 1.38) 0.581 
multivariate adjusted 112 1.00 1.01 (0.65 . 1.56) 1.05 (0.65 . 1.67) 0.856 
vitamin E level 
No.ofMI 33 49 42 
energy-adjusted 
vitamin E intake (lOg/d) < 10.2 10.2· 14.2 > 14.2 
Relative risk (95% CI) 
age and sex adjusted 1.00 1.41 (0.90·2.23) 1.05 (0.66· 1.69) 0.916 
multivariate adjusted II 1.00 1.40 (0.90 . 2.22) 1.07 (0.67· 1.73) 0.836 
multivariate adjusted 112 1.00 1.52 (0.97 - 2.42) 1.21 (0.75 - 1.98) 0.528 
multivariate adjusted 112 1.00 1.0 I (0.65 . 1.56) 1.05 (0.65 - 1.67) 0.856 
* reference category 
'multivariate adjusted I adjusted for age, sex, BMI, packyears smoked, equivalent household income (five 
categories, education (five categories), and alcohol intake (five categories) 
2multivariate adjusted II additionally adjusted categories of energy~adjusted 8-carotene, vitamin C, and 
vitamin E, use of multivitamin supplements 
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Table 3: Tertil.s of energy-adjusted dietary ll-carotene intake and risk of myocardial 
infarction (95% confidence interval) according to smoking status 
Variable 
cnergy~adjusted 
dietary O-carotene (mg/d) 
smokers (n ~ 1133) 
former smokers (11 ~ 1984) 
non-smokers (11 = 1685) 
* reference category 
J multivariate adjusted model 
Tertiles of energy~adjusted dietary 8-carotene 
intake 
P value 
for trend 
1 (Lowest)' 
< 1.13 
1.00 
1.00 
1.00 
2 3 (Highest) 
1.13 - 1.57 > 1.57 
0.87 (0.42 - 1.83) 0.45 (0.17 - 1.1 0) 0.058 
0.53 (0.27 - 1.01) 0.32 (0.14 - 0.66) 0.002 
1.00 (0.39 - 2.55) 1.68 (0.65 - 4.39) 0.299 
adjusted for age, sex, body mass index, packyears smoked, equivalent 
household income (5 cat.), education (5 cat.), and alcohol intake (5 cat.), 
cat. of energy-adjusted vitamin C, vitamin E and antioxidative supplements 
(dietary B-carotene, vitamin C, vitamin E or multivitamin supplements) was included 
in the multivariate model. For users of antioxidant vitamin supplements the RR was 
0.49 (95% CI: 0.2\,0.99; p = 0.008) compared to non-users. The relative risk of the 
highest compared to the lowest tertile of B-carotene intake was 0.55 (95% CI: 
0.34,0.83; p = 0.0\3). Further adjustment for dietary fats and cholesterol did not 
change the observed association. For B-carotene combined from food sources and 
supplements the age- and sex-adjusted RR was 0.49 (95% CI: 0.3\,0.86, Plrend 0.0\9) 
for the highest compared to the lowest tertile of B-carotene consumption. Multivariate 
adjustment led only to slight changes in the point estimate (highest compared to lowest 
tertile: RR = 0.50; 95% CI, 0.3\ - 0.82, P"md = 0.006). 
The association between dietary B-carotene and the risk of MI differed significantly 
according to baseline smoking status. We observed a significant inverse association 
between B-carotene and fisk of MI among former smokers and a nonsignificant one 
among current smokers (table 3). Interaction between B-carotene and smoking status 
was not observed. These associations where comparable when B-carotene from food 
and supplements were combined (table 3). We did not observe an association for 
tertiles of vitamin C intake from food sources or food sources and supplements 
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combined with risk of M! in an age- and sex-adjusted model (table 2). Also no 
association with M! was observed for tertiles of vitamin E. Stratification by smoking 
status did not alter these results. 
DISCUSSION 
In the elderly cohort of the Rotterdam Study we observed an inverse association of Jl-
carotene intake with risk of myocardial infarction independent of the use of 
antioxidative vitamin supplement use. The association observed was most evident in 
former and current smokers. Vitamin C or vitamin E from food sources or from food 
sources and vitamin supplements combined were not associated with risk ofM!. 
Before interpreting these results some methodological issues should be considered. 
Potential bias due to incomplete follow-up was unlikely to occur due to the high 
follow-up rate (94%) achieved. Ascertainment of cases was facilitated through the 
close cooperation with GPs working in the study district of Ommoord and linkage to 
the municipal health service in Rotterdam. Since all events were classified 
independently by two research physicians and subsequently by a cardiovascular 
disease expert, inaccuracies in coding of diagnosis was minimized. Because subjects 
with a previous diagnosis of myocardial infarction may have altered their diet as a 
consequence of the disease, subjects reporting hospitalization for myocardial infarction 
at baseline were excluded from the analysis. Certain methodological issues may 
weaken the observed association between dietary antioxidant vitamins and risk of 
disease. A serious limitation of studies addressing diet are inaccuracies in measurement 
of intake. Random misclassification of dietary habits may decrease the ability to detect 
associations between diet and disease as do changes in dietary habits during the 
follow-up period. Weak correlation between vitamin intake and bioavailability may 
have further diluted the observed associations. Insufficient heterogeneity of dietary 
intake in the population may make it more difficult to detect diet-disease associations. 
In the current study contrasts in the range of dietary intake of the lowest to the highest 
tertile were modest for Jl-carotene, vitamin E, and vitamin C, i.e. between-person 
variation in the current study was modest. In addition, Jl-carotene, vitamin E, and 
vitamin C supplements were only used by a small propOltion of the population. Figures 
were 0.6% fot' Jl-carotene, 1.4% for vitamin E, and 5.7% fot' vitamin C. Inclusion of 
138 
Dietary antioxidants and myocardial infarction 
supplemental dietary intake somewhat strengthened the association between Jl-carotene 
intake and risk ofM!. 
Observational studies have indicated that Jl-carotene may exert a protective effect on 
incidence and mortality of coronary heart disease, though the evidence is not 
conclusive lO, Studies focusing on plasma or adipose tissue concentration of Jl-carotene, 
however, yielded in general consistent results, Biologically plausible mechanisms such 
as the antioxidant potential to scavenge free radicals21 and the ability to inhibit LOL 
oxidation22 supported these findings, In middle-aged populations, subjects with low 
plasma concentration of Jl-carotene were found to have an elevated risk for angina 
pectoris I and of MI23, while the latter appeared to be limited to smokers with low Jl-
carotene serum levels, Risk of MI was also considerably elevated in current smokers 
with low Jl-carotene adipose tissue concentrations24, In contrast, an inverse association 
between total plasma carotenoids and risk of fatal coronary heart disease and non-fatal 
MI in hyperlipidemic men was present in non-smokers2s, Studies focusing on the 
elderly showed either no association between carotenoid concentrations and dietary 
intake and risk of coronary heart disease7 or an inverse association between carotene-
containing fruit and vegetables and the risk of cardiac death due to MI and eROS, In 
the current study, we observed a significant protective effect of increased Jl-carotene 
intake with risk of MI in the elderly population of the Rotterdam Study that was most 
evident in current and former smokers (table 3), 
The effects of Jl-carotene found in our study and other observational studies are at odds 
with recent findings of large supplement intervention trials for chronic disease 
prevention26,3o, These trials reported either no effect of Jl-carotene supplementation on 
the incidence of cardiovascular disease27 or a slight increase in cardiovascular 
mortality26,28,3o, However, only one of these trials was designed to address 
cardiovascular disease in particular27, To explain the disparity between results obtained 
by observational and intervention studies several reasons were proposed, 
Administration may have been too late in the cancerogenic or atherogenic process (a 
protective effect of Jl-carotene may be most beneficial in an early phase of the 
cancerogenic or atherosclerotic process) and inadequate duration and dosage of 
supplement use has been discussed3l ,32, Adverse effects of supplemental Jl-carotene on 
plasma concentrations of other carotenoids have been reported33,34 and there is limited 
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evidence that B-carotene could function as a prooxidant at higher concentrations31 . The 
associations found, however, may not be ascribed to B-carotene exclusively. Possibly, 
B-carotene could only be a marker for some other substance in B-carotene containing 
foods or to dietary patterns and lifestyle behaviour closely linked to a diet rich in 
vegetables and fruit that is associated with reduced risk of coronary heart disease. A 
habitual diet rich in B-carotene-containing products may thus also protect against 
coronary heart disease among the elderly. 
In the current study, we did not observe an association of dietary vitamin C and risk of 
myocardial infarction. Our results are in line with several other studies that did not find 
vitamin C to be associated with a protective effect as summarized by Jha et al. lo. In 
studies in the elderly, some investigators observed an inverse association of high 
dietary vitamin C intake and high plasma levels 7 with cardiovascular disease, whereas 
others observed no association with dietary and plasma vitamin C17 or use of vitamin C 
supplements9. Results of a Finnish study linking vitamin C deficiency to increased risk 
ofM!18 suggest that suboptimal vitamin C concentrations elevate the risk ofM!. These 
findings are supported by experimental data showing that detectable lipid peroxidation 
starts only after all ascorbate has been completely used Up19. The most consistent and 
reliable effect of antioxidants and fatal and nonfatal cardiovascular disease in middle-
aged populations in the literature has been seen with vitamin E. The relations have 
been seen both with supplementation and with relatively high levels of dietary 
intake l.4.8.'O that are sustained for two or more years'·3. The relative risk reduction for 
various cardiovascular end points ranged from 31% to 65%10. In the current study, 
however, we did not observe an association between dietary vitamin E and M!. This is 
consistent with most studies investigating the association between dietary and plasma 
vitamin E and risk of heart disease mortality in the elderly7. Only one study observed 
an inverse association of vitamin E supplementation on coronary heart disease risk in 
the elderl/. 
In summary, we found an inverse association of high dietary B-carotene intake on risk 
of myocardial infarction in an elderly population. Whether this association may be 
ascribed to B-carotene exclusively, to a diet rich in B-carotene containing products, or 
to dietary patterns and lifestyle behaviour closely linked to a diet rich in vegetables and 
fruit remains to be elucidated. 
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PRO- AND ANTIOXIDANTS IN ATHEROSCLEROSIS AND CORONARY HEART DISEASE 
Free iron - a catalyst of the production of free radicals - has been implicated in 
ischemic myocardial damage and lipid peroxidation. Plausible hypotheses as to how 
free iron may accelerate the progression of atherosclerosis 01' contribute to myocardial 
injury after an ischemic event have been generated from basic research. Direct 
evidence that high iron stores or high iron intake increase the incidence of coronary 
heart disease in humans, however, is limited. So far the strongest supporting evidence 
for iron as a coronary heart disease risk factor stems from a cohort study of eastern 
Finnish men, where high levels of serum ferritin and dietary iron were positively 
associated with incidence of myocardial infarction I. Furthermore, serum ferritin was 
observed to be one of the strongest indicators of presence and progression of carotid 
artery disease,,3 and blood donation, depleting iron stores in blood donors, was 
associated with reduced risk of myocardial infarction 4 and cardiovascular disease'. 
However, subsequent studies investigating whether iron status or dietary iron intake 
are associated with increased risk of myocardial infarction or coronary heart disease 
have not provided consistent results·· I '. The results presented in the current thesis 
suggest that elevated serum ferritin (Chapter 3.2) and high dietary heme iron intake 
(Chapter 3,3) are associated with increased risk of myocardial infarction, Most studies 
did not discriminate between non-fatal and fatal myocardial infarction, although iron 
may be directly involved in the myocardial injury caused by ischemia and reperfusion, 
Indirect evidence that iron is involved in reperfusion injury after an ischemic event has 
been provided by results of animal experiments showing that free radicals are 
generated after restoration of blood flow to ischemic myocardium I., contributing to the 
subsequent myocardial injuryl7, Experiments with an iron chelatorl8,19 or iron-
overloading'O in animals emphasize this notion, It has subsequently been suggested 
that elevated iron stores may have an adverse effect on the survival after a myocardial 
infarction'l, Our observation of a considerably more pronounced association between 
heme iron intake and fatal myocardial infarction may be supportive of this hypothesis, 
even though the number of fatal cases in the current study was small (Chapter 3.3). 
Besides iron, copper and ceruloplasmin have been suggested to be independent risk 
factors for coronary heart disease8,,,.,., Recent experimental studies demonstrating the 
ability of ceruloplasmin to oxidatively modify low-density lipoprotein",28 seem to 
underline this idea. However, the question has been raised whether elevated 
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ceruloplasmin is not merely an indicator of inflammation given its acute-phase protein 
property. Our results suggest that a substantial part of the increased risk of myocardial 
infarction associated with elevated levels of serum ceruloplasmin may be attributed to 
inflammation processes (Chapter 3.1), supporting the conception that serum 
ceruloplasmin may reflect low-level inflammation involved in the coronary heart 
disease process. The remaining elevated risk may be due to other properties of 
ceruloplasmin, like its pro-oxidant activity. Since serum ferritin is regarded as an 
indicator of chronic inflammation, we aimed to circumvent the problem of 
misclassification of iron status with respect to disease by a priori exclusion of subjects 
with high levels of C-reactive protein, respectively elevated erythrocyte sedimentation 
rate from analysis (Chapter 3.2). This provision, however, may not have ruled out the 
possibility that our results on serum ferritin and myocardial infarction may at least to a 
certain extent reflect low-level inflammation involved in the coronary heart disease 
process. 
Observational studies have indicated that dietary antioxidants may exert a protective 
effect on incidence and mortality of cardiovascular disease29.37 and suggest that 
antioxidative vitamins may be able to reduce atherosclerosis3"40. The most consistent, 
reliable, published beneficial effects of antioxidants on fatal and nonfatal 
cardiovascular diseases in middle-aged populations have been observed with 
vitamin E29.32.35. Beta-carotene and vitamin C intake have been less clearly associated 
with a reduced risk4!.42. Recent findings from supplement intervention trials only partly 
support these observations. Vitamin E supplementation in subjects with previous 
cardiovascular disease was reported to be associated with less coronary artery lesion 
progression43 and reduced risk of cardiovascular death and non-fatal myocardial 
infarction4!, but also with non-significantly increased risk ofCHD44 and CVD deaths43• 
For vitamin C no effect of supplementation on reduction of progression in coronary 
artery lesion 40 was seen and for B-carotene either no effect on the incidence of 
cardiovascular disease 44 or a slight increase in cardiovascular mortality 45-47 was 
reported. Further results from ongoing intervention trials testing antioxidants 48·50 in 
cardiovascular disease prevention may be able to help clarifYing associations between 
antioxidants and cardiovascular disease. The results presented in Chapter 4.3 of this 
thesis are supportive of a beneficial effect of dietary B-carotene intake on risk of 
myocardial infarction in an elderly popUlation. For dietary vitamin C and vitamin E, 
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however, no beneficial effect on risk of myocardial infarction was observed. Using a 
nested case-control design, we subsequently investigated whether serum carotenoids 
were associated with aortic atherosclerosis assessed by presence of calcified plaques in 
the abdominal aorta. Our results suggest that among the major sel1lm carotenoids, 
Iycopene may play a protective role in the development of atherosclerosis. For 
concentrations of serum a-carotene, j3-carotene, j3-cryptoxanthin, lutein, or zeaxanthin 
no association with presence of aortic atherosclerosis was observed (Chapter 4.1). 
Notwithstanding the objections that different mechanisms may operate on the 
development of aortic atherosclerosis and myocardial infarction, one might have 
expected to observe serum B-carotene to be inversely associated with a011ic 
atherosclerosis. A possible explanation for the absence of such a relationship might be 
that the effect observed for dietary B-carotene on myocardial infarction risk may be 
attributed rather to dietary Iycopene or to some other substance in foods containing this 
carotenoid or to dietary patterns and lifestyle behaviour closely linked to a diet rich in 
vegetables and fruit associated with reduced risk of coronary heart disease. 
A common condition among the elderly is peripheral artery disease. Cross-sectional 
analysis allowed us to investigate whether elevated dietary antioxidant intake was 
associated with a lower prevalence of peripheral artery disease (Chapter 4.2). We 
observed sex-specific risks: dietary B-carotene and vitamin E were inversely associated 
with peripheral artery disease in men, whereas dietary vitamin C was inversely 
associated with peripheral artery disease in women. The association of vitamin C with 
peripheral artery disease in women remained after multivariate adjustment. Possibly 
the difference between men and women is partly explained by differences in smoking 
history. Stratification by smoking status indicated that current or former smokers 
benefit most of elevated dietary antioxidant intake. 
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Exposure measurement 
Dietary assessment 
General Discussion 
A serious limitation of studies addressing diet are inaccuracies in measurement of 
intake. Use of food composition tables will invariably introduce further measurement 
error. This is due to the assumption that the nutrient content of a specific food is 
approximately constant, non-random sampling of foods for the chemical analysis, 
errors in the chemical analysis themselves, incorrect use of values from other food 
composition tables, and missing data51 • For iron and the antioxidant (pro)vitamins, the 
errors are probably larger than for macronutrients, because the variation in the vitamin 
and mineral content of foods is generally much greater than the variation in 
macronutrient content of foods51 , and also because many values, and especially those 
for vitamins in food composition tables are determined with less reliable analytical 
techniques than those currently available52• 
Results of studies on diet and disease are often difficult to interpret unless the method 
used to measure diet has been validated in a population reasonably similar to that being 
investigated. Without documentation of validity, null associations could simply be due 
to lack of variation in dietary exposure in the study population or the inability of the 
dietary assessment method to detect existing differences in diet. Dietary assessment in 
the cohort of the Rotterdam Study was conducted by a semiquantitative food frequency 
questionnaire (SFFQ) adapted to the elderly. Adaptation of the SFFQ aimed at 
completion of the dietary assessment within a limited time-frame and at ease in 
administration. This was achieved by use of a two-step approach consisting of a simple 
self-administered food list-based questionnaire that was completed at home (completion 
time: 20 minutes) and a subsequent stmctured interview with a dietitian (time 
allocated: 20 minutes) based on the contents of the completed questionnaire (Chapter 
2.2). Validity of the modified SFFQ was assessed in a subsample of 80 men and 
women (55 - 75 years) of the Rotterdam Study. Multiple food records (FR) collected 
over a one year period served as reference method. 24-h urine urea was used as indirect 
marker for protein intake. For evaluation of presence of gross underreporting of energy 
we applied the Goldberg cut-off3. Measures of concordance used to assess the ability 
of the SFFQ to adequately rank nutrients encompassed the correlation coefficient, 
cross-classification by quintile category, the difference between means, and the ratio of 
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SFFQ to FR (Chapter 2.1). Our results indicated relatively good validity and were 
similar to results in other elderly"·62 and middle_aged63.76 populations. 
Dietary assessment is often assumed to reflect long-term intake. The time period 
addressed by the SFFQ applied in the elderly cohort of the Rotterdam Study was one 
year as for most other (S)FFQs. For the original version of the SFFQ Goldbohm et a\.77 
determined the 5-year reproducibility, indicating the potential of a single SFFQ 
measurement to rank subjects according to nutrient intake. Since elderly people tend to 
have fairly definite likes and dislikes, it is likely that the diet of an older person is more 
uniform compared to a younger person. Thus, use of a single dietary assessment as a 
proxy for long-term dietary intake seems to be justified. However, if with prolonged 
follow-up dietary exposure tends to change over time and if recent exposure is relevant 
to risk of disease, misclassification of dietary exposure increases over time. Repeated 
assessment of diet during the follow-up period would allow for a more accurate 
measure of diet during different time periods. 
Conscious or unconscious underreporting can have a profound effect on the quality of 
the dietary data. Results of various studies employing different methodologies and 
investigating different populations demonstrated that underestimation of energy intake 
seem to be a common problem of questionnaire or recording based measurement 
. 78.8°0 '1'1 'dd' h lIlstruments . verwelg It, lema e sex, age, attame e ucatlOn are among t e 
variables discussed to independently predict underreporting. For the elderly cohort of 
the Rotterdam Study we observed a significant association between age and the ratio of 
energy intake to estimated basal metabolic rate (EIIBMR) suggesting underrepOliing to 
be present more often in younger subjects. EIIBMR was furthermore observed to be 
significantly inversely associated with body mass index independent of age (Chapter 
2.2). Some studies reported that some food items are particularly susceptible to be 
underreported81 .83. If celiain items are related to disease, reporting bias may lead to 
differential misclassification of dietary intake and generate misleading associations 
between dietary exposure and the disease under stud/'. To compare nutrient intakes of 
subjects independent of variations in energy intake, to control for confounding, and to 
d t . . 8' 85 'd I' d' d . re uce ex raneous vanahon' we perlorme ana YS1S on energy-a ~uste nutnents. 
Energy-adjusted nutrients were obtained by regressing individual nutrient intakes on 
the respective total energy intake86. 
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Biochemical illdicators o/diet 
The studies on dietary intake of pro- and antioxidants of this thesis were 
complemented by studies applying biochemical indicators of diet. Requirement for a 
valid biochemical indicator is not only sensitivity to intake, but it should also reflect 
the cumulative effect of diet over an extended period of time"'. Biochemical indicators 
can be used as a surrogate for actual dietary intake in studies of disease occurence, as 
advocated in Chapter 4.1 where we investigated the association between serum 
carotenoids and aortic atherosclerosis. A related use of biochemical indicators is to 
predict disease risk, irrespective of whether the level of the biochemical measure is 
determined by dietary intake or other factors which is the case when tissue levels are 
highly regulated and poorly reflect dietary intake. Our studies on serum ferritin 
(Chapter 3.2) and ceruloplasmin (Chapter 3.1) are good examples for this type of 
studies. Serum studies are considered to be potentially more objective since they are 
not subject to the errors in measuring diet, e.g. under- or overreporting of foods or 
nutrients by participants. Still, one has to be aware that in general, biochemical 
measures are almost always subject to the same problems of misclassification and bias 
as measures of diet"'. The power of a single measurement to predict long-term average 
levels or to estimate long-term dietary intake is low, if the within-person variation of 
the biochemical indicator of interest is large. Further issues which need to be taken into 
consideration are measurement variation (between-person variation), sampling of 
fasting or nonfasting blood, or whether the biochemical measures are affected by 
storage time or temperature. As for dietary measures repeated measurements will 
reduce non-differential error, i.e. will account for individual changes and secular trends 
in nutrient intake. Agreement in effect estimates between independent measures, e.g 
diet and biochemical indicators of diet with respect to risk allow greater confidence in 
the validity of both sets of results as it is the case with our results on dietary heme iron 
(Chapter 3.3) and serum ferritin (Chapter 3.1) with respect to risk of myocardial 
infarction. 
Outcome measurement 
Asymptomatic atherosclerosis and myocardial infarction were the outcome 
measurements applied in the studies of this thesis. In our studies on dietary 
antioxidants we have been able to investigate dietary intake, respectively serum levels 
with regard to both, atherosclerosis and myocardial infarction. Our results concerning a 
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modest inverse association of serum lycopene concentrations with calcified plaques of 
the aorta (asymptomatic atherosclerosis) and a significantly inverse association of 
dietary ll-carotene with myocardial infarction are supportive of the hypothesis that 
dietary antioxidants, i.e. carotenoids are beneficial in both the prevention of 
atherosclerosis and coronary heart disease. Myocardial infarction was the only 
endpoint for our studies on measures of iron status. Our results of an increased 
myocardial infarction risk with elevated dietary heme iron and serum ferritin 
concentrations are supportive of the iron hypothesis. Although we have not been able 
to present results on measures of iron status and atherosclerosis, recent results 
observing serum ferritin to be a risk factor for presence and progression of carotid 
artery disease") suggest iron status to be considered a risk factor in atherosclerosis and 
coronary heart disease. 
Fatal and nonfatal outcomes are often pooled in epidemiological studies. In our follow-
up study on dietary iron intake and myocardial infarction we were able to demonstrate 
that risk of myocardial infarction with dietary heme iron intake was considerably more 
pronounced in fatal than non-fatal cases. Although the sample size for this sub-analysis 
was small, the differing results between fatal and non-fatal cases of myocardial 
infarction may suggest that high iron stores may affect the fatality rate of myocardial 
infarction apart from an effect on the incidence of myocardial infarction". Numbers in 
our study on serum ferritin and myocardial infarction were, however, too small to 
differentiate between fatal and nonfatal myocardial infarction. In future studies on iron 
status and coronary heart disease, respectively cardiovascular disease, it may be 
worthwhile to discriminate between fatal and non-fatal events. 
Effect modification 
Investigation of interaction may point at the existence of high risk groups for whom 
modification of risk factors may be particularly beneficial. Biological interaction is 
considered present when the joint effect of two risk factors is more, or less, than the 
sum or the multiple of the effects of each individual risk factor. Biological interaction 
indicates that two risk factors are not acting independently, but have a synergistic or 
antagonistic effect on the outcome. The effects of pro- and antioxidants on 
cardiovascular disease described in the studies of this thesis were studied in older 
people. A potential modifying effect of age may affect generalizability of the results of 
this thesis to the general population. In all studies of this thesis we observed 
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susceptibility to smoking status. Higb dietary intake of antioxidants or elevated levels 
of serum carotenoids were observed to be most beneficial in current or ever smokers. 
For the same group of subjects, higb dietary heme iron intake or elevated serum ferritin 
levels were observed to have a harmful effect. Furthermore, in the case of dietary heme 
iron and serum ferritin, stratification by hypertension, hypercholesterolemia, or 
diabetes modified the association considerably suggesting that dietary heme iron or 
serum ferritin may adversely affect coronary heart disease risk only in the presence of 
other risk factors. 
Future Research 
Generally, investigation of dietary determinants of cardiovascular disease has mainly 
focused on single nutrients such as antioxidants. Conflicting evidence regarding the 
potential of single nutrients in the prevention of atherosclerosis and coronary events 
raises the question whether research should only be focused on nutrients. Certainly, an 
optimal approach to epidemiologic analyses will employ both, research on nutrients 
and foods, strenghtening the case for causality when an association is observed with 
overall intake of a nutrient and also with more than one food source of that nutrient. 
Conducting randomized trials on foods, such as fruit and vegetables, in addition to the 
supplement intervention trials currently under way may help to clarifY the relation of 
nutrients and foods to cardiovascular disease. With respect to fruit and vegetables, until 
then, from a public health point of view, recommendations for a diet rich in fruit and 
vegetables should also be extended to the elderly population. 
With respect to iron stores (e.g. serum ferritin levels) or dietalY iron intake, further 
research should be directed towards investigation of possible harmful effects of iron on 
coronary heart disease in the presence of known modifiable risk factors such as 
cigarette smoking or hypercholesterolemia and on the effect of elevated iron stores on 
case fatality. Clinical trials of interventions to lower body iron stores such as blood 
donation for prevention of coronary events have already been suggested to clarifY the 
role of iron in coronary heart disease'. Genetic susceptibility to hemochromatosis is a 
related issue and recent work suggests heterozygosity for the HFE Cys282Tyr 
polymorphism88 to be an independent risk factor for cardiovascular mortality (D.E. 
Grobbee, personal communication), underlining that research on genetic susceptibility 
may further extend our knowledge on effects of nutrients on health and disease. 
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SUMMARY 
Diet is an important aspect of lifestyle and may affect life expectancy, morbidity and 
mortality of older adults. This thesis focuses on the deleterious and beneficial effects of 
dietary pro- and antioxidant intake and its effects on the development of 
atherosclerosis and coronary heart disease in the elderly cohort of the Rotterdam study. 
The overall aim of the conununity based prospective Rotterdam Study is to investigate 
the incidence of and the risk factors for chronic and disabling diseases. 
Following the introductory chapter we examined in chapter 2 of this thesis the dietary 
assessment method applied to the elderly population of the Rotterdam Study. Chapter 
2.1 reports on the relative validity of nutrient intake estimated by an adapted 
semiquantitative food frequency questionnaire (SFFQ) for dietary assessment in the 
elderly compared to 15-d food records and protein intake estimated from protein 
excretion. In general, the ability of the SFFQ to adequately rank subjects according to 
their dietary intake was found to be comparable to results of previous validation 
studies in middle-aged and elderly populations. This supports the idea that age has 
little adverse effects on the validity of questionnaires if administered appropriately. We 
applied the SFFQ across a wide age range in an elderly population, and reported 
estimates of nutrient intake and factors possibly influencing intake (Chapter 2.2). The 
SFFQ facilitated collection of data on dietary habits in the elderly within a limited time 
frame, making the method an attractive instrument for dietary assessment in large-scale 
epidemiologic studies in the elderly. 
Chapter 3 discusses the effects of prooxidants on coronary heart disease in the 
Rotterdam Study. Free iron has been implicated in lipid peroxidation and ischemic 
myocardial damage in the literature. In a nested case-control setting we investigated 
whether serum ceruloplasmin and iron parameters - ferritin, transferrin, serum iron, 
and dietary iron - were related to myocardial infarction. Serum ceruloplasmin was 
significantly associated with increased myocardial infarction risk. Taking markers of 
inflammation (C-reactive protein, white blood cell count) into account reduced the 
excess risk for myocardial infarction by 33% suggesting that part of the observed risk 
associated with high levels of ceruloplasmin can be attributed to its property as acute 
phase protein (Chapter 3.1). For serum ferritin levels above 200 1lg/1 we observed an 
odds ratio of 1.82 (95% confidence interval 0.88-3.74), whereas for serum iron, 
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transferrin, and total dietary iron no association with myocardial infarction was seen. 
Heme iron intake, however, seemed to be a coronary heart disease risk factor (Chapter 
3.2). In a subsequent follow-up analysis dietary heme iron was associated with a two-
fold increased risk of myocardial infarction (Chapter 3.3). Distinction between fatal 
and non-fatal cases showed risk of myocardial infarction to be more pronounced in 
fatal cases suggesting that high iron stores may affect the fatality rate of myocardial 
infarction. 
Chapter 4 describes the effects of antioxidants on coronary heart disease. In the study 
described in Chapter 4.2 we examined cross-sectionally whether dietary antioxidants 
were associated with peripheral artery disease and found vitamin C to be inversely 
associated with peripheral artery disease in women, and p-carotene and vitamin E in 
men. Next, we investigated whether high circulating levels of the major serum 
carotenoids - a-carotene, p-carotene, P-cryptoxanthin, lutein, Iycopene, and zeaxanthin 
- were associated with atherosclerosis assessed by the presence of calcified plaques in 
the aorta (Chapter 4.1). There was a modest inverse association between age- and sex-
adjusted serum Iycopene and aortic atherosclerosis, but no association was observed 
for concentrations of serum a-carotene, p-carotene, P-cryptoxanthin, lutein, and 
zeaxanthin. Finally, in the study described in Chapter 4.3 we investigated whether 
dietary antioxidants were related to risk of myocardial infarction. We observed dietary 
Jl-carotene to be inversely associated with myocardial infarction. If p-carotene intake 
from food sources and supplements was combined, the inverse relation with risk of 
myocardial infarction was slightly more pronounced. 
Smoking status - current or ever cigarette smoking - had a profound effect on the 
results of our studies on dietary and serum pro- and antioxidants and coronary heart 
disease. In current or ever smokers high heme iron intake or elevated serum ferritin 
levels had a hazardous effect on coronary heart disease risk, whereas high dietary 
intake of dietary antioxidants, mainly vitamin C or p-carotene, or high serum levels of 
lycopene showed a beneficial effect on coronary heart disease risk especially in 
smokers. 
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SAMENVATTING 
Voeding maakt een belangrijk onderdeel uit van de leefstijl en is mogelijk van invloed 
op de levensverwachting en het voorkomen van ziekte een sterfte bij OlIderen. Dit 
proefschrift richt zich op de schadelijke en gunstige effecten van de inneming van pro-
en antioxidanten op de ontwikkeling van atherosclerose en coronaire hartziekten. Dit is 
onderzocht bitmen het 'Erasmus Rotterdam Gezondheid en Ouderen' (ERGO) 
onderzoek. Het prospectieve ERGO-onderzoek (in het Engels: The Rotterdam Study) 
heeft als doel het ontstaan van chronische en invaliderende ziekten en de risicofactoren 
daarvoor binnen een algemene populatie van ouderen te bestuderen. 
In hoofdstuk 2 van dit proefschrift hebben we de meting van de voedingsinname 
bestudeerd welke is toegepast bitmen de oudere populatie van het ERGO-onderzoek. 
Hoofdstuk 2.1 gaat over de relatieve validiteit van de nutrientinneming bepaald met 
een, voor ouderen aangepaste, semikwantitatieve voedselfrequentievragenlijst (SFFQ) 
ten opzichte van een IS-daagse opschrijfmethode en de uit de excretie geschatte 
eiwititmeming. De mate waarin de SFFQ in staat was om personen adequaat te 
rangschikken naar hun voedselinneming was vergelijkbaar met bevindingen uit eerdere 
validatie-onderzoeken in populaties van middelbare of oudere leeftijd. Dit ondersteunt 
het idee dat een vragenlijst ook op oudere leeftijd valide is wanneer deze op juiste 
wijze wordt afgenomen. De SFFQ is toegepast binnen een groep ouderen met een 
breed leeftijdspectnlm. De geschatte inname van nutrienten in deze populatie en 
factoren welke deze belnvloeden worden gerapporteerd in hoofdstuk 2.2. De SFFQ 
vereenvoudigt het meten van voedingsgewoonten bij ouderen in een korte tijdsperiode 
en vormt daarmee een aantrekkelijke voedingsmeetmethode voor grootschalig 
epidemiologisch ouderenonderzoek. 
Hoofdstuk 3 beschrijft de rol van pro-oxidanten bij het ontstaan van corona ire 
hartziekten binnen het ERGO-onderzoek. Er zijn aanwijzingen in de literatuur dat vrije 
ijzerionen betrokken zijn bij de vetzuurperoxidatie en ischemische schade aan het hart. 
In een genest patient-controle-onderzoek zijn het serumceruloplasmine en parameters 
van de ijzerstatus - ferritine, transfen'ine en serumijzer - bestudeerd in relatie tot het 
optreden van een myocardinfarct. Ceruloplasmine in het serum was significant 
geassocieerd met een verhoogd risico op myocardinfarct. Na adjustering voor 
onstekingsparameters ('C-reactive protein' en aantal witte bloedceUen) nam het 
toegenomen risico op een myocardinfarct met 33% af, hetgeen sllggereert dat de 
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waargenomen relatie deeIs verklaard kan worden door de rol van ceruloplasmine als 
acute-fase-eiwit (Hoofdstuk 3.1). Bij een serumgehalte van ferritine boven 200 mg/I 
werd een odds-ratio van 1.85 (95% betrouwbaarheidsinterval 0.88-3.74) met 
myocardinfarct waargenomen, tenvijl voor serumijzer en transferrine geen associatie 
werd gevonden. Haemijzer Iijkt een risicofactor voor coronaire hartziekten te zijn 
(Hoofdstuk 3.2). Vervolgens was in een follow-up onderzoek haemijzer in de voeding 
geassocieerd met een verdubbeld risico op een myocardinfarct. Dit verband bleek meer 
uitgesproken voor fatale dan voor niet-fatale infarcten (Hoofdstuk 3.3). Oit suggereert 
dat een grote ijzervoorraad in het Iichaam de sterftekans na een myocardinfarct 
vergroot. 
Hoofdstuk 4 beschrijft een onderzoek naar antioxidanten in relatie tot coronaire 
hartziekten. In een cross-sectioneel onderzoek, beschreven in hoofdstuk 4.2, werd de 
relatie tussen antioxidanten in de voeding en perifeer vaatlijden bestudeerd. Er werd 
een omgekeerd verband waargenomen tussen perifeer vaatlijden en inneming van 
vitamine C in vrouwen en /I-caroteen en vitamine E in mannen. Daarna onderzochten 
we of hoge serumconcentraties van carotenolden, a-caroteen, /I-caroteen, 
/I-cryptoxanthine, lutelne, Iycopeen en zeaxanthine, geassocieerd waren met 
atheroscIerose, gemeten door middel van detectie van gecalcificeerde plaques 
(Hoofdstuk 4.1). De aanwezigheid van atherosclerose in de aorta vertoonde een matig 
sterk, omgekeerd verband met het lycopeengehaIte in het serum, maar niet met de 
serumconcentraties van a-caroteen, /I-caroteen, /I-cryptoxanthine, lutelne en 
zeaxanthine na adjustering voor leeftijd en geslacht. Tenslotte onderzochten we in 
hoofdstuk 4.3 of antioxidanten in de voeding een rol spelen bij het ontstaan van een 
myocardinfarct. De inneming van /I-caroteen via de voeding verlaagde de kans op een 
myocardinfarct. Het beschermend effect werd iets versterkt wanneer b-caroteen uit 
voedingssupplementen in de analyse werd meegenomen. 
Roken, zowel huidig roken als het ooit gerookt hebben van sigaretten, bleek onze 
bevindingen aangaande pro- en antioxidanten in relatie tot coronaire hartziekten sterk 
te belnvloeden. In (ex-) rokers was het risico op coronaire hartziektell toegenomen bij 
een hoge inneming van haemijzer via de voeding en een verhoogd serum-
ferritinegehalte, tenvijl een hoge inneming van antioxidanten via de voeding met name 
/I-caroteen en vitamine C en een hoog serumgehalte van Iycopeen beschermde vooral 
in rokers tegen coronaire hartziekten. 
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ZUSAMMENFASSUNG 
Em~hrung ist ein wichtiger Teil des Lebensstils von dem man annimmt, daB er die 
Lebenserwartung, Morbidittit und Mortalita! alterer Menschen beeinfluBt. Die 
vorliegende Dissertation beschiiftigt sich mit nachteiligen und vorteilhaften Effekten 
der nutritiven Aufuahme von Pro- bzw. Antioxidantien, sowie deren EinfluB auf die 
Entstehung von Atherosklerose und koronarer Hel'zerkrankung in del' Kohorte der 
Rotterdam-Studie. Ziel der Rotterdam-Studie ist die Untersuchung von Inzidenz und 
Risikofaktoren chronischer und degenerativer Erkrankungen bei alteren Person en. 
1m AnschluB an das einleitende Kapitel beschiiftigt sich Kapitel 2 dieser Dissertation 
mit der Emiihrungserhebungsmethode, die bei der alteren Population der Rotterdam-
Studie angewendet wurde. Kapitel 2.1 behandelt die relative Validitiit del' 
Niihrstoffaufuahme aus dem angepaBten semiquantitativen Emiihrungshaufigkeits-
fragebogen (SFFQ) im Vergleich zur N~hrstoffaufnahme aus Em~hrungsprotokollen 
(insgesamt 15 Tage), sowie zu der aus der Proteinausscheidung geschatzten 
Proteinaufuahme. Die Fiihigkeit des SFFQ, Studienteilnehmer adiiquat anhand ihrer 
Nahrstoffaufuahme zu klassifizieren, war mit den Ergebnissen publizierter 
Validierungsstudien in Populationen mittleren und hilheren Alters vergleichbar. Dies 
stUtzt die These, daB Alter lediglich einen geringen Effekt auf die Validitat solchel' 
Fragebilgen hat, sofem diese in geeigneter Form angewendet werden. Kapitel 2.2 
beschreibt die Anwendung des SFFQ tiber eine groBe Altersspanne in der alleren 
Population der Rotterdam-Studie, macht Angaben tiber die geschiitzte 
Nahrstoffaufuahme und untersucht Faktoren, die diese Nahrstoffaufuahme 
beeinflussen. Der eingesetzte Ernahrungsfragebogen erleichterte die El'hebung von 
Ernahrungsdaten innerhalb einer vorgegebenen Zeitspanne bei alteren Pel'sonen, so daB 
er als adiiquates Instrument filr Ernahrungserhebungen in groB angelegten 
epidemiologischen Studien betrachtet werden kann. 
Kapitel 3 beschreibt die Untersuchungen zum Effekt von Prooxidantien auf koronare 
Herzerkrankungen in der Rotterdam-Studie. In del' Literatur wUl'de frei verfilgbares 
Eisen in Verbindung mit Lipidperoxidation und ischamischen Myokardschiidigungen 
gebracht. In einer in eine prospektive Kohortenstudie eingebetteten Fall-Kontrollstudie 
untersuchten wir, inwiefern Coeruloplasmin und verschiedene Eisenparameter 
(Ferritin, Transferrin, Serumeisen und Eisenaufuahme) mit dem Risiko eines 
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